Abiopharma

News bot June 18, 2026, 5:18 p.m.

📋 PFIZER INC (PFE) - Regulatory Update

Filing Date: 2026-06-18

Accepted: 2026-06-18 13:17:22

Event Type: Regulatory Update

Event Details:

PFIZER INC (PFE) Announces Regulatory Update PFIZER INC (PFE) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

🔬 Clinical Development Pipeline (PFIZER INC):

Product	Type	Development Stage	Therapeutic Area	Source
Premarin®/MPA currently marketed product	Other	Phase PHASE1	Menopause	ClinicalTrials.gov
anti-COVID19 mRNA-based vaccine (BNT162b2, Comirnaty®, commercialized by Pfizer)	Other	Phase PHASE3	Coronavirus Disease 2019 (Covid19)	ClinicalTrials.gov
Paxlovid	Other	Phase PHASE1	Biological Availability	ClinicalTrials.gov
PF-07799933 film-coated tablets following rabeprazole pretreatment fasted	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
23-valent pneumococcal conjugate vaccine (vaccine)	Other	Phase PHASE2	HIV Infections	ClinicalTrials.gov
meningococcal B rLP2086 vaccine candidate	Other	Phase PHASE1	Meningitis, Meningococcal	ClinicalTrials.gov
7-valent pneumococcal conjugate vaccine (vaccine)	Other	Phase PHASE2	HIV Infections	ClinicalTrials.gov
Prazosin (drug)	Drug	Phase PHASE2	Hepatitis C, Chronic	ClinicalTrials.gov
Talazoparib	Other	Phase PHASE2	Ovarian Cancer	ClinicalTrials.gov
ZEN003694	Other	Phase PHASE2	Ovarian Cancer	ClinicalTrials.gov
PF-07799933 film-coated tablets fasted	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07799933 film-coated tablets with PF-07799544 fed	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07799933 film-coated tablets with PF-07799544 fasted	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07799933 tablets with PF-07799544 fasted	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
IV [14C] PF-07799544	Other	Phase PHASE1	Healthy Male Volunteers	ClinicalTrials.gov
Oral [14C] PF-07799544	Other	Phase PHASE1	Healthy Male Volunteers	ClinicalTrials.gov
Oral Unlabeled PF-07799544	Other	Phase PHASE1	Healthy Male Volunteers	ClinicalTrials.gov
Placebo	Other	Phase PHASE3	Respiratory Syncytial Virus (RSV)	ClinicalTrials.gov
RSVpreF	Other	Phase PHASE3	Respiratory Syncytial Virus (RSV)	ClinicalTrials.gov
PF-07275315-dose 3	Other	Phase PHASE2	Moderate to Severe Chronic Obstructive Pulmonary Disease	ClinicalTrials.gov
PF-07275315-dose 2	Other	Phase PHASE2	Moderate to Severe Chronic Obstructive Pulmonary Disease	ClinicalTrials.gov
PF-07275315 dose 1	Other	Phase PHASE2	Moderate to Severe Chronic Obstructive Pulmonary Disease	ClinicalTrials.gov
Ritlecitinib lower dose	Other	Phase PHASE3	Severe Alopecia Areata	ClinicalTrials.gov
Ritlecitinib higher dose	Other	Phase PHASE3	Severe Alopecia Areata	ClinicalTrials.gov
Elranatamab injection	Other	Phase PHASE2	Refractory Multiple Myeloma	ClinicalTrials.gov
Placebo - 100 mg	Other	Phase PHASE2	Chronic Spontaneous Urticaria	ClinicalTrials.gov
Placebo - 50 mg	Other	Phase PHASE2	Chronic Spontaneous Urticaria	ClinicalTrials.gov
Ritlecitinib 100 mg	Other	Phase PHASE2	Chronic Spontaneous Urticaria	ClinicalTrials.gov
Ritlecitinib 50 mg	Other	Phase PHASE2	Chronic Spontaneous Urticaria	ClinicalTrials.gov
ibuzatrelvir	Other	Phase PHASE3	COVID-19 SARS-CoV-2 Infection	ClinicalTrials.gov
Elranatamab	Other	Phase PHASE4	Multiple Myeloma	ClinicalTrials.gov
Itraconazole	Other	Phase PHASE1	Metastatic Castration Resistant Prostate Cancer (mCRPC)	ClinicalTrials.gov
Enzalutamide	Other	Phase PHASE1	Metastatic Castration Resistant Prostate Cancer (mCRPC)	ClinicalTrials.gov
Mervometostat (PF-06821497)	Other	Phase PHASE1	Metastatic Castration Resistant Prostate Cancer (mCRPC)	ClinicalTrials.gov
Rimegepant (PF-07899801)	Other	Phase PHASE3	Acute Treatment of Migraine	ClinicalTrials.gov
Cyclophosphamide	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Elranatamab-bcmm	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
PF-06821497	Other	Phase PHASE3	Metastatic Castration-Resistant Prostate Cancer	ClinicalTrials.gov
Matching placebo	Other	Phase PHASE3	Pediatric Migraine	ClinicalTrials.gov
Rimegepant/BHV3000	Other	Phase PHASE3	Pediatric Migraine	ClinicalTrials.gov
Carfilzomib	Other	Phase PHASE3	Multiple Myeloma	ClinicalTrials.gov
Bortezomib	Other	Phase PHASE3	Multiple Myeloma	ClinicalTrials.gov
Dexamethasone	Other	Phase PHASE3	Multiple Myeloma	ClinicalTrials.gov
Pomalidomide	Other	Phase PHASE3	Multiple Myeloma	ClinicalTrials.gov
Elotuzumab	Other	Phase PHASE3	Multiple Myeloma	ClinicalTrials.gov
placebo for remdesivir	Other	Phase PHASE3	COVID-19 Infection	ClinicalTrials.gov
placebo for ibuzatrelvir	Other	Phase PHASE3	COVID-19 Infection	ClinicalTrials.gov
remdesivir	Other	Phase PHASE3	COVID-19 Infection	ClinicalTrials.gov
TNF alpha blockers	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
TNF blockers monotherapy	Drug	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
tofacitinib	Other	Phase PHASE3	Ulcerative Colitis	ClinicalTrials.gov
FOLFOX	Other	Phase PHASE2	Metastatic Colorectal Cancer	ClinicalTrials.gov
Bevacizumab	Other	Phase PHASE2	Metastatic Colorectal Cancer	ClinicalTrials.gov
FOLFIRI	Other	Phase PHASE2	Metastatic Colorectal Cancer	ClinicalTrials.gov
Onvansertib	Other	Phase PHASE2	Metastatic Colorectal Cancer	ClinicalTrials.gov
Standard Adjuvant Endocrine Therapy	Drug	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
Palbociclib	Other	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
Elranatamab (Elra)	Other	Phase PHASE2	Plasmablastic Lymphoma	ClinicalTrials.gov
Half Dose Pantoprazole plus matching placebo	Other	Phase PHASE2	Esophagitis	ClinicalTrials.gov
Full dose Pantoprazole plus matching placebo	Other	Phase PHASE2	Esophagitis	ClinicalTrials.gov
carboplatin	Other	Phase PHASE3	Urothelial Carcinoma	ClinicalTrials.gov
cisplatin	Other	Phase PHASE3	Urothelial Carcinoma	ClinicalTrials.gov
gemcitabine	Other	Phase PHASE3	Urothelial Carcinoma	ClinicalTrials.gov
pembrolizumab	Other	Phase PHASE3	Urothelial Carcinoma	ClinicalTrials.gov
disitamab vedotin	Other	Phase PHASE3	Urothelial Carcinoma	ClinicalTrials.gov
PF-06801591	Other	Phase PHASE1	Advanced Malignancies	ClinicalTrials.gov
Talazoparib with enzalutamide	Other	Phase PHASE2	Prostate Cancer (Adenocarcinoma)	ClinicalTrials.gov
PF-07209326	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Peg-interferon alpha 2b + Ribavirin(drug)	Drug	Phase PHASE2	Hepatitis C, Chronic	ClinicalTrials.gov
PF-08642534	Other	Phase PHASE1	Healthy Participant	ClinicalTrials.gov
Rabeprazole	Other	Phase PHASE1	Healthy Adults	ClinicalTrials.gov
PF-08049820	Other	Phase PHASE1	Healthy Adults	ClinicalTrials.gov
Radical Prostatectomy	Other	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Sunitinib Malate	Other	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
LHRH Agonist	Other	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Standard of Care Chemotherapy	Drug	Phase PHASE3	Endometrial Neoplasms	ClinicalTrials.gov
PF-08634404	Other	Phase PHASE3	Endometrial Neoplasms	ClinicalTrials.gov
Nivolumab	Other	Phase PHASE2	Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma	ClinicalTrials.gov
Chemotherapy	Drug	Phase PHASE2	Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma	ClinicalTrials.gov
Quadrivalent Influenza Vaccine (QIV)	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
Influenza ModRNA Vaccine	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
MET097 Injection	Other	Phase PHASE2	Obesity in Diabetes	ClinicalTrials.gov
40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone acetate	Other	Phase PHASE3	Endometriosis	ClinicalTrials.gov
Nephrectomy	Other	Phase PHASE2	Renal Cell Carcinoma	ClinicalTrials.gov
Sunitinib	Other	Phase PHASE2	Renal Cell Carcinoma	ClinicalTrials.gov
Part B: Multiple-dose ATM-AVI, Cohorts 1-4	Other	Phase PHASE2	Gram-negative Bacterial Infection	ClinicalTrials.gov
Part A: ATM-AVI Single Dose, Cohorts 1-4	Other	Phase PHASE2	Gram-negative Bacterial Infection	ClinicalTrials.gov
Capecitabine	Other	Phase PHASE3	Neoplasms	ClinicalTrials.gov
5-FU	Other	Phase PHASE3	Neoplasms	ClinicalTrials.gov
Leucovorin	Other	Phase PHASE3	Neoplasms	ClinicalTrials.gov
Irinotecan	Other	Phase PHASE3	Neoplasms	ClinicalTrials.gov
Oxaliplatin	Other	Phase PHASE3	Neoplasms	ClinicalTrials.gov
Cetuximab	Other	Phase PHASE3	Neoplasms	ClinicalTrials.gov
Encorafenib	Other	Phase PHASE3	Neoplasms	ClinicalTrials.gov
dacomitinib hydrate	Other	Preclinical	EGFR Mutation-positive Inoperable or Reccrent NSCLC	ClinicalTrials.gov
BAT	Other	Phase PHASE2	Gram-negative Bacterial Infections	ClinicalTrials.gov
ATM-AVI	Other	Phase PHASE2	Gram-negative Bacterial Infections	ClinicalTrials.gov
MET097	Other	Phase PHASE3	Obesity and Overweight	ClinicalTrials.gov
ALLR3	Other	Phase PHASE2	ACUTE LYMPHOBLASTIC LEUKEMIA	ClinicalTrials.gov
Inotuzumab ozogamicin	Other	Phase PHASE2	ACUTE LYMPHOBLASTIC LEUKEMIA	ClinicalTrials.gov
ponsegromab	Other	Phase PHASE2	Cachexia	ClinicalTrials.gov
PF-07799933	Other	Phase PHASE1	Melanoma	ClinicalTrials.gov
PF-07799544	Other	Phase PHASE1	Melanoma	ClinicalTrials.gov
ODT2 Test formulation	Other	Phase PHASE1	Migraine	ClinicalTrials.gov
ODT Reference formulation	Other	Phase PHASE1	Migraine	ClinicalTrials.gov
ABRYSVO	Other	Preclinical	Respiratory Syncytial Virus (RSV)	ClinicalTrials.gov
Mevrometostat	Other	Phase PHASE3	Metastatic Castration Sensitive Prostate Cancer (mCSPC)	ClinicalTrials.gov
PF-08653945	Other	Phase PHASE2	Overweight	ClinicalTrials.gov
PF-08653944	Other	Phase PHASE2	Overweight	ClinicalTrials.gov
etrasimod	Other	Phase PHASE2	Pouchitis	ClinicalTrials.gov
Electronic Diary	Other	Preclinical	Sickle Cell Disease	ClinicalTrials.gov
Rimegepant	Other	Phase PHASE3	Menstrual Migraine	ClinicalTrials.gov
Standard of Care	Other	Phase PHASE3	Menstrual Migraine	ClinicalTrials.gov
Placebo Comparator	Other	Phase PHASE3	Menstrual Migraine	ClinicalTrials.gov
Lorlatinib	Other	Phase PHASE2	Anaplastic Large Cell Lymphoma, ALK-Positive	ClinicalTrials.gov
Iberdomide	Other	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Ritlecitinib	Other	Preclinical	Severe Alopecia Areata	ClinicalTrials.gov
Multivalent Pneumococcal Vaccine - Formulation 4	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Multivalent Pneumococcal Vaccine - Formulation 3	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Licensed pneumococcal comparator vaccine	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
20-valent pneumococcal conjugate vaccine (20vPnC)	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Multivalent Pneumococcal Vaccine - Formulation 2	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Multivalent Pneumococcal Vaccine - Formulation 1	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Lenalidomide	Other	Phase PHASE3	Multiple Myeloma	ClinicalTrials.gov
Daratumumab	Other	Phase PHASE3	Multiple Myeloma	ClinicalTrials.gov
Fluconazole	Other	Phase PHASE1	Healthy Adults	ClinicalTrials.gov
PF-07248144	Other	Phase PHASE1	Healthy Adults	ClinicalTrials.gov
Prevnar 20	Other	Phase PHASE3	Healthy	ClinicalTrials.gov
Infanrix	Other	Phase PHASE3	Healthy	ClinicalTrials.gov
Pediarix	Other	Phase PHASE3	Healthy	ClinicalTrials.gov
Prevenar 20	Other	Phase PHASE3	Healthy	ClinicalTrials.gov
Infanrix hexa	Other	Phase PHASE3	Healthy	ClinicalTrials.gov
Multivalent Group B streptococcus vaccine	Other	Phase PHASE3	Healthy	ClinicalTrials.gov
Chemotherapy Regimen 2	Drug	Phase PHASE2	Carcinoma	ClinicalTrials.gov
Chemotherapy Regimen 1	Drug	Phase PHASE2	Carcinoma	ClinicalTrials.gov
0.9% Saline	Other	Phase PHASE3	Chronic Daily Headache	ClinicalTrials.gov
Ketamine	Other	Phase PHASE3	Chronic Daily Headache	ClinicalTrials.gov
PG4	Other	Phase PHASE3	Pneumococcal Disease	ClinicalTrials.gov
Fulvestrant	Other	Phase PHASE2	Metastatic Breast Cancer	ClinicalTrials.gov
fluorouracil	Other	Phase PHASE1	Melanoma	ClinicalTrials.gov
midazolam	Other	Phase PHASE1	Melanoma	ClinicalTrials.gov
binimetinib	Other	Phase PHASE1	Melanoma	ClinicalTrials.gov
Somatrogon	Other	Preclinical	Dwarfism, Pituitary	ClinicalTrials.gov
Ipilimumab	Other	Phase PHASE1	Carcinoma, Hepatocellular	ClinicalTrials.gov
Combination Agent 1	Other	Phase PHASE1	Advanced/Metastatic Non-Small Cell Lung Cancer	ClinicalTrials.gov
Sigvotatug Vedotin	Other	Phase PHASE1	Advanced/Metastatic Non-Small Cell Lung Cancer	ClinicalTrials.gov
Enfortumab Vedotin	Other	Phase PHASE1	Urothelial Cancer	ClinicalTrials.gov
Single dose of PF-07220060 as third tablet formulation	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Single dose of PF-07220060 as a Tablet formulation under Rabeprazole administration	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Single dose of PF-07220060 as a Tablet Formulation	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Single dose of PF-07220060 as second Tablet Formulation	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Single dose of PF-07220060 as first Tablet Formulation	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Imatinib	Other	Phase PHASE2	Melanoma Stage III	ClinicalTrials.gov
levoleucovorin	Other	Phase PHASE3	Colorectal Neoplasms	ClinicalTrials.gov
trastuzumab	Other	Phase PHASE3	Colorectal Neoplasms	ClinicalTrials.gov
tucatinib	Other	Phase PHASE3	Colorectal Neoplasms	ClinicalTrials.gov
Saline	Other	Phase PHASE3	Lyme Disease	ClinicalTrials.gov
VLA15	Other	Phase PHASE3	Lyme Disease	ClinicalTrials.gov
Atezolizumab	Other	Phase PHASE2	Small Cell Lung Cancer (SCLC)	ClinicalTrials.gov
Axitinib	Other	Phase PHASE1	Neoplasm Metastasis	ClinicalTrials.gov
Sasanlimab	Other	Phase PHASE1	Neoplasm Metastasis	ClinicalTrials.gov
PF-07265807	Other	Phase PHASE1	Neoplasm Metastasis	ClinicalTrials.gov
PF-07284892	Other	Phase PHASE1	Solid Tumor	ClinicalTrials.gov
Tafamidis	Other	Phase PHASE1	Healthy Adults	ClinicalTrials.gov
Avastin	Other	Preclinical	Colorectal Cancer	ClinicalTrials.gov
Bevacizumab-Pfizer Biosimilar	Other	Preclinical	Colorectal Cancer	ClinicalTrials.gov
Placebo for ponsegromab	Other	Phase PHASE2	Non-small Cell Lung Cancer	ClinicalTrials.gov
MARSTACIMAB	Other	Phase PHASE1	Severe Hemophilia A	ClinicalTrials.gov
Palbociclib plus fulvestrant	Other	Preclinical	Breast Neoplasms	ClinicalTrials.gov
Palbociclib plus an aromatase inhibitor	Other	Preclinical	Breast Neoplasms	ClinicalTrials.gov
PF-07257876	Other	Phase PHASE1	Non-Small Cell Lung Cancer	ClinicalTrials.gov
[oxoisoindolin-14C]ARV-471	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
[phenyl-14C]ARV-471	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
13-valent Pnumococcal Conjugate vaccine	Other	Phase PHASE3	Pneumococcal Infection	ClinicalTrials.gov
7-valent Pneumococcal Conjugate Vaccine	Other	Phase PHASE3	Pneumococcal Infection	ClinicalTrials.gov
Bortezomib (Velcade®)	Other	Phase PHASE3	Multiple Myeloma, Newly Diagnosed	ClinicalTrials.gov
Autologous Stem Cell Transplantation	Other	Phase PHASE3	Multiple Myeloma, Newly Diagnosed	ClinicalTrials.gov
Daratumumab SC (Darzalex)	Other	Phase PHASE3	Multiple Myeloma, Newly Diagnosed	ClinicalTrials.gov
Lenalidomide (Revlimid®)	Other	Phase PHASE3	Multiple Myeloma, Newly Diagnosed	ClinicalTrials.gov
PF-07994525	Other	Phase PHASE1	Advanced Malignancies	ClinicalTrials.gov
PF-06823859	Other	Phase PHASE3	Myositis	ClinicalTrials.gov
MET233 and MET097	Other	Phase PHASE1	Obesity and Obesity-related Medical Conditions	ClinicalTrials.gov
PF-06838435/ fidanacogene elaparvovec	Other	Phase PHASE3	Hemophilia B	ClinicalTrials.gov
RSV prefusion F protein-based vaccine	Other	Phase PHASE4	RSV	ClinicalTrials.gov
Abrocitinib 200 MG Oral Tablet	Other	Phase PHASE2	Diabetes Mellitus, Type 1	ClinicalTrials.gov
Placebo (A placebo does not have any medicine in it but looks just like the medicine being studied.)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-08057418	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
docetaxel	Other	Phase PHASE3	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
High Dose PF-07328948	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Medium Dose PF-07328948	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Low Dose PF-07328948	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Testing of hepatic AAV Vector integration	Other	Phase PHASE3	Hemophilia A	ClinicalTrials.gov
Isavuconazole	Other	Phase PHASE4	Invasive Fungal Disease	ClinicalTrials.gov
PF-07328948	Other	Phase PHASE1	Hepatic Impairment	ClinicalTrials.gov
MET233	Other	Phase PHASE1	Obesity and Overweight	ClinicalTrials.gov
LMWH	Other	Preclinical	Neoplasms	ClinicalTrials.gov
VKA	Other	Preclinical	Neoplasms	ClinicalTrials.gov
Dabigatran	Other	Preclinical	Neoplasms	ClinicalTrials.gov
Edoxaban	Other	Preclinical	Neoplasms	ClinicalTrials.gov
Rivaroxaban	Other	Preclinical	Neoplasms	ClinicalTrials.gov
Apixaban	Other	Preclinical	Neoplasms	ClinicalTrials.gov
Vitamin K antagonist (VKA)	Other	Preclinical	Atrial Fibrillation	ClinicalTrials.gov
Saline Placebo	Other	Phase PHASE3	Clostridioides Difficile Associated Disease	ClinicalTrials.gov
C.difficile vaccine	Other	Phase PHASE3	Clostridioides Difficile Associated Disease	ClinicalTrials.gov
Paclitaxel	Other	Phase PHASE1	Carcinoma, Pancreatic Ductal	ClinicalTrials.gov
pemetrexed	Other	Phase PHASE1	Carcinoma, Pancreatic Ductal	ClinicalTrials.gov
Nab-paclitaxel	Other	Phase PHASE1	Carcinoma, Pancreatic Ductal	ClinicalTrials.gov
PF-07985045	Other	Phase PHASE1	Carcinoma, Pancreatic Ductal	ClinicalTrials.gov
Zavegepant	Other	Phase PHASE3	Migraine	ClinicalTrials.gov
Rimegepant 75 MG [Nurtec]	Other	Phase PHASE2	Irritable Bowel Syndrome	ClinicalTrials.gov
tafamidis 61mg (based on prescription data)	Other	Preclinical	ATTR-CM (Transthyretin Amyloid Cardiomyopathy)	ClinicalTrials.gov
locoregional treatment	Drug	Approved	Breast Cancer Stage IV	ClinicalTrials.gov
Placebo for PF-07868489	Other	Phase PHASE1	Pulmonary Arterial Hypertension	ClinicalTrials.gov
PF-07868489	Other	Phase PHASE1	Pulmonary Arterial Hypertension	ClinicalTrials.gov
Elranatamab (PF-06863135)	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
prifetrastat in combination with fulvestrant	Other	Phase PHASE2	Metastatic (Stage IV) Melanoma	ClinicalTrials.gov
prifetrastat monotherapy for 15 days then combination with fulvestrant	Drug	Phase PHASE2	Metastatic (Stage IV) Melanoma	ClinicalTrials.gov
Temozolomide	Other	Phase PHASE1	Recurrent Solid Tumor	ClinicalTrials.gov
Onivyde	Other	Phase PHASE1	Recurrent Solid Tumor	ClinicalTrials.gov
PF-06700841	Other	Phase PHASE2	Cicatricial Alopecia	ClinicalTrials.gov
ribociclib	Other	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
abemaciclib	Other	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
letrozole	Other	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
PF-07220060	Other	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
PF-07055480 (giroctocogene fitelparovec): Recombinant AAV2/6 Human Factor VIII Gene Therapy	Drug	Phase PHASE3	Hemophilia A	ClinicalTrials.gov
Litfulo	Other	Preclinical	Severe Alopecia Areata	ClinicalTrials.gov
Treatment for TTR amyloidosis	Drug	Preclinical	Transthyretin (TTR) Amyloid Cardiomyopathy	ClinicalTrials.gov
Velsipity	Other	Preclinical	Ulcerative Colitis (UC)	ClinicalTrials.gov
PINPOINT Digital Educational Tool	Other	Approved	Clinical Trials	ClinicalTrials.gov
Azithromycin	Other	Approved	Mycobacterium Avium-Intracellulare Infection	ClinicalTrials.gov
Celecoxib	Other	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Estramustine Phosphate	Other	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Epirubicin	Other	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Sildenafil citrate	Other	Phase PHASE2	Hypertension	ClinicalTrials.gov
amiodarone	Other	Phase PHASE3	Atrial Fibrillation	ClinicalTrials.gov
rhIL-11	Other	Phase PHASE1	Ulcerative Colitis	ClinicalTrials.gov
sirolimus	Other	Phase PHASE4	Graft Rejection	ClinicalTrials.gov
prednisolone	Other	Phase PHASE4	Graft Rejection	ClinicalTrials.gov
methylprednisolone	Other	Phase PHASE4	Graft Rejection	ClinicalTrials.gov
mycophenolate mofetil	Other	Phase PHASE4	Graft Rejection	ClinicalTrials.gov
tacrolimus	Other	Phase PHASE4	Graft Rejection	ClinicalTrials.gov
Ethinyl Estradiol	Other	Phase PHASE2	Ovulation	ClinicalTrials.gov
Levonorgestrel	Other	Phase PHASE2	Ovulation	ClinicalTrials.gov
Pregabalin	Other	Phase PHASE3	Epilepsies, Partial	ClinicalTrials.gov
Cialis (Tadalafil)	Other	Phase PHASE2	Impotence	ClinicalTrials.gov
UK0369,003	Other	Phase PHASE2	Impotence	ClinicalTrials.gov
Olanzapine	Other	Phase PHASE1	Schizophrenia	ClinicalTrials.gov
PF-00184562	Other	Phase PHASE1	Schizophrenia	ClinicalTrials.gov
UK-369,003	Other	Phase PHASE2	Impotence	ClinicalTrials.gov
CP-481,715	Other	Phase PHASE1	Dermatitis, Allergic Contact	ClinicalTrials.gov
SU011248	Other	Phase PHASE2	Colorectal Neoplasms	ClinicalTrials.gov
eplerenone	Other	Preclinical	Hyperaldosteronism	ClinicalTrials.gov
LXR-623	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
PD-217,014	Other	Phase PHASE2	Pain	ClinicalTrials.gov
CI-1033	Other	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
(PN-152,243)/ PN-196,444	Other	Phase PHASE3	Non-Hodgkin Lymphoma	ClinicalTrials.gov
[S,S]-Reboxetine	Other	Phase PHASE2	Pain	ClinicalTrials.gov
simvastatin	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
torcetrapib/atorvastatin	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
ibuprofen	Other	Phase PHASE4	Ischemic Heart Disease	ClinicalTrials.gov
Enbrel (etanercept)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Premarin/MPA 0.45 mg/1.5 mg	Other	Phase PHASE1	Postmenopause	ClinicalTrials.gov
Desvenlafaxine Sustained Release	Other	Phase PHASE2	Fibromyalgia	ClinicalTrials.gov
conjugated estrogens/progestin (MPA)	Other	Phase PHASE1	Estrogen Replacement Therapy	ClinicalTrials.gov
Etanercept	Other	Phase PHASE3	Psoriasis	ClinicalTrials.gov
PLA-695	Other	Phase PHASE1	Arthritis, Rheumatoid	ClinicalTrials.gov
Pneumococcal Conjugated Vaccine (Prevnar®)	Other	Preclinical	Pneumococcal Infections	ClinicalTrials.gov
Bazedoxifene	Other	Phase PHASE2	Postmenopausal Osteoporosis	ClinicalTrials.gov
17b Estradiol	Other	Phase PHASE4	Postmenopause	ClinicalTrials.gov
Trimegestone	Other	Phase PHASE4	Postmenopause	ClinicalTrials.gov
Temsirolimus	Other	Preclinical	Squamous Cell Carcinoma	ClinicalTrials.gov
BeneFIX	Other	Phase PHASE3	Hemophilia B	ClinicalTrials.gov
Moxifloxacin	Other	Phase PHASE1	Alzheimer Disease	ClinicalTrials.gov
Lecozotan SR	Other	Phase PHASE1	Alzheimer Disease	ClinicalTrials.gov
pneumococcal conjugate vaccine	Other	Preclinical	Pneumococcal Infections	ClinicalTrials.gov
Tigecycline	Other	Phase PHASE4	Skin Diseases, Infectious	ClinicalTrials.gov
Investigational drug	Drug	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Amphotericin B	Other	Approved	Meningitis, Cryptococcal	ClinicalTrials.gov
Flucytosine	Other	Approved	Meningitis, Cryptococcal	ClinicalTrials.gov
Ketoconazole	Other	Approved	Candidiasis, Esophageal	ClinicalTrials.gov
Clotrimazole	Other	Approved	Candidiasis, Oral	ClinicalTrials.gov
AS-101	Other	Approved	HIV Infections	ClinicalTrials.gov
Clarithromycin	Other	Phase PHASE3	Mycobacterium Avium-intracellulare Infection	ClinicalTrials.gov
Ethambutol hydrochloride	Other	Phase PHASE3	Mycobacterium Avium-intracellulare Infection	ClinicalTrials.gov
Rifabutin	Other	Phase PHASE3	Mycoses	ClinicalTrials.gov
Nystatin	Other	Approved	Candidiasis, Oral	ClinicalTrials.gov
Zidovudine	Other	Approved	HIV Infections	ClinicalTrials.gov
Health education information	Other	Approved	Depression	ClinicalTrials.gov
Rapamycin medication	Drug	Phase PHASE4	Heart Transplantation	ClinicalTrials.gov
Cyclosporine discontinuation	Other	Phase PHASE4	Heart Transplantation	ClinicalTrials.gov
Atorvastatin	Other	Phase PHASE4	Type 2 Diabetes Mellitus	ClinicalTrials.gov
pegaptanib sodium	Other	Approved	Macular Degeneration	ClinicalTrials.gov
LV5FU2 + irinotecan	Other	Phase PHASE3	Cancer of the Rectum	ClinicalTrials.gov
5FU/LV Mayo Clinic or LV5FU2	Other	Phase PHASE3	Cancer of the Rectum	ClinicalTrials.gov
Donepezil	Other	Phase PHASE4	Stroke	ClinicalTrials.gov
Quinapril	Other	Phase PHASE4	CABG	ClinicalTrials.gov
Carboplatin plus Irinotecan vs Carboplatin plus Etoposide	Other	Phase PHASE2	Small Cell Lung Cancer	ClinicalTrials.gov
Viagra	Other	Approved	Impotence	ClinicalTrials.gov
pegaptanib sodium (Macugen)	Other	Phase PHASE2	Age-Related Macular Degeneration	ClinicalTrials.gov
Macugen ™ (pegaptanib sodium injection)	Other	Phase PHASE2	Macular Degeneration	ClinicalTrials.gov
azithromycin (drug)	Drug	Phase PHASE2	COPD	ClinicalTrials.gov
Laparoscopic Roux-en-Y Gastric Bypass	Other	Preclinical	Morbid Obesity	ClinicalTrials.gov
Mylotarg (gemtuzumab ozogamicin) Injection	Other	Phase PHASE2	Acute Myelogenous Leukemia	ClinicalTrials.gov
Levonorgestrel 90 mg and Ethinyl Estradiol 20 mg	Other	Phase PHASE3	Oral Contraceptive	ClinicalTrials.gov
Venlafaxine ER	Other	Phase PHASE3	Social Anxiety Disorder	ClinicalTrials.gov
atorvastatin (drug)	Drug	Approved	Coronary Artery Disease	ClinicalTrials.gov
sumanirole	Other	Phase PHASE3	Parkinson Disease	ClinicalTrials.gov
ropinirole	Other	Phase PHASE3	Parkinson Disease	ClinicalTrials.gov
traxiprodil (CP-101,606)	Other	Phase PHASE2	Stroke	ClinicalTrials.gov
Weight loss intervention	Other	Phase PHASE4	Obesity	ClinicalTrials.gov
Caltrate® 600 + D	Other	Phase PHASE4	Obesity	ClinicalTrials.gov
Pneumo 23	Other	Phase PHASE4	Pneumococcal Infections	ClinicalTrials.gov
Sildenafil 100mg	Other	Phase PHASE2	Impotence	ClinicalTrials.gov
PF-00592379	Other	Phase PHASE2	Impotence	ClinicalTrials.gov
sildenafil	Other	Phase PHASE4	Sexual Dysfunction	ClinicalTrials.gov
Ziprasidone	Other	Phase PHASE4	Posttraumatic Stress Disorder	ClinicalTrials.gov
NR2B NMDA Antagonist CP-101,606 (traxoprodil)	Other	Phase PHASE2	Parkinson's Disease	ClinicalTrials.gov
NMDA Antagonist, CP-101,606 (traxoprodil)	Other	Phase PHASE2	Depressive Disorder, Major	ClinicalTrials.gov
Premarin	Other	Preclinical	Postmenopause	ClinicalTrials.gov
rhBMP-2/CPM	Other	Phase PHASE1	Osteoarthritis	ClinicalTrials.gov
CP-547,632	Other	Phase PHASE2	Ovarian Neoplasms	ClinicalTrials.gov
GTN	Other	Phase PHASE1	Patients With Pace Makers But no Evidence of Ischemic Heart Disease	ClinicalTrials.gov
CI 1033	Other	Phase PHASE1	Carcinoma, Non-Small Cell Lung	ClinicalTrials.gov
PELITREXOL/AG-2037	Other	Phase PHASE2	Colorectal Neoplasms	ClinicalTrials.gov
(PN-152,243)/PN-196,444	Other	Phase PHASE3	Neoplasms	ClinicalTrials.gov
Atorvastatin calcium	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
Pravastatin	Other	Phase PHASE4	Coronary Arteriosclerosis	ClinicalTrials.gov
Diclofenac	Other	Phase PHASE4	Osteoarthritis, Hip	ClinicalTrials.gov
MST-997	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Peptide YY3-36	Other	Phase PHASE1	Obesity	ClinicalTrials.gov
DVS-233 SR	Other	Phase PHASE3	Vasomotor Symptoms	ClinicalTrials.gov
Genotropin	Other	Phase PHASE3	Juvenile Idiopathic Arthritis	ClinicalTrials.gov
Macugen (pegaptanib sodium)	Other	Phase PHASE4	Age-Related Macular Degeneration	ClinicalTrials.gov
Photodynamic Therapy (PDT) with Visudyne (verteporfin)	Drug	Phase PHASE4	Age-Related Macular Degeneration	ClinicalTrials.gov
Aerobic exercise	Other	Phase PHASE1	Restless Legs Syndrome	ClinicalTrials.gov
cyclosporine	Other	Phase PHASE3	Renal Transplantation	ClinicalTrials.gov
Inhaled human insulin	Other	Phase PHASE3	Diabetes Mellitus, Type 1	ClinicalTrials.gov
Inhaled human insulin (EXUBERA™)	Other	Phase PHASE3	Diabetes Mellitus, Type 2	ClinicalTrials.gov
DETRUSITOL	Other	Phase PHASE4	Overactive Bladder	ClinicalTrials.gov
Low Molecular Weight Heparin (dalteparin)	Other	Phase PHASE4	Deep Vein Thrombosis	ClinicalTrials.gov
piperacillin-tazobactam	Other	Preclinical	Gram-Positive Bacterial Infections	ClinicalTrials.gov
vancomycin-resistant enterococci and ESBL	Other	Preclinical	Escherichia Coli Infections	ClinicalTrials.gov
Piperacillin/tazobactam and other β-lactam/β-lactamase	Other	Preclinical	Gram-Positive Bacterial Infections	ClinicalTrials.gov
Mylotarg	Other	Preclinical	Acute Myeloid Leukemia	ClinicalTrials.gov
ezetimibe	Other	Phase PHASE4	Atrial Fibrillation	ClinicalTrials.gov
TTI-237	Other	Phase PHASE1	Tumors	ClinicalTrials.gov
DVS-233 SR (desvenlafaxine sustained release )	Other	Phase PHASE3	Major Depressive Disorder	ClinicalTrials.gov
ERB-041	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
rice wheat (placebo)	Other	Approved	Colonic Diseases, Functional	ClinicalTrials.gov
wheat bran (dietary supplement)	Other	Approved	Colonic Diseases, Functional	ClinicalTrials.gov
psyllium fibre (dietary supplement)	Other	Approved	Colonic Diseases, Functional	ClinicalTrials.gov
Treatment of psychiatric symptoms associated to alcoholism	Drug	Phase PHASE3	Depression	ClinicalTrials.gov
dalteparin	Other	Phase PHASE3	Venous Thromboembolism	ClinicalTrials.gov
Laser Doppler imaging	Other	Phase PHASE4	Menopause	ClinicalTrials.gov
Treatment with Genotropin in different dosages	Drug	Phase PHASE3	Growth Disorder	ClinicalTrials.gov
CI-1040	Other	Phase PHASE2	Colorectal Neoplasms	ClinicalTrials.gov
Donepezil (Aricept)	Other	Approved	Alzheimer Disease	ClinicalTrials.gov
Psychosocial information, counseling, and support	Other	Approved	Alzheimer Disease	ClinicalTrials.gov
SU-011,248	Other	Phase PHASE2	Kidney Neoplasms	ClinicalTrials.gov
Rapamune	Other	Phase PHASE3	Renal Allograft Recipients	ClinicalTrials.gov
sildenafil (viagra)	Other	Phase PHASE4	Erectile Dysfunction	ClinicalTrials.gov
Effexor XR	Other	Phase PHASE3	Depression	ClinicalTrials.gov
Milnacipran	Other	Phase PHASE3	Depression	ClinicalTrials.gov
controlled-release levodopa / carbidopa	Other	Phase PHASE4	Parkinson Disease	ClinicalTrials.gov
cabergoline	Other	Phase PHASE4	Parkinson Disease	ClinicalTrials.gov
Premarin® oral tablets	Other	Phase PHASE1	Atrophic Vaginitis	ClinicalTrials.gov
Premarin® Vaginal Cream	Other	Phase PHASE1	Atrophic Vaginitis	ClinicalTrials.gov
Glyceryl trinitrate	Other	Phase PHASE4	Angina Pectoris	ClinicalTrials.gov
DVS-233	Other	Phase PHASE3	Menopause	ClinicalTrials.gov
Fragmin (dalteparin sodium)	Other	Preclinical	Renal Insufficiency	ClinicalTrials.gov
CP-526,555 (varenicline)	Other	Phase PHASE2	Smoking Cessation	ClinicalTrials.gov
varenicline (CP-526,555)	Other	Phase PHASE3	Smoking Cessation	ClinicalTrials.gov
Radiography	Other	Phase PHASE4	Growth Hormone Deficiency	ClinicalTrials.gov
Blood sample	Other	Phase PHASE4	Growth Hormone Deficiency	ClinicalTrials.gov
Growth Hormone	Other	Preclinical	Growth Hormone Deficiency	ClinicalTrials.gov
UK-500,001	Other	Phase PHASE2	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
Corticosteroids	Other	Phase PHASE2	Kidney Transplantation	ClinicalTrials.gov
Rapamune® (Sirolimus)	Other	Phase PHASE2	Kidney Transplantation	ClinicalTrials.gov
SKI-606	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
cardiac echosonography	Other	Preclinical	Heart Valve Diseases	ClinicalTrials.gov
Gabapentin	Other	Phase PHASE3	Neuroleptic-Induced Tremor	ClinicalTrials.gov
Enoxaparin	Other	Phase PHASE2	Venous Thrombosis	ClinicalTrials.gov
PD 0348292	Other	Phase PHASE2	Venous Thrombosis	ClinicalTrials.gov
2 NRTIs	Other	Phase PHASE2	HIV Infections	ClinicalTrials.gov
Kaletra	Other	Phase PHASE2	HIV Infections	ClinicalTrials.gov
capravirine	Other	Phase PHASE2	HIV Infections	ClinicalTrials.gov
Piperacillin/Tazobactam (Tazocin)	Other	Phase PHASE3	Hematologic Neoplasms	ClinicalTrials.gov
Venlafaxine XR	Other	Phase PHASE4	Anxiety Disorders	ClinicalTrials.gov
Effexor® (Venlafaxine)	Other	Phase PHASE4	Depression	ClinicalTrials.gov
Sertraline and Alprazolam XR	Other	Phase PHASE4	Panic Disorder	ClinicalTrials.gov
Usual Care (UC)	Other	Approved	Depressive Disorder	ClinicalTrials.gov
Computerized Decision Support System for Depression (CDSS-D)	Other	Approved	Depressive Disorder	ClinicalTrials.gov
Fenofibrate	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
MYO-029	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Low dose aspirin	Other	Approved	Recurrent Pregnancy Loss	ClinicalTrials.gov
Low molecular weight heparin and low dose aspirin	Other	Approved	Recurrent Pregnancy Loss	ClinicalTrials.gov
vabicaserin	Other	Phase PHASE1	Schizophrenia	ClinicalTrials.gov
SCA-136	Other	Phase PHASE1	Schizophrenia	ClinicalTrials.gov
SAM-315	Other	Phase PHASE1	Alzheimer Disease	ClinicalTrials.gov
PPM-204	Other	Phase PHASE1	Diabetes Mellitus	ClinicalTrials.gov
Desvenlafaxine Sustained Release (DVS SR)	Other	Phase PHASE1	Depressive Disorder, Major	ClinicalTrials.gov
AGG-523	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
IMA-638	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
desvenlafaxine 100 mg	Other	Phase PHASE3	Depressive Disorder, Major	ClinicalTrials.gov
desvenlafaxine 50 mg	Other	Phase PHASE3	Depressive Disorder, Major	ClinicalTrials.gov
MnB rLP2086	Other	Phase PHASE1	Meningitis, Meningococcal	ClinicalTrials.gov
Bifeprunox	Other	Phase PHASE3	Depression Bipolar	ClinicalTrials.gov
Sodium chloride injection USP (0.9%)	Other	Phase PHASE1	HIV Infections	ClinicalTrials.gov
IL-12 DNA (formulated with bupivacaine)	Other	Phase PHASE1	HIV Infections	ClinicalTrials.gov
IL-15 DNA (formulated with bupivacaine)	Other	Phase PHASE1	HIV Infections	ClinicalTrials.gov
HIV-1 gag DNA (formulated with bupivacaine)	Other	Phase PHASE1	HIV Infections	ClinicalTrials.gov
rFIX-R	Other	Phase PHASE3	Hemophilia B	ClinicalTrials.gov
rFIX	Other	Phase PHASE3	Hemophilia B	ClinicalTrials.gov
paroxetine	Other	Phase PHASE3	Depression	ClinicalTrials.gov
desipramine	Other	Phase PHASE3	Depression	ClinicalTrials.gov
desvenlafaxine SR	Other	Phase PHASE3	Depression	ClinicalTrials.gov
Leios/Alesse	Other	Preclinical	Contraceptives, Oral, Combined	ClinicalTrials.gov
SAM-531	Other	Phase PHASE1	Alzheimer Disease	ClinicalTrials.gov
Tazocin (Piperacillin/Tazobactem)	Other	Phase PHASE4	Bacterial Infections	ClinicalTrials.gov
pantoprazole	Other	Phase PHASE3	Gastroesophageal Reflux	ClinicalTrials.gov
ezetimibe/simvastatin	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
olanzapine (15 mg)	Other	Phase PHASE2	Schizophrenia	ClinicalTrials.gov
SCA-136 (400 mg)	Other	Phase PHASE2	Schizophrenia	ClinicalTrials.gov
SCA-136 (200 mg)	Other	Phase PHASE2	Schizophrenia	ClinicalTrials.gov
CMD-193	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
PVC (twice weekly)	Other	Phase PHASE3	Atrophic Vaginitis	ClinicalTrials.gov
PVC (daily for 21 days, 7 days off)	Other	Phase PHASE3	Atrophic Vaginitis	ClinicalTrials.gov
0.9% Sodium Chloride, USP	Other	Phase PHASE2	Arrhythmia	ClinicalTrials.gov
GAP-486 (ZP-123)	Other	Phase PHASE2	Arrhythmia	ClinicalTrials.gov
Citalopram	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Enbrel	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
pneumococcus conjugate vaccine	Other	Phase PHASE4	Vaccines, Pneumococcal Conjugate Vaccine	ClinicalTrials.gov
Recombinant Factor IX Coagulation	Other	Phase PHASE4	Hemophilia B	ClinicalTrials.gov
pneumococcus conjugate vaccine 7 valent to reduce carriage	Other	Phase PHASE4	Vaccines, Pneumococcal	ClinicalTrials.gov
bazedoxifene/conjugated estrogens combination	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Conjugated Estrogen Cream (Premarin®)	Other	Preclinical	Postmenopause	ClinicalTrials.gov
Bazedoxifene/conjugated estrogens	Other	Phase PHASE1	Postmenopause	ClinicalTrials.gov
Bazedoxifene/Conjugated Estrogens 20 mg/0.625 mg tablet	Other	Phase PHASE1	Menopause	ClinicalTrials.gov
Codeine	Other	Phase PHASE1	Depressive Disorder, Major	ClinicalTrials.gov
Combination of Temsirolimus and Sunitinib	Other	Phase PHASE1	Renal Cell Carcinoma	ClinicalTrials.gov
desvenlafaxine succinate sustained release (DVS SR)	Other	Phase PHASE1	Vasomotor Symptoms	ClinicalTrials.gov
bazedoxifene BZA-20	Other	Phase PHASE3	Postmenopause	ClinicalTrials.gov
DVS-SR 100 mg	Other	Phase PHASE3	Major Depressive Disorder	ClinicalTrials.gov
DVS-SR 50 mg	Other	Phase PHASE3	Major Depressive Disorder	ClinicalTrials.gov
Dimebon	Other	Phase PHASE1	Huntington's Disease	ClinicalTrials.gov
naproxen	Other	Phase PHASE1	Osteoarthritis	ClinicalTrials.gov
CJ-023,423	Other	Phase PHASE1	Osteoarthritis	ClinicalTrials.gov
IMA-026	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
AG-013736 (axitinib)	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Bazedoxifene/Conjugated Estrogen	Other	Phase PHASE3	Vaginal Atrophy	ClinicalTrials.gov
Mitoxantrone	Other	Phase PHASE3	Secondary Progressive Multiple Sclerosis	ClinicalTrials.gov
ReFacto	Other	Phase PHASE4	Hemophilia A	ClinicalTrials.gov
Premarin ®	Other	Phase PHASE2	Parkinson's Disease	ClinicalTrials.gov
Insulin Glargine (Lantus)	Other	Phase PHASE4	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Inhaled Human Insulin (Exubera)	Other	Phase PHASE4	Diabetes Mellitus, Type 2	ClinicalTrials.gov
donezepil (Aricept)	Other	Approved	Alzheimer's Disease	ClinicalTrials.gov
IFN-alpha2A	Other	Phase PHASE2	Memory Disorders	ClinicalTrials.gov
Aricept	Other	Phase PHASE2	Memory Disorders	ClinicalTrials.gov
Venlafaxine	Other	Phase PHASE4	Osteoarthritis	ClinicalTrials.gov
Exubera	Other	Phase PHASE4	Type 1 Diabetes Mellitus	ClinicalTrials.gov
Control Group	Other	Approved	Diabetes	ClinicalTrials.gov
Literacy/Numeracy oriented educational intervention	Other	Approved	Diabetes	ClinicalTrials.gov
Regular Human Insulin	Other	Phase PHASE3	Diabetes Mellitus	ClinicalTrials.gov
Low to moderate risk	Other	Approved	Cardiovascular Diseases	ClinicalTrials.gov
High risk assessment	Other	Approved	Cardiovascular Diseases	ClinicalTrials.gov
Blood draw	Other	Phase PHASE4	Colorectal Neoplasms	ClinicalTrials.gov
Sertraline	Other	Phase PHASE2	Depressive Disorder, Major	ClinicalTrials.gov
CP-316,311	Other	Phase PHASE2	Depressive Disorder, Major	ClinicalTrials.gov
Irinotecan plus capecitabine	Other	Phase PHASE2	Carcinoma, Hepatocellular	ClinicalTrials.gov
6-methyl-prednisolone	Other	Phase PHASE4	Multiple Organ Dysfunction Syndrome	ClinicalTrials.gov
valdecoxib/placebo	Other	Phase PHASE3	Pain	ClinicalTrials.gov
valdecoxib	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Lecozotan	Other	Phase PHASE1	Alzheimer Disease	ClinicalTrials.gov
Self help	Other	Approved	Obesity	ClinicalTrials.gov
Counseling by a dietitian via e-mail (months 1-3: weekly, months 4-6: every other week)	Other	Approved	Obesity	ClinicalTrials.gov
Counseling by a dietitian via telephone (months 1-3: weekly, months 4-6: every other week)	Other	Approved	Obesity	ClinicalTrials.gov
Face-to-face counseling by a dietitian (monthly)	Other	Approved	Obesity	ClinicalTrials.gov
Face-to-face counseling by a dietitian (months 1-3: weekly, months 4-6: every other week)	Other	Approved	Obesity	ClinicalTrials.gov
Prevenar	Other	Preclinical	Pneumococcal Infections	ClinicalTrials.gov
Metformin	Other	Approved	Type 2 Diabetes Mellitus	ClinicalTrials.gov
Rosiglitazone	Other	Approved	Type 2 Diabetes Mellitus	ClinicalTrials.gov
Xalacom	Other	Phase PHASE3	Glaucoma, Open-Angle	ClinicalTrials.gov
varenicline	Other	Phase PHASE1	Smoking Cessation	ClinicalTrials.gov
Protocol biopsies	Other	Phase PHASE4	Kidney Transplantation	ClinicalTrials.gov
Prednisone	Other	Phase PHASE4	Kidney Transplantation	ClinicalTrials.gov
Cyclosporine A	Other	Phase PHASE4	Kidney Transplantation	ClinicalTrials.gov
PF-00446687	Other	Phase PHASE2	Erectile Dysfunction	ClinicalTrials.gov
Parecoxib/Valdecoxib	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Treatment C	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
Treatment B	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
Treatment A	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04447943	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04457845	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
HKI-357	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PRA-027	Other	Phase PHASE1	Uterine Leiomyomata (Fibroids)	ClinicalTrials.gov
Zyvox® / Linezolid	Other	Phase PHASE3	Bacterial Infections	ClinicalTrials.gov
DATscan and SPECT imaging	Other	Approved	Parkinson Disease	ClinicalTrials.gov
carbidopa/levodopa	Other	Approved	Parkinson Disease	ClinicalTrials.gov
TMI-005	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Tygacil	Other	Preclinical	Peritonitis	ClinicalTrials.gov
pemetrexed + PF-3512676	Other	Phase PHASE2	Carcinoma, Non-Small Cell Lung	ClinicalTrials.gov
carboplatin + paclitaxel + bevacizumab + PF-3512676	Other	Phase PHASE2	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
paclitaxel + carboplatin + bevacizumab	Other	Phase PHASE2	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
Clinical record review	Other	Preclinical	Infection	ClinicalTrials.gov
glycopeptide	Other	Preclinical	Hematological Malignancy	ClinicalTrials.gov
sunitinib, docetaxel, cisplatin	Other	Phase PHASE2	Non Small Cell Lung Cancer	ClinicalTrials.gov
30 mg/kg azithromycin IR	Other	Phase PHASE2	Acute Otitis Media	ClinicalTrials.gov
60 mg/kg azithromycin ER	Other	Phase PHASE2	Acute Otitis Media	ClinicalTrials.gov
Promoting Resilience in Women with Breast Cancer (PRISM)	Other	Approved	Breast Cancer	ClinicalTrials.gov
Rituxan	Other	Preclinical	Lymphoma	ClinicalTrials.gov
Rituximab Pfizer	Other	Preclinical	Lymphoma	ClinicalTrials.gov
Dazukibart	Other	Phase PHASE3	Dermatomyositis	ClinicalTrials.gov
Rimegepant sulfate	Other	Preclinical	Migraine With or Without Aura	ClinicalTrials.gov
doxycycline carragenate tablet	Other	Phase PHASE4	Bacterial Infection	ClinicalTrials.gov
doxycycline monohydrate tablet	Other	Phase PHASE4	Bacterial Infection	ClinicalTrials.gov
Inhaled Insulin	Other	Phase PHASE3	Diabetes Mellitus	ClinicalTrials.gov
Subcutaneous Insulin	Other	Phase PHASE3	Diabetes Mellitus	ClinicalTrials.gov
Personal Digital Assisstant (PDA)	Other	Approved	Fibromyalgia	ClinicalTrials.gov
Interactive Voice Response System (IVRS)	Other	Approved	Fibromyalgia	ClinicalTrials.gov
anidulafungin	Other	Phase PHASE4	Aspergillosis	ClinicalTrials.gov
voriconazole	Other	Phase PHASE4	Aspergillosis	ClinicalTrials.gov
Varenicline Tartarate	Other	Phase PHASE3	Smoking Cessation	ClinicalTrials.gov
Treatment E	Drug	Phase PHASE1	Asthma	ClinicalTrials.gov
Treatment D	Drug	Phase PHASE1	Asthma	ClinicalTrials.gov
daclizumab	Other	Phase PHASE3	Graft vs Host Disease	ClinicalTrials.gov
Cyclosporine or Tacrolimus	Other	Phase PHASE3	Liver Transplantation	ClinicalTrials.gov
Sirolimus (Rapamune)	Other	Phase PHASE3	Liver Transplantation	ClinicalTrials.gov
5 fluorouracil	Other	Phase PHASE4	Metastatic Colorectal Cancer	ClinicalTrials.gov
Combination therapy of irinotecan with 5-FU, leucovorin plus bevacizumab in the neoadjuvant setting.	Drug	Phase PHASE2	Colorectal Neoplasms	ClinicalTrials.gov
CP-724,714	Other	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
Lersivirine	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Lersivirine (if necessary)	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Raloxifene 60 mg	Other	Preclinical	Postmenopause	ClinicalTrials.gov
Bazedoxifene 40 mg/CE 0.45 mg	Other	Preclinical	Postmenopause	ClinicalTrials.gov
Bazedoxifene 20 mg/CE 0.45 mg	Other	Preclinical	Postmenopause	ClinicalTrials.gov
Bazedoxifene 10 mg/CE 0.45 mg	Other	Preclinical	Postmenopause	ClinicalTrials.gov
Bazedoxifene 40 mg/CE 0.625 mg	Other	Preclinical	Postmenopause	ClinicalTrials.gov
Bazedoxifene 20 mg/CE 0.625 mg	Other	Preclinical	Postmenopause	ClinicalTrials.gov
Bazedoxifene 10 mg/CE 0.625 mg	Other	Preclinical	Postmenopause	ClinicalTrials.gov
Fesoterodine	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Oxycodone 20mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo suspension	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04531083 2000mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04531083 100mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Bazedoxifene and conjugated estrogens	Other	Phase PHASE1	Postmenopause	ClinicalTrials.gov
systemic chemotherapy	Drug	Phase PHASE2	Colorectal Cancer	ClinicalTrials.gov
FUFA	Other	Phase PHASE2	Colorectal Cancer	ClinicalTrials.gov
PF-00610355	Other	Phase PHASE2	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
CP-866,087	Other	Phase PHASE2	Sexual Dysfunction, Physiological	ClinicalTrials.gov
Salmeterol	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
PF-610,355	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
Maraviroc	Other	Phase PHASE4	Human Immunodeficiency Virus (HIV) Infection	ClinicalTrials.gov
Saquinavir	Other	Phase PHASE4	Human Immunodeficiency Virus (HIV) Infection	ClinicalTrials.gov
Ritonavir	Other	Phase PHASE4	Human Immunodeficiency Virus (HIV) Infection	ClinicalTrials.gov
15 mg PF-04995274	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
1.0 mg PF-04995274	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
10 mg PF-04995274	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
1 mg PF-04995274	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
0.1 mg PF-04995274	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Sunitinib-Malate	Other	Phase PHASE2	Gastric Adenocarcinoma	ClinicalTrials.gov
Abacavir/Lamivudine	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Maraviroc + Fosamprenavir/ritonavir	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Fosamprenavir/ritonavir	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
In-vitro testing	Other	Preclinical	Community Acquired Infections	ClinicalTrials.gov
7 valent pneumococcal conjugate vaccine	Other	Phase PHASE3	Pneumococcal Infections	ClinicalTrials.gov
13-valent Pneumococcal Conjugate Vaccine	Other	Phase PHASE3	Pneumococcal Infections	ClinicalTrials.gov
Aricept® Evess	Other	Preclinical	Alzheimer's Disease	ClinicalTrials.gov
SS-RBX	Other	Phase PHASE2	Urinary Incontinence, Stress	ClinicalTrials.gov
CP-75385-02 Cefoperazone/sulbactam	Other	Preclinical	Abscess, Intra-Abdominal	ClinicalTrials.gov
exemestane (Aromasin®)	Other	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
Ampicillin/sulbactam	Other	Phase PHASE4	Pneumonia	ClinicalTrials.gov
Non-Interventional Study	Other	Preclinical	Ulcerative Colitis	ClinicalTrials.gov
Prazosin HCl	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
GAP-134	Other	Phase PHASE1	Arrhythmia	ClinicalTrials.gov
FXR 450	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Rapamune (Sirolimus)	Other	Phase PHASE3	Kidney Failure	ClinicalTrials.gov
Steroids	Other	Phase PHASE3	Kidney Failure	ClinicalTrials.gov
Clamoxyl	Other	Phase PHASE4	Tonsillitis	ClinicalTrials.gov
Zithromax	Other	Phase PHASE4	Tonsillitis	ClinicalTrials.gov
azithromycin SR	Other	Phase PHASE3	Pneumonia	ClinicalTrials.gov
clarithromycin extended release (ER)	Other	Phase PHASE3	Pneumonia	ClinicalTrials.gov
tolterodine PR	Other	Phase PHASE3	Urinary Bladder, Overactive	ClinicalTrials.gov
propiverine	Other	Phase PHASE3	Urinary Bladder, Overactive	ClinicalTrials.gov
cefuroxime	Other	Phase PHASE3	Pneumonia	ClinicalTrials.gov
azithromycin (Zithromax)	Other	Phase PHASE3	Pneumonia	ClinicalTrials.gov
cefuroxime plus erythromycin	Other	Phase PHASE3	Pneumonia	ClinicalTrials.gov
somatropin	Other	Phase PHASE4	Brain Injuries	ClinicalTrials.gov
varenicline tartrate	Other	Phase PHASE1	Smoking	ClinicalTrials.gov
Edotecarin	Other	Phase PHASE2	Stomach Neoplasms	ClinicalTrials.gov
Lomustine (CCNU)	Other	Phase PHASE3	Glioblastoma	ClinicalTrials.gov
Carmustine (BCNU)	Other	Phase PHASE3	Glioblastoma	ClinicalTrials.gov
latanoprost 0.005% (Xalatan)	Other	Phase PHASE4	Ocular Hypertension	ClinicalTrials.gov
Sandostatin LAR	Other	Phase PHASE4	Acromegaly	ClinicalTrials.gov
Pegvisomant	Other	Phase PHASE4	Acromegaly	ClinicalTrials.gov
quinapril 40 mg	Other	Phase PHASE4	Hypertension	ClinicalTrials.gov
quinapril 20 mg plus hydrochlorothiazide 12.5 mg	Other	Phase PHASE4	Hypertension	ClinicalTrials.gov
quinapril 20 mg	Other	Phase PHASE4	Hypertension	ClinicalTrials.gov
SPM 907	Other	Phase PHASE3	Overactive Bladder	ClinicalTrials.gov
HCV-796	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Parecoxib and placebo	Other	Phase PHASE3	Pain, Postoperative	ClinicalTrials.gov
BDDrFVIII	Other	Phase PHASE3	Hemophilia A	ClinicalTrials.gov
B-Domain deleted Recombinant Factor VIII	Other	Phase PHASE3	Hemophilia A	ClinicalTrials.gov
ReFacto AF	Other	Phase PHASE3	Hemophilia A	ClinicalTrials.gov
MRI	Other	Phase PHASE4	Acromegaly	ClinicalTrials.gov
Blood tests: IGF-1, AST/ALT/ALP/TBIL, GTT	Other	Phase PHASE4	Acromegaly	ClinicalTrials.gov
Sign and symptoms: questionnaire	Other	Phase PHASE4	Acromegaly	ClinicalTrials.gov
Medical History, demographics	Other	Phase PHASE4	Acromegaly	ClinicalTrials.gov
Pegvisomant treatment	Drug	Phase PHASE4	Acromegaly	ClinicalTrials.gov
Quinapril 10 mg and amlodipine 5 mg	Other	Phase PHASE4	Hypertension	ClinicalTrials.gov
Parecoxib	Other	Phase PHASE3	Colic	ClinicalTrials.gov
TRU-015	Other	Phase PHASE1	Systemic Lupus Erythematosus	ClinicalTrials.gov
MnB vaccine rLP8026	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Raloxifene	Other	Phase PHASE3	Endometrial Hyperplasia	ClinicalTrials.gov
Bazedoxifene/Conjugate Estrogens (CE)	Other	Phase PHASE3	Endometrial Hyperplasia	ClinicalTrials.gov
Habit Reversal Training	Other	Phase PHASE4	Impulse Control Disorders	ClinicalTrials.gov
CP-690-,550	Other	Phase PHASE2	Kidney Transplantation	ClinicalTrials.gov
Celebrex	Other	Phase PHASE3	Osteoarthritis,Knee	ClinicalTrials.gov
Measurement of nasal congestion using acoustic rhinometry.	Other	Phase PHASE1	Seasonal Allergic Rhinitis	ClinicalTrials.gov
Collection of nasal effluent using filter paper.	Other	Phase PHASE1	Seasonal Allergic Rhinitis	ClinicalTrials.gov
Intra-nasal allergen challenge with Phleum pratense.	Other	Phase PHASE1	Seasonal Allergic Rhinitis	ClinicalTrials.gov
low or high sodium diet	Other	Phase PHASE1	Inflammation	ClinicalTrials.gov
aldosterone	Other	Phase PHASE1	Inflammation	ClinicalTrials.gov
Buspirone	Other	Phase PHASE2	Attention Deficit Disorder With Hyperactivity	ClinicalTrials.gov
Atomoxetine	Other	Phase PHASE2	Attention Deficit Disorder With Hyperactivity	ClinicalTrials.gov
Risperidone 2 mg	Other	Approved	Schizophrenia	ClinicalTrials.gov
Totelle®	Other	Phase PHASE4	Hot Flashes	ClinicalTrials.gov
Xal-Ease device to be used with Xalatan eye drops	Device	Approved	Glaucoma	ClinicalTrials.gov
Somatropin and pegvisomant	Other	Approved	Metabolism	ClinicalTrials.gov
Rimonabant	Other	Phase PHASE4	Atherosclerosis	ClinicalTrials.gov
Aspirin or clopidogrel	Other	Phase PHASE4	Atherosclerosis	ClinicalTrials.gov
Enalapril	Other	Phase PHASE4	Atherosclerosis	ClinicalTrials.gov
Simvastatin or Atorvastatin	Other	Phase PHASE4	Atherosclerosis	ClinicalTrials.gov
tiotropium	Other	Preclinical	COPD	ClinicalTrials.gov
AG-024322	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
voice acoustics	Other	Approved	Depressive Disorder, Major	ClinicalTrials.gov
Leucovorin calcium	Other	Phase PHASE1	Toxoplasmosis, Cerebral	ClinicalTrials.gov
Pyrimethamine	Other	Phase PHASE1	Toxoplasmosis, Cerebral	ClinicalTrials.gov
Genotropin (human recombinant Growth hormone)	Other	Phase PHASE4	HIV Infections	ClinicalTrials.gov
Mefloquine	Other	Phase PHASE3	Malaria	ClinicalTrials.gov
Azithromycin plus Chloroquine	Other	Phase PHASE3	Malaria	ClinicalTrials.gov
celecoxib 400 mg bid	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
Depo-Provera Contraceptive Injection - DP150CI	Other	Phase PHASE4	Contraception	ClinicalTrials.gov
Dalteparin sodium	Other	Phase PHASE4	Thromboembolism	ClinicalTrials.gov
exemestane	Other	Phase PHASE4	Breast Neoplasms	ClinicalTrials.gov
PF-00915275	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Vfend®; I.V.	Other	Phase PHASE1	Kidney Failure	ClinicalTrials.gov
5-fluorouracil	Other	Phase PHASE2	Neoplasm Metastasis	ClinicalTrials.gov
Blood samples	Other	Approved	Platelet Aggregation	ClinicalTrials.gov
Acetaminophen	Other	Approved	Platelet Aggregation	ClinicalTrials.gov
dipyrone	Other	Approved	Platelet Aggregation	ClinicalTrials.gov
PF-3463275	Other	Phase PHASE1	Schizophrenia	ClinicalTrials.gov
lorazepam	Other	Approved	Anxiety Disorders	ClinicalTrials.gov
Placebo/Placebo	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Placebo/Valdecoxib	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Parecoxib Sodium/Valdecoxib	Other	Phase PHASE3	Pain	ClinicalTrials.gov
clinic-administered injections	Other	Approved	Contraception	ClinicalTrials.gov
Pharmacist-administered	Other	Approved	Contraception	ClinicalTrials.gov
Anidulafungin, VER002	Other	Phase PHASE2	Candidiasis	ClinicalTrials.gov
Amoxicillin/clavulinic acid	Other	Phase PHASE3	Bronchitis, Chronic	ClinicalTrials.gov
Glipizide GITS	Other	Preclinical	Diabetes Mellitus, Non-Insulin-Dependent	ClinicalTrials.gov
Bosutinib (SKI-606)	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
852A	Other	Phase PHASE2	Melanoma	ClinicalTrials.gov
recombinant human growth hormone	Other	Phase PHASE3	Abdominal Obesity	ClinicalTrials.gov
levodopa	Other	Phase PHASE3	Restless Legs Syndrome	ClinicalTrials.gov
Sertraline and Elzasonan Combination	Other	Phase PHASE2	Depressive Disorder, Major	ClinicalTrials.gov
Sulfadoxine-Pyrimethamine/Chloroquine	Other	Phase PHASE2	Malaria, Falciparum	ClinicalTrials.gov
Azithromycin/Chloroquine	Other	Phase PHASE2	Malaria, Falciparum	ClinicalTrials.gov
Raltegravir	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
UK-453,061	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Ziprasidone Hydrochloride	Other	Phase PHASE2	Conduct Disorder	ClinicalTrials.gov
Mikacin (Amikacin Sulphate Injection IP) Aristo Pharmaceuticals Ltd.	Other	Phase PHASE4	Infection	ClinicalTrials.gov
Metrogyl (Metronidazole Injection IP) J.B.Chemicals & Pharmaceuticals Ltd.	Other	Phase PHASE4	Infection	ClinicalTrials.gov
Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited	Other	Phase PHASE4	Infection	ClinicalTrials.gov
Magnex (Sulbactam Sodium/Cefoperazone Sodium 1:1) Pfizer Ltd.	Other	Phase PHASE4	Infection	ClinicalTrials.gov
Latanoprost with Pilocarpine vs Timolol or Cosopt	Other	Approved	Exfoliation Syndrome	ClinicalTrials.gov
sildenafil matching placebo	Other	Phase PHASE1	Prostatic Hyperplasia	ClinicalTrials.gov
UK369,003	Other	Phase PHASE1	Prostatic Hyperplasia	ClinicalTrials.gov
Vitamin D + Exercise	Other	Phase PHASE1	Elderly, Frail	ClinicalTrials.gov
Vitamin D Placebo + Sham Exercise	Other	Phase PHASE1	Elderly, Frail	ClinicalTrials.gov
Vitamin D Placebo + Exercise	Other	Phase PHASE1	Elderly, Frail	ClinicalTrials.gov
Vitamin D + Sham Exercise	Other	Phase PHASE1	Elderly, Frail	ClinicalTrials.gov
Progesterone	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
Estrogen	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
Varenicline free base patch	Other	Phase PHASE1	Smoking Cessation	ClinicalTrials.gov
Varenicline free base solution	Other	Phase PHASE1	Smoking Cessation	ClinicalTrials.gov
PAZ-417	Other	Phase PHASE1	Alzheimer Disease	ClinicalTrials.gov
Premarin®/MPA formulation C	Other	Phase PHASE1	Menopause	ClinicalTrials.gov
Premarin®/MPA formulation B	Other	Phase PHASE1	Menopause	ClinicalTrials.gov
Premarin®/MPA formulation A	Other	Phase PHASE1	Menopause	ClinicalTrials.gov
Temozolomide and SU11248	Other	Phase PHASE1	Metastatic Malignant Melanoma	ClinicalTrials.gov
Bosutinib	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
CPG 7909 Injection	Other	Phase PHASE2	Carcinoma, Melanoma	ClinicalTrials.gov
dacarbazine	Other	Phase PHASE2	Carcinoma, Melanoma	ClinicalTrials.gov
CPG 7909	Other	Phase PHASE2	Carcinoma, Non-Small Cell Lung	ClinicalTrials.gov
PD 0200390	Other	Phase PHASE2	Insomnia	ClinicalTrials.gov
PF-3512676	Other	Phase PHASE1	Lymphoma, T-Cell, Cutaneous	ClinicalTrials.gov
Internet-based tailored advice on cardiovascular risk	Other	Approved	Hypercholesterolemia	ClinicalTrials.gov
NSA-789	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
[14C]-PF-00868554	Other	Phase PHASE1	HCV	ClinicalTrials.gov
Dimebon + Dextromethorphan	Other	Phase PHASE1	Huntington Disease	ClinicalTrials.gov
Dextromethorphan	Other	Phase PHASE1	Huntington Disease	ClinicalTrials.gov
Herceptin®	Other	Phase PHASE2	Carcinoma, Breast	ClinicalTrials.gov
0.16 mg/kg CpG 7909	Other	Phase PHASE2	Carcinoma, Breast	ClinicalTrials.gov
0.12 mg/kg CpG 7909	Other	Phase PHASE2	Carcinoma, Breast	ClinicalTrials.gov
0.08 mg/kg CpG 7909	Other	Phase PHASE2	Carcinoma, Breast	ClinicalTrials.gov
0.04 mg/kg CpG 7909	Other	Phase PHASE2	Carcinoma, Breast	ClinicalTrials.gov
PD-0325901	Other	Phase PHASE2	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
52364 1 mg	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
52364 100 mg	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
52364 30 mg	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
52364 10 mg	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Placebo Comparator: Cohorts 2, 3, 4 & 5 Two subjects each arm will be assigned to receive placebo	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
52364 3 mg	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Placebo Comparator: Cohort 1 Placebo	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF03635659	Other	Phase PHASE1	Chronic Obstructive Pulmonary Disease	ClinicalTrials.gov
caloric restriction - Control	Other	Approved	Obesity	ClinicalTrials.gov
caloric restriction - 50%	Other	Approved	Obesity	ClinicalTrials.gov
caloric restriction - 25%	Other	Approved	Obesity	ClinicalTrials.gov
caloric restriction - 10%	Other	Approved	Obesity	ClinicalTrials.gov
Forteo	Other	Approved	Osteoporosis	ClinicalTrials.gov
HSD-016	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Nelfinavir	Other	Phase PHASE4	Healthy Volunteers	ClinicalTrials.gov
X-ray; magnetic resonance imaging	Other	Preclinical	Osteoarthritis	ClinicalTrials.gov
Azithromycin and Chloroquine	Other	Phase PHASE1	Malaria	ClinicalTrials.gov
Fixed combination of Azithromycin and Chloroquine	Other	Phase PHASE1	Malaria	ClinicalTrials.gov
varenicline free base	Other	Phase PHASE1	Smoking Cessation	ClinicalTrials.gov
zolpidem	Other	Phase PHASE1	Methodology Study	ClinicalTrials.gov
ERB-257	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
PF-04629991	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
CP-778,875	Other	Phase PHASE2	Dyslipidemia	ClinicalTrials.gov
An IT-based patient follow-up and reminder system	Other	Approved	Hypertension	ClinicalTrials.gov
Usual care	Other	Approved	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Pharmacist collaboration in diabetes care	Other	Approved	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Maraviroc +PF-03716539	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Darunavir + PF-03716539	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Darunavir	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Midazolam + PF-03716539 (100 mg)	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Midazolam + PF-03716539 (50 mg)	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-03716539	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Standard formula	Other	Approved	Healthy	ClinicalTrials.gov
Lutein fortification	Other	Approved	Healthy	ClinicalTrials.gov
CR 3	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
CR 2	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
CR 1	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
suspension IR	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
digoxin	Other	Phase PHASE1	Alzheimer Disease	ClinicalTrials.gov
Multiple dose-Group B	Other	Phase PHASE1	Colitis, Ulcerative	ClinicalTrials.gov
Multiple dose- Group B	Other	Phase PHASE1	Colitis, Ulcerative	ClinicalTrials.gov
Single dose-group A	Other	Phase PHASE1	Colitis, Ulcerative	ClinicalTrials.gov
PET imaging	Other	Preclinical	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
Pharmacokinetics	Other	Phase PHASE1	Hepatitis C Virus	ClinicalTrials.gov
verapamil	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PD 0360324	Other	Phase PHASE1	Arthritis, Rheumatoid	ClinicalTrials.gov
linezolid	Other	Phase PHASE1	Burns	ClinicalTrials.gov
PF-04620110	Other	Phase PHASE1	Overweight	ClinicalTrials.gov
PF-04360365 10 mg/kg	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
PF-04360365 5 mg/kg	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
PF-04360365 3 mg/kg	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
PF-04360365 1 mg/kg	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
AGG-523 (Aggrecanase Inhibitor)	Other	Phase PHASE1	Osteoarthritis	ClinicalTrials.gov
PF-04603629	Other	Phase PHASE1	Diabetes Mellitus, Type 2	ClinicalTrials.gov
AG-013736	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
SLV-313 SR	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
SLV-351	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
VIP program	Other	Approved	Vascular Disease	ClinicalTrials.gov
Action Score	Other	Approved	Vascular Disease	ClinicalTrials.gov
PF-04457845, FAAH inhibitor	Other	Phase PHASE1	Acute Pain	ClinicalTrials.gov
pharmacokinetic (how the body absorbs and eliminates) interaction	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
levonorgestrel/ethinyl estradiol	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Arginine	Other	Approved	Diabetes Mellitus	ClinicalTrials.gov
Glucose clamp	Other	Approved	Diabetes Mellitus	ClinicalTrials.gov
MR imaging	Other	Approved	Diabetes Mellitus	ClinicalTrials.gov
CP-945,598	Other	Phase PHASE1	Obesity	ClinicalTrials.gov
PF-04171327 Tablet	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Placebo Solution	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-04171327	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Rifampin	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
sibutramine	Other	Phase PHASE2	Obesity	ClinicalTrials.gov
CP-690,550 + midazolam; midazolam	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
midazolam; CP-690,550 + midazolam	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
CP- 690,550 and Cyclosporine	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
CP- 690,550 and Tacrolimus	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Active treatment	Drug	Phase PHASE1	Non-Alcoholic Steatohepatitis(NASH)	ClinicalTrials.gov
UFT	Other	Phase PHASE3	Colon Cancer	ClinicalTrials.gov
Isovorin	Other	Phase PHASE3	Colon Cancer	ClinicalTrials.gov
TS-1	Other	Phase PHASE3	Gastric Cancer	ClinicalTrials.gov
Paracoxib	Other	Phase PHASE3	Colectomy	ClinicalTrials.gov
PF-04494700 - High Dose Arm	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
PF-04494700 - Low Dose Arm	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
Bazedoxifene Acetate (TSE-424)	Other	Phase PHASE3	Osteoporosis	ClinicalTrials.gov
EKB-569	Other	Phase PHASE2	Colorectal Neoplasms	ClinicalTrials.gov
MAC-321	Other	Phase PHASE2	Colorectal Neoplasms	ClinicalTrials.gov
Gemtuzumab Ozogamicin	Other	Phase PHASE2	Acute Myeloid Leukemia	ClinicalTrials.gov
Ambulatory Blood Pressure and Heart Rate Monitoring	Other	Preclinical	Heart Rate	ClinicalTrials.gov
Treadmill testing	Other	Preclinical	Heart Rate	ClinicalTrials.gov
SKI-606 (Bosutinib)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Non Interventional Observation	Other	Preclinical	Acromegaly	ClinicalTrials.gov
HTC-867	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
ambulatory blood pressure monitoring	Other	Phase PHASE4	Hypertension	ClinicalTrials.gov
Ramipril	Other	Phase PHASE4	Hypertension	ClinicalTrials.gov
Insulin lispro (Humalog)	Other	Phase PHASE4	Diabetes Mellitus, Type 1	ClinicalTrials.gov
Inhaled Human Insulin (Exubera®)	Other	Phase PHASE4	Diabetes Mellitus, Type 1	ClinicalTrials.gov
SRA-333	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
InductOs	Other	Phase PHASE4	Tibial Fractures	ClinicalTrials.gov
Third generation cephalosporins	Other	Phase PHASE4	ICU Patient	ClinicalTrials.gov
PSI-697	Other	Phase PHASE1	Scleritis	ClinicalTrials.gov
28 Joint Disease Activity Score	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Musculoskeletal Ultrasound	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
PF-00572778	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
alprazolam	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Dicloxacillin	Other	Phase PHASE3	Bacterial Infections	ClinicalTrials.gov
Oxacillin	Other	Phase PHASE3	Bacterial Infections	ClinicalTrials.gov
Vancomycin	Other	Phase PHASE3	Bacterial Infections	ClinicalTrials.gov
support and visits	Other	Phase PHASE2	Tobacco Dependence	ClinicalTrials.gov
Blood Sampling	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ILV-095	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Normal Saline	Other	Phase PHASE4	Sedation	ClinicalTrials.gov
Dexmedetomidine	Other	Phase PHASE4	Sedation	ClinicalTrials.gov
Atorvastatin (10 mg or 80 mg)	Other	Phase PHASE2	Foot Ulcer	ClinicalTrials.gov
piperacillin/tazobactam	Other	Preclinical	Urinary Infections	ClinicalTrials.gov
SU011248 (sunitinib)	Other	Phase PHASE2	Carcinoma, Renal Cell Metastasis	ClinicalTrials.gov
PF-04494700 (TTP488)	Other	Phase PHASE2	Diabetic Nephropathy	ClinicalTrials.gov
ADEC Program	Other	Preclinical	Disease Management	ClinicalTrials.gov
Dalbavancin	Other	Phase PHASE1	Bacterial Infections	ClinicalTrials.gov
RN624 (PF-04383119)	Other	Phase PHASE2	Osteoarthritis	ClinicalTrials.gov
CE 224,535	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
CE-224,535	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
PF-04360365	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
CP-464,005	Other	Phase PHASE3	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Unfractionated heparin	Other	Phase PHASE4	Venous Thromboembolism	ClinicalTrials.gov
Dalteparin (Fragmin)	Other	Phase PHASE4	Venous Thromboembolism	ClinicalTrials.gov
PF-04455242	Other	Phase PHASE1	Bipolar Depression	ClinicalTrials.gov
PF-00868554 or Placebo	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Amlodipine	Other	Phase PHASE3	Hypertension	ClinicalTrials.gov
Azithromycin SR Placebo	Other	Phase PHASE3	Chronic Bronchitis	ClinicalTrials.gov
Moxifloxacin Placebo	Other	Phase PHASE3	Chronic Bronchitis	ClinicalTrials.gov
Sunitinib malate (SU011248)	Other	Phase PHASE1	Gastrointestinal Stromal Tumors	ClinicalTrials.gov
AG-103736	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Dimebon + Omeprazole	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
Dimebon + Ketoconazole	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
Dimebon alone	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
PF-04878691 9mg	Other	Phase PHASE1	Hepatitis C Virus	ClinicalTrials.gov
PF-04878691 6mg	Other	Phase PHASE1	Hepatitis C Virus	ClinicalTrials.gov
PF-04878691 3mg	Other	Phase PHASE1	Hepatitis C Virus	ClinicalTrials.gov
Losartan	Other	Phase PHASE2	Hypertension	ClinicalTrials.gov
Message Prime	Other	Phase PHASE4	Smoking Cessation	ClinicalTrials.gov
Midazolam 2 mg	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-04171327 25 mg	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
neoadjuvant therapy	Drug	Phase PHASE2	Esophageal Cancer	ClinicalTrials.gov
conventional surgery	Procedure	Phase PHASE2	Esophageal Cancer	ClinicalTrials.gov
adjuvant therapy	Drug	Phase PHASE2	Esophageal Cancer	ClinicalTrials.gov
CP-675,206	Other	Preclinical	Advanced Unresectable Melanoma	ClinicalTrials.gov
Diuretic-Based or Non-Diuretic Based Hypertension Therapy	Drug	Approved	Hypertension	ClinicalTrials.gov
PF-03654764	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04531083	Other	Preclinical	Pain	ClinicalTrials.gov
Tolterodine & Pregabalin	Other	Phase PHASE2	Overactive Bladder	ClinicalTrials.gov
Tolterodine	Other	Phase PHASE2	Overactive Bladder	ClinicalTrials.gov
Endurance exercise	Other	Phase PHASE3	Renal Cell Carcinoma	ClinicalTrials.gov
PF 03882845 and Placebo	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Olmesartan medoxomil	Other	Preclinical	Hypertension	ClinicalTrials.gov
Taxotere	Other	Phase PHASE1	Breast Neoplasms	ClinicalTrials.gov
Sunitinib (Sutent)	Other	Phase PHASE1	Breast Neoplasms	ClinicalTrials.gov
test [PF-00299804 + dextromethorphan]	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
reference [dextromethorphan]	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
spiradoline	Other	Phase PHASE1	Bipolar Depression	ClinicalTrials.gov
PF-3864086	Other	Phase PHASE1	Pain	ClinicalTrials.gov
Varenicline Tartrate Controlled Release	Other	Phase PHASE1	Pharmacokinetics	ClinicalTrials.gov
Dimebon MR4	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
Dimebon MR3	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
Dimebon MR2	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
Dimebon MR1	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
Dimebon IR Tablet	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
Minocycline capsules,	Other	Phase PHASE3	Acne Vulgaris	ClinicalTrials.gov
Azithromycin microspheres-placebo	Other	Phase PHASE3	Acne Vulgaris	ClinicalTrials.gov
minocycline-placebo capsules	Other	Phase PHASE3	Acne Vulgaris	ClinicalTrials.gov
Azithromycin microspheres	Other	Phase PHASE3	Acne Vulgaris	ClinicalTrials.gov
Oral Capecitabine with Irinotecan	Other	Phase PHASE3	Colorectal Neoplasms	ClinicalTrials.gov
Infusional 5-FU/LV with Irinotecan	Other	Phase PHASE3	Colorectal Neoplasms	ClinicalTrials.gov
miFL + bevacizumab	Other	Phase PHASE3	Colorectal Neoplasms	ClinicalTrials.gov
FOLFIRI + bevacizumab	Other	Phase PHASE3	Colorectal Neoplasms	ClinicalTrials.gov
Modified Bolus 5-FU/LV with Irinotecan	Other	Phase PHASE3	Colorectal Neoplasms	ClinicalTrials.gov
Imipramine, pregabalin	Other	Phase PHASE4	Polyneuropathy	ClinicalTrials.gov
Imipramine	Other	Phase PHASE4	Polyneuropathy	ClinicalTrials.gov
AG 6013736	Other	Phase PHASE2	Thyroid Cancer	ClinicalTrials.gov
CE-326,597	Other	Phase PHASE1	Obesity	ClinicalTrials.gov
Diptheria and tetanus toxoids and accelular pertussis vaccine (DTaP)	Other	Phase PHASE1	Pneumococcal Infections	ClinicalTrials.gov
PF-03526299	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Montelukast	Other	Phase PHASE1	Asthma	ClinicalTrials.gov
PF-03893787	Other	Phase PHASE1	Asthma	ClinicalTrials.gov
Interferon-alfa	Other	Phase PHASE3	Carcinoma, Renal Cell	ClinicalTrials.gov
PF-04308515	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Randomization to Exubera (insulin human [rDNA origin] inhalation powder) or Usual Diabetes Care	Other	Phase PHASE4	Diabetes Mellitus	ClinicalTrials.gov
Dimebon Transdermal	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
Dimebon IR	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
PF-04191834	Other	Preclinical	Asthma	ClinicalTrials.gov
anidulafungin and voriconazole	Other	Phase PHASE4	Aspergillosis	ClinicalTrials.gov
Darunavir/ritonavir	Other	Phase PHASE4	HIV-1 Adults Patients	ClinicalTrials.gov
PF-02413873 Placebo	Other	Phase PHASE1	Endometriosis	ClinicalTrials.gov
PF-02413873 500 mg QD	Other	Phase PHASE1	Endometriosis	ClinicalTrials.gov
PF-02413873 20 mg QD	Other	Phase PHASE1	Endometriosis	ClinicalTrials.gov
PF-02413873 1500 mg QD	Other	Phase PHASE1	Endometriosis	ClinicalTrials.gov
PF-02413873 100 mg QD	Other	Phase PHASE1	Endometriosis	ClinicalTrials.gov
CP-690,550	Other	Phase PHASE1	Hepatic Insufficiency	ClinicalTrials.gov
PD 0332334	Other	Phase PHASE1	Generalized Anxiety Disorder	ClinicalTrials.gov
cimetidine	Other	Phase PHASE1	Generalized Anxiety Disorder	ClinicalTrials.gov
PD-0332334	Other	Phase PHASE1	Renal Dialysis	ClinicalTrials.gov
carboplatin + SU011248 (sunitinib) + paclitaxel	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Sunitinib (SU011248)	Other	Phase PHASE2	Liver Neoplasms	ClinicalTrials.gov
Irinotecan + cisplatin	Other	Phase PHASE3	Small Cell Lung Carcinoma	ClinicalTrials.gov
Etoposide + cisplatin	Other	Phase PHASE3	Small Cell Lung Carcinoma	ClinicalTrials.gov
Alprazolam extended release	Other	Phase PHASE2	Generalized Anxiety Disorder	ClinicalTrials.gov
PF-03882845 or Placebo	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
SU011248 capsule	Other	Phase PHASE2	Carcinoma, Renal Cell	ClinicalTrials.gov
Celecoxib + Exemestane	Other	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
Rapamune®	Other	Phase PHASE3	Kidney Disease	ClinicalTrials.gov
[14C]PF00299804	Other	Phase PHASE1	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
Amoxicillin/Clavulanate	Other	Phase PHASE4	Sinusitis	ClinicalTrials.gov
Azithromycin Extended Release	Other	Phase PHASE4	Sinusitis	ClinicalTrials.gov
Insulin Lispro	Other	Phase PHASE3	Diabetes Mellitus	ClinicalTrials.gov
Miat Monohaler	Other	Preclinical	Asthma	ClinicalTrials.gov
Twisthaler	Other	Preclinical	Asthma	ClinicalTrials.gov
Diskus	Other	Preclinical	Asthma	ClinicalTrials.gov
CRC-749	Other	Preclinical	Asthma	ClinicalTrials.gov
PF-04776548	Other	Phase PHASE1	Human Immunodeficiency Virus (HIV)	ClinicalTrials.gov
GSI-136	Other	Phase PHASE1	Alzheimer Disease	ClinicalTrials.gov
Smoking counseling	Other	Phase PHASE4	Smoking	ClinicalTrials.gov
Exubera® (inhaled insulin)	Other	Phase PHASE2	Diabetes Mellitus	ClinicalTrials.gov
PF-04531083 or Placebo	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Amodiaquine (Comparator)	Other	Phase PHASE1	Falciparum Malaria	ClinicalTrials.gov
Amodiaquine (Test)	Other	Phase PHASE1	Falciparum Malaria	ClinicalTrials.gov
Flavoquine®, Camoquin® Suspension	Other	Phase PHASE4	Falciparum Malaria	ClinicalTrials.gov
Active	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Sirolimus (Rapamune®)	Other	Phase PHASE3	Renal Transplant	ClinicalTrials.gov
Ertapenem	Other	Phase PHASE3	Bacterial Infections	ClinicalTrials.gov
SU011248; Gemcitabine	Other	Phase PHASE1	Solid Tumors	ClinicalTrials.gov
SU011248; Capecitabine	Other	Phase PHASE1	Solid Tumors	ClinicalTrials.gov
pantoprazole sodium enteric-coated spheroid suspension	Other	Phase PHASE3	Gastroesophageal Reflux	ClinicalTrials.gov
pantoprazole sodium enteric-coated spheroid	Other	Phase PHASE3	Gastroesophageal Reflux	ClinicalTrials.gov
Fluticasone propionate	Other	Phase PHASE1	Allergic Rhinitis	ClinicalTrials.gov
Arsuamoon	Other	Phase PHASE4	Healthy Volunteers	ClinicalTrials.gov
artesunate sachets	Other	Phase PHASE4	Healthy Volunteers	ClinicalTrials.gov
Genotonorm (Somatropin)	Other	Phase PHASE3	Fetal Growth Retardation	ClinicalTrials.gov
CP 690,550 oral solutions	Other	Phase PHASE1	Arthritis, Rheumatoid	ClinicalTrials.gov
Moxifloxacin 400 mg	Other	Phase PHASE1	Bacterial Infections	ClinicalTrials.gov
Linezolid 600 mg	Other	Phase PHASE1	Bacterial Infections	ClinicalTrials.gov
Linezolid 1200 mg	Other	Phase PHASE1	Bacterial Infections	ClinicalTrials.gov
Linezolid 900 mg	Other	Phase PHASE1	Bacterial Infections	ClinicalTrials.gov
PF-00734200 2 mg QD	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
PF-00734200 5 mg QD	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
PF-00734200 20 mg QD	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
PF-00734200 10 mg QD	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Artesunate (Comparator)	Other	Phase PHASE1	Falciparum Malaria	ClinicalTrials.gov
Artesunate (Test)	Other	Phase PHASE1	Falciparum Malaria	ClinicalTrials.gov
PF-01913539 5 mg	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
Etanercept (Enbrel)	Other	Phase PHASE4	Ankylosing Spondylitis	ClinicalTrials.gov
Rescriptor	Other	Preclinical	HIV-1 Infection	ClinicalTrials.gov
PF-04457845 / matched placebo	Other	Phase PHASE1	Sleep	ClinicalTrials.gov
growth hormone and gonadotropin-releasing hormone agonist	Other	Approved	SGA and Growth	ClinicalTrials.gov
varenicline tartrate (CP-526, 555-18)	Other	Phase PHASE4	Smoking Cessation	ClinicalTrials.gov
crizotinib	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Aromasin (exemestane)	Other	Preclinical	Post Menopausal Women With Early Breast Cancer	ClinicalTrials.gov
Placebo PF	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04447943 25 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
CSF cohort	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Food Effect cohort	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-03382792	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-03382792 Cohort 2	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-03382792 Cohort 1	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04991532	Other	Phase PHASE1	Diabetes Mellitus	ClinicalTrials.gov
CP-690,550 + ethinyloestradiol (EE) and levonorgestrel (LN), ethinyloestradiol (EE) and levonorgestrel (LN)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ethinyloestradiol (EE) and levonorgestrel (LN), CP-690,550 + ethinyloestradiol (EE) and levonorgestrel (LN)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tasocitinib 10 mg IV Infusion	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tasocitinib 10 mg oral tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Fragmin (dalteparin sodium )	Other	Preclinical	Acute Deep Vein Thrombosis	ClinicalTrials.gov
Allegra-D	Other	Phase PHASE2	Allergic Rhinitis	ClinicalTrials.gov
Allegra	Other	Phase PHASE2	Allergic Rhinitis	ClinicalTrials.gov
SAM-531 and gemfibrozil	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05241328	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05150122	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05089771	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05186462	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
chloroquine (CQ)	Other	Phase PHASE1	Malaria Prophylaxis	ClinicalTrials.gov
azithromycin (AZ)	Other	Phase PHASE1	Malaria Prophylaxis	ClinicalTrials.gov
test chloroquine (CQ) formulation	Other	Phase PHASE1	Malaria Prophylaxis	ClinicalTrials.gov
azithromycin (AZ) microsphere	Other	Phase PHASE1	Malaria Prophylaxis	ClinicalTrials.gov
Lersivirine + Methadone	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Methadone	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Methotrexate; sulfasalazine; hydroxychloroquine;leflunomide	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Etanercept , Methotrexate	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Moxidectin	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04995274	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Folinic Acid + 5 FU	Other	Phase PHASE3	Colorectal Neoplasms	ClinicalTrials.gov
Irinotecan + 5 FU + folinic acid	Other	Phase PHASE3	Colorectal Neoplasms	ClinicalTrials.gov
PF-04634817	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04634817 Placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
fesoterodine fumarate	Other	Phase PHASE3	Overactive Bladder	ClinicalTrials.gov
Sitaxentan sodium/Placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tasocitinib (CP-690,550) plus Rifampin	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
FXR-450	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04418948	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tibolone (Livial)	Other	Phase PHASE4	Vasomotor Symptoms	ClinicalTrials.gov
17B Estradiol (1mg) / (0.125 mg) TMG Continuous combined (Totelle)	Other	Phase PHASE4	Vasomotor Symptoms	ClinicalTrials.gov
no drug	Drug	Preclinical	Choroidal Neovascularization (CNV)	ClinicalTrials.gov
Maraviroc (UK-427,857)	Other	Phase PHASE2	HIV Infections	ClinicalTrials.gov
Atorvastatin, 10mg, 20mg, 40mg	Other	Phase PHASE4	Diabetes Mellitus, Hypercholessterolemia	ClinicalTrials.gov
maraviroc (Selzentry, Celsentri)	Other	Phase PHASE1	Human Immunodeficiency Virus (HIV) Infection	ClinicalTrials.gov
Sutent: observational study	Other	Preclinical	Renal Cell Carcinoma	ClinicalTrials.gov
Genotonorm	Other	Phase PHASE3	Growth Disorders	ClinicalTrials.gov
Etanercept, Methotrexate, Prednisolone	Other	Approved	Behcet Syndrome	ClinicalTrials.gov
PF-04236921	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Muscle biopsy	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-04805712	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Optimized Background Therapy (OBT)	Drug	Phase PHASE2	HIV Infections	ClinicalTrials.gov
CVX-045	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
PF-00232798	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Erlotinib	Other	Phase PHASE2	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
PF-3512676 + Erlotinib	Other	Phase PHASE2	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
solifenacin	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Epirubicin: Observational Study	Other	Preclinical	Breast Neoplasm	ClinicalTrials.gov
PF-03715455	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Pegaptanib	Other	Preclinical	Macular Degeneration	ClinicalTrials.gov
Treatment G	Drug	Phase PHASE1	Pharmacokinetics	ClinicalTrials.gov
Treatment F	Drug	Phase PHASE1	Pharmacokinetics	ClinicalTrials.gov
SNRI or SSRI second-line treatment charts	Drug	Preclinical	Major Depressive Disorder	ClinicalTrials.gov
SNRI or SSRI first-line treatment charts	Drug	Preclinical	Major Depressive Disorder	ClinicalTrials.gov
Pristiq second-line treatment charts	Drug	Preclinical	Major Depressive Disorder	ClinicalTrials.gov
Pristiq first-line treatment charts	Drug	Preclinical	Major Depressive Disorder	ClinicalTrials.gov
New Genotropin Pen	Other	Phase PHASE3	Growth Hormone Deficiency	ClinicalTrials.gov
voriconazole (Vfend)	Other	Phase PHASE2	Candidiasis	ClinicalTrials.gov
Minocycline	Other	Phase PHASE2	Amyotrophic Lateral Sclerosis	ClinicalTrials.gov
Creatine	Other	Phase PHASE2	Amyotrophic Lateral Sclerosis	ClinicalTrials.gov
Tolterodine ER	Other	Phase PHASE3	Overactive Bladder	ClinicalTrials.gov
10 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
5 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
1 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tasocitinib (CP-690,55) plus Ketoconazole	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Observational Trial	Other	Preclinical	Siderosis	ClinicalTrials.gov
Test Drug	Drug	Phase PHASE1	Bioequivalence	ClinicalTrials.gov
Reference Drug	Drug	Phase PHASE1	Bioequivalence	ClinicalTrials.gov
Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)	Other	Phase PHASE2	Depression	ClinicalTrials.gov
Morphine	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Diphenhydramine	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Cyclosporin or tacrolimus	Other	Phase PHASE3	Graft Rejection	ClinicalTrials.gov
PH-797804 Phase2b/3 without sodium lauryl sulphate	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PH-797804 Phase2b/3 with sodium lauryl sulphate	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PH-797804 material sparing tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05212377 (SAM-760)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05161704 or Placebo	Other	Phase PHASE1	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Bendamustine	Other	Phase PHASE1	Mantle Cell Lymphoma	ClinicalTrials.gov
sunitinib + mFOLFOX6	Other	Phase PHASE1	Colorectal Neoplasms	ClinicalTrials.gov
PD-0299685	Other	Phase PHASE2	Hot Flashes	ClinicalTrials.gov
Sunitinib, Pemetrexed	Other	Phase PHASE1	Neoplasm, Malignant	ClinicalTrials.gov
imatinib mesylate	Other	Phase PHASE3	Gastrointestinal Stromal Tumor	ClinicalTrials.gov
Retrospective study-	Other	Preclinical	Parkinson's Disease	ClinicalTrials.gov
etest susceptability testing	Other	Preclinical	Methicillin-resistant Staphylococcal Aureus Pneumonia	ClinicalTrials.gov
timolol	Other	Phase PHASE3	Glaucoma	ClinicalTrials.gov
PhXA41	Other	Phase PHASE3	Glaucoma	ClinicalTrials.gov
placebo for PD 0299685	Other	Phase PHASE2	Interstitial Cystitis	ClinicalTrials.gov
PD 0299685 at 30mg BID	Other	Phase PHASE2	Interstitial Cystitis	ClinicalTrials.gov
PD 0299685 at 15mg BID	Other	Phase PHASE2	Interstitial Cystitis	ClinicalTrials.gov
Begacestat	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Donepezil plus placebo	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
GSI-953	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
esreboxetine	Other	Phase PHASE1	Fibromyalgia	ClinicalTrials.gov
[14C]-esreboxetine	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Sunitinib, Pemetrexed, Cisplatin, Carboplatin	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Tazocin (pipercillin/tazobactam)	Other	Phase PHASE4	Bacterial Infections	ClinicalTrials.gov
Extended-Spectrum-Lactamases (ESBLs)	Other	Phase PHASE4	Bacterial Infection	ClinicalTrials.gov
Letrozole / Temsirolimus (CCI-779)	Other	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
Lansoprazole	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
filibuvir + Oral Contraceptives	Other	Phase PHASE1	Hepatitis C	ClinicalTrials.gov
PF-03463275	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Serum pregnancy test (for women of child-bearing potential)	Other	Phase PHASE2	Sinusitis	ClinicalTrials.gov
Blood sampling for plasma chemistry profile	Other	Phase PHASE2	Sinusitis	ClinicalTrials.gov
Blood sampling for hematology	Other	Phase PHASE2	Sinusitis	ClinicalTrials.gov
Endoscopic Sinus Surgery	Procedure	Phase PHASE2	Sinusitis	ClinicalTrials.gov
Zithromax™ (azithromycin) 500mg tablets	Other	Phase PHASE2	Sinusitis	ClinicalTrials.gov
Fentanyl	Other	Phase PHASE4	Otitis	ClinicalTrials.gov
AD-Standard (Advance Directive-Standard)	Other	Approved	Aging	ClinicalTrials.gov
AD-Easy (Advance Directive-Easy)	Other	Approved	Aging	ClinicalTrials.gov
Desvenlafaxine Succinate	Other	Phase PHASE3	Major Depressive Disorder	ClinicalTrials.gov
Lincomycin	Other	Phase PHASE1	Bacterial Infections	ClinicalTrials.gov
tanezumab	Other	Phase PHASE1	Osteoarthritis Pain	ClinicalTrials.gov
Diflucan IV, oral	Other	Phase PHASE3	Candidiasis	ClinicalTrials.gov
Conventional amphotericin B	Other	Phase PHASE3	Candidiasis	ClinicalTrials.gov
VFENDÂ® I.V., Oral	Other	Phase PHASE3	Candidiasis	ClinicalTrials.gov
Chloroquine	Other	Phase PHASE2	Malaria, Falciparum	ClinicalTrials.gov
Antibiotic	Other	Phase PHASE3	Pneumonia, Pneumococcal	ClinicalTrials.gov
PF-05212365	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
No intervention	Other	Preclinical	Alzheimer Disease	ClinicalTrials.gov
Nelfinavir mesylate, 625 mg	Other	Phase PHASE4	HIV Infection	ClinicalTrials.gov
PF-000592379	Other	Phase PHASE2	Osteoarthritis	ClinicalTrials.gov
Oxycodone	Other	Phase PHASE2	Osteoarthritis	ClinicalTrials.gov
PF 03654746	Other	Phase PHASE1	Schizophrenia	ClinicalTrials.gov
PF-04287881	Other	Phase PHASE1	Respiratory Tract Infections	ClinicalTrials.gov
exemestane (Aromasin)	Other	Phase PHASE3	Metastatic Breast Cancer	ClinicalTrials.gov
Megestrol acetate	Other	Phase PHASE3	Metastatic Breast Cancer	ClinicalTrials.gov
Desvenlafaxine Succinate Sustained-Release 50 mg	Other	Phase PHASE3	Major Depressive Disorder	ClinicalTrials.gov
Desvenlafaxine Succinate Sustained-Release 10mg	Other	Phase PHASE3	Major Depressive Disorder	ClinicalTrials.gov
Azithromycin microspheres 2.0 single dose	Other	Phase PHASE3	Community-Acquired Pneumonia	ClinicalTrials.gov
levofloxacin	Other	Phase PHASE3	Maxillary Sinusitis	ClinicalTrials.gov
azithromycin SR (Zithromax; compound: CP-62,993)	Other	Phase PHASE3	Maxillary Sinusitis	ClinicalTrials.gov
nadifloxacin	Other	Phase PHASE4	Acne Vulgaris	ClinicalTrials.gov
clindamycin	Other	Phase PHASE4	Acne Vulgaris	ClinicalTrials.gov
Atovaquone/Proguanil	Other	Phase PHASE2	Malaria, Falciparum	ClinicalTrials.gov
PHA-794428	Other	Phase PHASE2	Growth Hormone Deficiency	ClinicalTrials.gov
CPG10101	Other	Phase PHASE1	Hepatitis, Chronic Active	ClinicalTrials.gov
Control	Other	Phase PHASE1	Hepatitis, Chronic Active	ClinicalTrials.gov
Lamivudine 150 mg twice daily	Other	Phase PHASE4	HIV Infection	ClinicalTrials.gov
Zidovudine 300 mg twice daily	Other	Phase PHASE4	HIV Infection	ClinicalTrials.gov
nelfinavir 1,250 mg twice daily	Other	Phase PHASE4	HIV Infection	ClinicalTrials.gov
100 mL 0.9% Sodium Chloride intravenous	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Combination ipratropium/salbutamol or placebo (nebulization)	Other	Preclinical	Mild Chronic Obstructive Pulmonary Disease	ClinicalTrials.gov
Treatment B-A	Drug	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Treatment A-B	Drug	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
eletriptan	Other	Phase PHASE4	Migraine	ClinicalTrials.gov
Alivium®	Other	Phase PHASE4	Healthy	ClinicalTrials.gov
Gefitinib + Sunitinib	Other	Phase PHASE1	Carcinoma, Renal Cell	ClinicalTrials.gov
PF-06273588	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Tafamidis meglumin	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05105679	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-02341066	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Morphine, Placebo	Other	Phase PHASE4	Pain, Postoperative	ClinicalTrials.gov
Morphine, Parecoxib	Other	Phase PHASE4	Pain, Postoperative	ClinicalTrials.gov
SD-6010	Other	Phase PHASE3	Knee Osteoarthritis	ClinicalTrials.gov
desvenlafaxine succinate sustained release	Other	Phase PHASE1	Depression - Major Depressive Disorder	ClinicalTrials.gov
PF-05190457	Other	Phase PHASE1	Diabetes Mellitus, Type 2	ClinicalTrials.gov
PH-797804	Other	Phase PHASE2	Neuralgia, Postherpetic	ClinicalTrials.gov
amoxicillin/clavulanate postassium (Augmentin ES-600)	Other	Phase PHASE3	Acute Otitis Media	ClinicalTrials.gov
amoxicillin	Other	Phase PHASE3	Tonsillitis	ClinicalTrials.gov
Zmax	Other	Phase PHASE3	Otitis Media	ClinicalTrials.gov
SU014813	Other	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
Methotrexate	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Imipenem/cilastatin	Other	Phase PHASE4	Methicillin-resistant Staphylococcus Aureus	ClinicalTrials.gov
Epirubicin with a Taxane	Other	Phase PHASE3	Adenocarcinoma	ClinicalTrials.gov
Epirubicin with Cyclophosphamide, followed by a Taxane	Other	Phase PHASE3	Adenocarcinoma	ClinicalTrials.gov
AG-013,958	Other	Phase PHASE1	Age-Related Macular Degeneration	ClinicalTrials.gov
Warfarin plus Fesoterodine	Other	Phase PHASE1	Urinary Bladder, Overactive	ClinicalTrials.gov
warfarin	Other	Phase PHASE1	Urinary Bladder, Overactive	ClinicalTrials.gov
fesoterodine plus fluconazole	Other	Phase PHASE1	Overactive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary Incontinence	ClinicalTrials.gov
Any	Other	Phase PHASE2	Pain	ClinicalTrials.gov
PF-03882845	Other	Phase PHASE1	Diabetes Mellitus, Type 2	ClinicalTrials.gov
filibuvir	Other	Phase PHASE1	Chronic Hepatitis C	ClinicalTrials.gov
Factor IX recovery	Other	Phase PHASE4	Hemophilia B	ClinicalTrials.gov
lamivudine + zidovudine	Other	Phase PHASE3	Diarrhea	ClinicalTrials.gov
Calcium carbonate not administered	Other	Phase PHASE3	Diarrhea	ClinicalTrials.gov
loperamide	Other	Phase PHASE3	Diarrhea	ClinicalTrials.gov
lamivudine	Other	Phase PHASE3	Diarrhea	ClinicalTrials.gov
Calcium Carbonate	Other	Phase PHASE3	Diarrhea	ClinicalTrials.gov
azithromycin immediate release (Zithromax)	Other	Phase PHASE2	Pharmacokinetics	ClinicalTrials.gov
Desvenlafaxine Succinate Sustained-Release (DVS SR)	Other	Phase PHASE3	Major Depressive Disorder	ClinicalTrials.gov
etanercept (EnbrelTM)	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Fx-1006A	Other	Phase PHASE1	Mild Hepatic Dysfunction	ClinicalTrials.gov
Radiotherapy	Drug	Phase PHASE1	Soft Tissue Sarcoma	ClinicalTrials.gov
PF-00299804	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
PF-00734200 30 mg QD	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Tranexamic Acid plus standard of care	Other	Phase PHASE4	Femoral Fractures	ClinicalTrials.gov
Formulation 3	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Formulation 2	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Formulation 1	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Spironolactone	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
100 mg PF-03882845	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
30 mg PF-03882845	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
10 mg PF-03882845	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
3 mg PF-03882845	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-05212377	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
lifestyle, PTA	Other	Approved	Peripheral Vascular Disease	ClinicalTrials.gov
Tigecycline (Tygacil)	Other	Preclinical	Complicated Skin and Skin Structure Infections	ClinicalTrials.gov
Esomeprazole	Other	Phase PHASE2	Gastroesophageal Reflux Disease	ClinicalTrials.gov
PF-00885706	Other	Phase PHASE2	Gastroesophageal Reflux Disease	ClinicalTrials.gov
23vPS	Other	Phase PHASE3	Pneumococcal Infections	ClinicalTrials.gov
13 valent Pneumococcal Conjugate Vaccine	Other	Phase PHASE3	Pneumococcal Infections	ClinicalTrials.gov
Review of clinical records	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
23-valent Pneumococcal Polysaccharide Vaccine	Other	Phase PHASE3	Pneumococcal Vaccines	ClinicalTrials.gov
SU011248/Trastuzumab	Other	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
PF-04308515 Tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
CP-741,952	Other	Phase PHASE2	Obesity	ClinicalTrials.gov
7-Valent Pneumococcal Conjugate Vaccine (7vPnc)	Other	Phase PHASE3	Vaccines, Pneumococcal Conjugate Vaccine	ClinicalTrials.gov
13-Valent Pneumococcal Conjugate Vaccine (13vPnC)	Other	Phase PHASE3	Vaccines, Pneumococcal Conjugate Vaccine	ClinicalTrials.gov
PF-03049423	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
DMARDs or Biologics	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
13vPnC	Other	Phase PHASE3	Pneumococcal Vaccines	ClinicalTrials.gov
Self administration	Other	Preclinical	Fertility	ClinicalTrials.gov
PF-04360365 8.5 mg/kg	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
PF-05212372	Other	Phase PHASE1	Phase 1	ClinicalTrials.gov
desvenlafaxine succinate (DVS) SR	Other	Phase PHASE3	Vasomotor Symptoms	ClinicalTrials.gov
Metformin/CP-690,550	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
voriconazole (VFEND®)	Other	Preclinical	Invasive Fungal Infections	ClinicalTrials.gov
Sunitinib Malate Schedule 4/2	Other	Phase PHASE2	Carcinoma, Renal Cell	ClinicalTrials.gov
Sunitinib Malate Continuous Daily Dosing	Other	Phase PHASE2	Carcinoma, Renal Cell	ClinicalTrials.gov
PF-04991532 + cyclosporine	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04991532 alone	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ANGIOTROFIN	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
TILACEM	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
There is no Intervention. The study is observational.	Other	Preclinical	Ankylosing Spondylitis	ClinicalTrials.gov
as clinical practice	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
Sirolimus (study drug)+ACE inhibitor + statin	Drug	Phase PHASE2	Glomerulonephritis, IGA	ClinicalTrials.gov
ACE inhibitor + statin	Other	Phase PHASE2	Glomerulonephritis, IGA	ClinicalTrials.gov
donepezil (5-10 mg/day)	Other	Phase PHASE2	Schizophrenia	ClinicalTrials.gov
Pegaptanib (Macugen®)	Other	Phase PHASE3	Age-related Macular Degeneration	ClinicalTrials.gov
metronidazole IV 500 mg	Other	Phase PHASE1	Infection	ClinicalTrials.gov
Vfend (voriconazole)	Other	Phase PHASE4	Candidiasis	ClinicalTrials.gov
Diflucan (fluconazole)	Other	Phase PHASE4	Candidiasis	ClinicalTrials.gov
Eraxis (anidulafungin)	Other	Phase PHASE4	Candidiasis	ClinicalTrials.gov
Simvastatin/PF-03882845	Other	Phase PHASE1	Human Volunteers	ClinicalTrials.gov
Recombinant Coagulation Factor IX (BeneFIX)	Other	Phase PHASE3	Hemophilia B	ClinicalTrials.gov
PF-05175157 or Placebo	Other	Phase PHASE1	Diabetes Mellitus, Type 2	ClinicalTrials.gov
PF-05230901	Other	Phase PHASE1	Cachexia	ClinicalTrials.gov
placebo patch	Other	Phase PHASE1	Smoking Cessation	ClinicalTrials.gov
FOLFIRI (The combination regimen of Irinotecan, l-Leucovorin and 5-Fluorouracil)	Other	Phase PHASE2	Unresectable or Metastatic Colorectal Cancer	ClinicalTrials.gov
Dalteparin ( Fragmin)	Other	Phase PHASE4	Angina, Unstable	ClinicalTrials.gov
Surveillance	Other	Preclinical	Pneumonia	ClinicalTrials.gov
Tamoxifen and Desvenlafaxine Succinate Sustained Release	Other	Phase PHASE4	Pharmacokinetics	ClinicalTrials.gov
Tamoxifen	Other	Phase PHASE4	Pharmacokinetics	ClinicalTrials.gov
Aripiprazole + desvenlafaxine succinate sustained release	Other	Phase PHASE4	Pharmacokinetics	ClinicalTrials.gov
Aripiprazole	Other	Phase PHASE4	Pharmacokinetics	ClinicalTrials.gov
Epidemiological study according to clinical practice	Other	Preclinical	Carcinoma, Renal Cell	ClinicalTrials.gov
Letrozole for 34 months	Other	Phase PHASE3	Breast Neoplasms	ClinicalTrials.gov
Temsirolimus (CCI-779) for 34 months	Other	Phase PHASE3	Breast Neoplasms	ClinicalTrials.gov
PF-04937319 / ketoconazole	Other	Phase PHASE1	Human Volunteers	ClinicalTrials.gov
PF-02545920	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF 05212389 or placebo	Other	Phase PHASE1	Obesity	ClinicalTrials.gov
Scopolamine + Donepezil Placebo + PF-04995274 15 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Scopolamine + Donepezil Placebo + PF-04995274 0.25 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Scopolamine + Donepezil 10mg + PF-04995274 Placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Scopolamine + Donepezil 5 mg + PF-04995274 Placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Scopolamine + Donepezil Placebo + PF-04995274 Placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Linezolid or Vancomycin	Other	Preclinical	Sepsis	ClinicalTrials.gov
IVR treatment	Drug	Phase PHASE1	Additional, Effective Methods to Stop Smoking	ClinicalTrials.gov
Varenicline (Champix)	Other	Phase PHASE1	Additional, Effective Methods to Stop Smoking	ClinicalTrials.gov
Extended IVR (integrated voice response technology)	Other	Phase PHASE1	Additional, Effective Methods to Stop Smoking	ClinicalTrials.gov
Sitaxentan	Other	Phase PHASE3	Hypertension, Pulmonary	ClinicalTrials.gov
Active (PF-03526299)	Other	Phase PHASE1	Asthma	ClinicalTrials.gov
Macugen ® (pegaptanib sodium)	Other	Phase PHASE4	Proliferative Diabetic Retinopathy	ClinicalTrials.gov
methylnaltrexone	Other	Phase PHASE4	Pharyngeal Dysfunction	ClinicalTrials.gov
Desvenlafaxine	Other	Phase PHASE4	Major Depression	ClinicalTrials.gov
Observational study so no intervention in the patient.	Other	Preclinical	Bacterial Infections	ClinicalTrials.gov
Crizotinib plus sorafenib	Other	Phase PHASE1	Carcinoma, Renal Cell	ClinicalTrials.gov
Crizotinib plus bevacizumab	Other	Phase PHASE1	Carcinoma, Renal Cell	ClinicalTrials.gov
Crizotinib plus sunitinib	Other	Phase PHASE1	Carcinoma, Renal Cell	ClinicalTrials.gov
Crizotinib plus axitinib	Other	Phase PHASE1	Carcinoma, Renal Cell	ClinicalTrials.gov
Crizotinib plus VEGF inhibitor combinations	Other	Phase PHASE1	Carcinoma, Renal Cell	ClinicalTrials.gov
EMLA positive control	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Capsaicin challenge	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04427429	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Amoxiclav	Other	Preclinical	Community-Acquired Pneumonia	ClinicalTrials.gov
pantoprazole for approximately 9 weeks.	Other	Phase PHASE3	Gastroesophageal Reflux	ClinicalTrials.gov
Paclitaxel,Gemcitabine,Sunitinib	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
Sugar pill	Other	Phase PHASE3	Delirium	ClinicalTrials.gov
PMI-150 (intranasal ketamine)	Other	Phase PHASE3	Pain	ClinicalTrials.gov
tofacitinib (CP-690,550) immediate-release formulation	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
tofacitinib (CP-690,550) modified-release formulation B2	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
tofacitinib (CP-690,550) modified-release formulation B1	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
tofacitinib (CP-690,550) modified-release formulation A	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Fragmin	Other	Phase PHASE2	Diabetic Foot Ulcer	ClinicalTrials.gov
etravirine	Other	Phase PHASE4	Hepatitis B	ClinicalTrials.gov
perioperative chemotherapy	Drug	Phase PHASE2	Colorectal Adenocarcinoma	ClinicalTrials.gov
Blood draw for laboratory testing	Other	Phase PHASE4	Hemophilia A	ClinicalTrials.gov
Moroctocog alfa(AF-CC)	Other	Phase PHASE4	Hemophilia A	ClinicalTrials.gov
anastrozole	Other	Phase PHASE3	Breast Neoplasms	ClinicalTrials.gov
PF-04620110 or Placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06291874 or Placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
linezolid (Zyvox)	Other	Phase PHASE4	Methicillin Resistant Staphylococcus Aureus (MRSA)	ClinicalTrials.gov
Placebo for PH-797804	Other	Phase PHASE1	Chronic Obstructive Pulmonary Disease (COPD)	ClinicalTrials.gov
Placebo for PF-03715455	Other	Phase PHASE1	Chronic Obstructive Pulmonary Disease (COPD)	ClinicalTrials.gov
SSRI	Other	Phase PHASE4	Major Depressive Disorder	ClinicalTrials.gov
Effexor	Other	Phase PHASE4	Major Depressive Disorder	ClinicalTrials.gov
etynodiol diacetate	Other	Phase PHASE1	Therapeutic Equivalency	ClinicalTrials.gov
desvenlafaxine succinate sustained-release	Other	Phase PHASE4	Major Depressive Disorder	ClinicalTrials.gov
Dialogues Time to Talk Program	Other	Phase PHASE4	Depressive Disorder, Major	ClinicalTrials.gov
Tranexamic acid + Standard of Care	Other	Phase PHASE4	Biliary Tract Surgical Procedures	ClinicalTrials.gov
PF-05180999	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
optimized background therapy	Drug	Phase PHASE2	HIV Infections	ClinicalTrials.gov
MARK VII pen	Other	Phase PHASE3	Growth Hormone Deficiency	ClinicalTrials.gov
Genotropin Pen	Other	Phase PHASE3	Growth Hormone Deficiency	ClinicalTrials.gov
adenosine	Other	Phase PHASE3	Coronary Artery Disease	ClinicalTrials.gov
binodenoson	Other	Phase PHASE3	Coronary Artery Disease	ClinicalTrials.gov
Vehicle gel	Other	Phase PHASE2	Foot Ulcer, Diabetic	ClinicalTrials.gov
MRE0094	Other	Phase PHASE2	Foot Ulcer, Diabetic	ClinicalTrials.gov
PF-04217903	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Axitinib [AG-013736]	Other	Phase PHASE2	Melanoma	ClinicalTrials.gov
AG013736	Other	Phase PHASE2	Thyroid Neoplasms	ClinicalTrials.gov
Tolterodine tartrate	Other	Preclinical	Urinary Bladder, Overactive	ClinicalTrials.gov
tacedinaline	Other	Phase PHASE3	Lung Cancer	ClinicalTrials.gov
gemcitabine hydrochloride	Other	Phase PHASE3	Lung Cancer	ClinicalTrials.gov
Standard Ibuprofen	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Novel Ibuprofen	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Placebo; oral	Other	Phase PHASE1	Type 2 Diabetes	ClinicalTrials.gov
ARRY-403, glucokinase activator; oral	Other	Phase PHASE1	Type 2 Diabetes	ClinicalTrials.gov
Dimebon tablet for oral administration	Other	Phase PHASE3	Alzheimer's Disease	ClinicalTrials.gov
PF-06273340	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
CP-424,391	Other	Phase PHASE2	Aging	ClinicalTrials.gov
Sitaxentan sodium	Other	Preclinical	Pulmonary Arterial Hypertension	ClinicalTrials.gov
Norco	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Vycavert	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo for Fluticasone Propionate	Other	Phase PHASE1	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
CP-533,536	Other	Phase PHASE2	Tibial Fractures	ClinicalTrials.gov
CP-533, 536	Other	Phase PHASE2	Tibial Fractures	ClinicalTrials.gov
13vPnC + TIV	Other	Phase PHASE3	Pneumococcal Infections	ClinicalTrials.gov
Interleukin-11 (IL-11 or Neumega)	Other	Phase PHASE2	Leukemia	ClinicalTrials.gov
sitaxsentan	Other	Phase PHASE1	Pulmonary Arterial Hypertension	ClinicalTrials.gov
tadalafil	Other	Phase PHASE1	Pulmonary Arterial Hypertension	ClinicalTrials.gov
marketed oxycodone hydrochloride	Other	Phase PHASE1	Analgesia	ClinicalTrials.gov
oxycodone hydrochloride	Other	Phase PHASE1	Analgesia	ClinicalTrials.gov
Fragmin® (Dalteparin Sodium)	Other	Preclinical	Venous Thromboembolism	ClinicalTrials.gov
Desvenlafaxine Succinate Sustained-Release Formulation 25 mg	Other	Phase PHASE4	Major Depressive Disorder	ClinicalTrials.gov
Desvenlafaxine Succinate Sustained-Release Formulation 50 mg	Other	Phase PHASE4	Major Depressive Disorder	ClinicalTrials.gov
Sutent	Other	Preclinical	Carcinoma, Renal Cell	ClinicalTrials.gov
Pf-04937319	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05297909 525 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05297909 250 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05297909 100 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05297909 25 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PARECOXIB SODIUM	Other	Phase PHASE4	Pain, Postoperative	ClinicalTrials.gov
Premarin new tablet (fed)	Other	Phase PHASE1	Primary Ovarian Insufficiency	ClinicalTrials.gov
Premarin reference tablet (fed)	Other	Phase PHASE1	Primary Ovarian Insufficiency	ClinicalTrials.gov
Premarin new tablet (fasted)	Other	Phase PHASE1	Primary Ovarian Insufficiency	ClinicalTrials.gov
Premarin reference tablet (fasted)	Other	Phase PHASE1	Primary Ovarian Insufficiency	ClinicalTrials.gov
ATR-107 (PF-05230900) IV Infusion	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo IV Infusion	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ATR-107 (PF-05230900) SC Injection	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo SC Injection	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Urine sample collection	Other	Preclinical	Pneumonia, Pneumococcal	ClinicalTrials.gov
Aromatase inhibitors	Other	Preclinical	Breast Neoplasms	ClinicalTrials.gov
Duloxetine 60 mg/day	Other	Phase PHASE3	Depressive Disorder, Major	ClinicalTrials.gov
PF-03732010	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
No Smoking Cessation Treatment Coverage (0%)	Drug	Phase PHASE4	Smoking Cessation	ClinicalTrials.gov
Full Smoking Cessation Treatment Coverage (100%)	Drug	Phase PHASE4	Smoking Cessation	ClinicalTrials.gov
PF-00477736	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Axitinib + Pemetrexed + Cisplatin (Cohort 9)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Axitinib + Gemcitabine + Cisplatin (Cohort 8)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Axitinib + Capecitabine (Cohort 7)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Axitinib + Capecitabine (Cohort 6)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Axitinib + Docetaxel (Cohort 5)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Axitinib + Docetaxel + Carboplatin (Cohort 4a)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Axitinib + Paclitaxel (Cohort 4)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Axitinib + Paclitaxel + Carboplatin (Cohort 3)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Axitinib + Paclitaxel + Carboplatin (Cohort 2)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Axitinib + Paclitaxel + Carboplatin (Cohort 1)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Pegaptanib Sodium 0.3 mg	Other	Phase PHASE4	Age Related Macular Degeneration (AMD)	ClinicalTrials.gov
delivery system	Other	Phase PHASE3	Erectile Dysfunction	ClinicalTrials.gov
Acitretin	Other	Phase PHASE4	Moderate to Severe Psoriasis	ClinicalTrials.gov
Etanercept + Acitretin	Other	Phase PHASE4	Moderate to Severe Psoriasis	ClinicalTrials.gov
Aromasin	Other	Preclinical	Breast Cancer	ClinicalTrials.gov
BMP-655/ACS or Standard of Care	Other	Phase PHASE1	Rotator Cuff Tear	ClinicalTrials.gov
sputum	Other	Approved	Community Acquired Pneumonia	ClinicalTrials.gov
Nasopharyngeal swab	Other	Approved	Community Acquired Pneumonia	ClinicalTrials.gov
urine specimen	Other	Approved	Community Acquired Pneumonia	ClinicalTrials.gov
Chest X-ray	Other	Approved	Community Acquired Pneumonia	ClinicalTrials.gov
Amoxiclav 1000 mg	Other	Preclinical	Maxillary Sinusitis	ClinicalTrials.gov
PF-00217830	Other	Phase PHASE2	Schizophrenia	ClinicalTrials.gov
Macugen (Pegaptanib)	Other	Approved	Proliferative Diabetic Retinopathy	ClinicalTrials.gov
axitinib: observational study	Other	Preclinical	Carcinoma, Renal Cell	ClinicalTrials.gov
Desvenlafaxine administered as a succinate salt in a sustained-release form (DVS SR)	Other	Phase PHASE3	Depression	ClinicalTrials.gov
AG2037	Other	Phase PHASE2	Lung Neoplasms	ClinicalTrials.gov
Elective or emergency abdominal surgery	Procedure	Preclinical	Surgical Wound Infection	ClinicalTrials.gov
Nurse administered treatment algorithm	Drug	Approved	Hypertension	ClinicalTrials.gov
PF-05175157	Other	Phase PHASE1	Diabetes Mellitus, Type 2	ClinicalTrials.gov
PF-05190457 or Placebo	Other	Phase PHASE1	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Axitinib (AG-013736)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Synercid	Other	Phase PHASE3	Gram-Positive Bacterial Infections	ClinicalTrials.gov
SNX-5422	Other	Phase PHASE1	Cancer	ClinicalTrials.gov
EMBEDA (morphine sulfate / naltrexone hydrochloride)	Other	Phase PHASE1	Nondependent Opioid Abuse, Episodic	ClinicalTrials.gov
MS Contin (morphine sulfate, controlled release)	Other	Phase PHASE1	Nondependent Opioid Abuse, Episodic	ClinicalTrials.gov
voriconazole tablet	Other	Preclinical	Serious Fungal Infections	ClinicalTrials.gov
voriconazole IV	Other	Preclinical	Serious Fungal Infections	ClinicalTrials.gov
Clindamycin (or Vancomycin if needed)	Other	Phase PHASE3	Skin Diseases	ClinicalTrials.gov
T-62	Other	Phase PHASE2	Postherpetic Neuralgia	ClinicalTrials.gov
heptavalent pneumococcal conjugate vaccine, Prevenar	Other	Phase PHASE3	Allogeneic Haematopoietic Stem Cell Transplantation	ClinicalTrials.gov
DTaP-IPV-HBV/Hib combination vaccine, Infanrix hexa	Other	Phase PHASE3	Allogeneic Haematopoietic Stem Cell Transplantation	ClinicalTrials.gov
morphine sulfate CR crushed.	Other	Phase PHASE1	Narcotic Abuse	ClinicalTrials.gov
EMBEDA - morphine sulfate/ naltrexone hydrochloride	Other	Phase PHASE1	Narcotic Abuse	ClinicalTrials.gov
CP 675,206	Other	Phase PHASE2	Hepatocellular Carcinoma	ClinicalTrials.gov
T-62 Dose 2	Other	Phase PHASE2	Postherpetic Neuralgia	ClinicalTrials.gov
T-62 Dose 1	Other	Phase PHASE2	Postherpetic Neuralgia	ClinicalTrials.gov
"Investigational"Auto-injector (sumatriptan succinate)	Other	Phase PHASE3	Migraine	ClinicalTrials.gov
Tofimilast	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
morphine sulfate extended release capsules	Other	Phase PHASE4	Pain	ClinicalTrials.gov
Treatment algorithm:caduet, Amlodipine, ACEI-ARB combo dose, a-blocker, b-blocker or spironolactone, dyslipidemic therapy with ezetamide	Drug	Phase PHASE4	Hypertension	ClinicalTrials.gov
fixed dose combination therapy	Drug	Phase PHASE4	Hypertension	ClinicalTrials.gov
Heatwrap 1	Other	Phase PHASE3	Healthy	ClinicalTrials.gov
Treatment switching	Drug	Preclinical	Ankylosing Spondylitis	ClinicalTrials.gov
lab draws and imaging	Other	Phase PHASE4	Psoriasis	ClinicalTrials.gov
Period 2	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Period 1	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Placebo + placebo	Other	Phase PHASE4	Gastric Motility Disorder	ClinicalTrials.gov
Methylnaltrexone + codeine	Other	Phase PHASE4	Gastric Motility Disorder	ClinicalTrials.gov
Codeine only	Other	Phase PHASE4	Gastric Motility Disorder	ClinicalTrials.gov
Methylnaltrexone only	Other	Phase PHASE4	Gastric Motility Disorder	ClinicalTrials.gov
PF-03814735	Other	Phase PHASE1	Solid Tumors	ClinicalTrials.gov
Sunitinib + Capecitabine	Other	Phase PHASE3	Breast Neoplasms	ClinicalTrials.gov
Vascular Endothelial Growth Factor Receptor [VEGFR] and Platelet-Derived Growth Factor Receptor [PDGFR] inhibitor	Other	Phase PHASE2	Kidney Neoplasms	ClinicalTrials.gov
Naltrexone block	Other	Phase PHASE1	Management of Moderate to Severe Pain	ClinicalTrials.gov
OxyContin	Other	Phase PHASE1	Management of Moderate to Severe Pain	ClinicalTrials.gov
ALO-02	Other	Phase PHASE1	Management of Moderate to Severe Pain	ClinicalTrials.gov
alprazolam 1mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
8mg fesoterodine	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
4mg fesoterodine	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Social-contact control	Other	Approved	Eye Disease	ClinicalTrials.gov
Eye care education	Other	Approved	Eye Disease	ClinicalTrials.gov
single blood draw	Other	Phase PHASE4	Hemophilia A	ClinicalTrials.gov
Zyvox (linezolid)	Other	Preclinical	Vancomycin Resistance Enterococcus Faecium	ClinicalTrials.gov
PF-06273340 or Placebo	Other	Phase PHASE1	PAIN	ClinicalTrials.gov
RN316	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ziprazidone	Other	Approved	Schizophrenia	ClinicalTrials.gov
tofacitinib 5 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
tofacitinib 10 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ampicillin sodium/sulbactam sodium	Other	Phase PHASE3	Pneumonia, Bacterial	ClinicalTrials.gov
EMBEDA™ (morphine sulfate/naltrexone hydrochloride) whole	Other	Phase PHASE4	Chronic Pain	ClinicalTrials.gov
EMBEDA™ (morphine sulfate/naltrexone hydrochloride) crush	Other	Phase PHASE4	Chronic Pain	ClinicalTrials.gov
Standard Treatment	Drug	Approved	Smoking Cessation	ClinicalTrials.gov
De-nicotinised cigarettes + standard treatment	Drug	Approved	Smoking Cessation	ClinicalTrials.gov
Arginine-hydrochloride	Other	Preclinical	Diabetes Mellitus, Type 1	ClinicalTrials.gov
18F-FP-DTBZ (18F-AV-133)	Other	Preclinical	Diabetes Mellitus, Type 1	ClinicalTrials.gov
Rimactane® (Rifampicin)	Other	Phase PHASE1	Tuberculosis	ClinicalTrials.gov
Myrin© 2 (Rifampicin + Isoniazid)	Other	Phase PHASE1	Tuberculosis	ClinicalTrials.gov
Biomarkers	Other	Phase PHASE2	Renal Cell Carcinoma	ClinicalTrials.gov
Tumor biopsy	Other	Phase PHASE2	Renal Cell Carcinoma	ClinicalTrials.gov
subjects will receive either infliximab, adalimumab or etanercept	Other	Approved	Psoriasis	ClinicalTrials.gov
Vancomycin (IV)	Other	Phase PHASE3	Bacteremia	ClinicalTrials.gov
Linezolid IV	Other	Phase PHASE3	Bacteremia	ClinicalTrials.gov
Cefazolin IV	Other	Phase PHASE3	Bacteremia	ClinicalTrials.gov
irinotecan hydrochloride	Other	Phase PHASE3	Colorectal Cancer	ClinicalTrials.gov
FOLFIRI regimen	Other	Phase PHASE3	Colorectal Cancer	ClinicalTrials.gov
prinomastat	Other	Phase PHASE2	Brain and Central Nervous System Tumors	ClinicalTrials.gov
mitoxantrone hydrochloride	Other	Phase PHASE3	Prostate Cancer	ClinicalTrials.gov
endocrine-modulating drug therapy	Drug	Phase PHASE3	Prostate Cancer	ClinicalTrials.gov
ampicillin-sulbactam	Other	Phase PHASE4	Skin Diseases, Bacterial	ClinicalTrials.gov
FLECTORÂ® Patch (diclofenac epolamine topical patch) 1.3%	Other	Phase PHASE4	Acute Back Strain	ClinicalTrials.gov
PH-797804 + erythromycin	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
semaxanib	Other	Phase PHASE1	Sarcoma	ClinicalTrials.gov
Non-interventional observational study	Other	Preclinical	Healthy Children After Vaccination	ClinicalTrials.gov
Cohort	Other	Preclinical	Major Depressive Disorder	ClinicalTrials.gov
Calcineurin Inhibitors (either cyclosporine or tacrolimus)+MMF or MPS or AZA+Steroid	Other	Phase PHASE4	Kidney Transplantation	ClinicalTrials.gov
Sirolimus+MMF or MPS or AZA+Steroid	Other	Phase PHASE4	Kidney Transplantation	ClinicalTrials.gov
leflunomide	Other	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
procarbazine hydrochloride	Other	Phase PHASE3	Brain and Central Nervous System Tumors	ClinicalTrials.gov
Vinorelbine	Other	Phase PHASE2	Breast Neoplasm	ClinicalTrials.gov
Hepatic Artery Embolizations	Other	Phase PHASE2	Neuroendocrine Tumor	ClinicalTrials.gov
Lersivirine Modified-Release (fed)	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Lersivirine Modified-Release #3 (fasted)	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Lersivirine Modified-Release #2 (fasted)	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Lersivirine Modified-Release #1 (fasted)	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Lersivirine Immediate-Release (fasted)	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Maraviroc + Telaprevir	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Maraviroc + Boceprevir	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Benzonatate - 600 mg	Other	Phase PHASE1	Cough	ClinicalTrials.gov
Benzonatate - 400 mg	Other	Phase PHASE1	Cough	ClinicalTrials.gov
Temodal/radiotherapy	Drug	Phase PHASE2	Naive Unresectable Glioblastoma	ClinicalTrials.gov
Avastin + Campto / radiotherapy + Temodal + Avastin (4 cures)	Drug	Phase PHASE2	Naive Unresectable Glioblastoma	ClinicalTrials.gov
ICA-105665	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo po TID	Other	Phase PHASE3	Alzheimer Disease	ClinicalTrials.gov
Dimebon 20 mg po TID	Other	Phase PHASE3	Alzheimer Disease	ClinicalTrials.gov
Gemcitabine, nucleoside analogue; intravenous	Other	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
ARRY-334543, EGFR/ErbB2 inhibitor; oral	Other	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
PF-04523655	Other	Phase PHASE1	Age-Related Macular Degeneration	ClinicalTrials.gov
Ramipril and hydrochlorothiazide	Other	Phase PHASE3	Hypertension	ClinicalTrials.gov
morphine sulfate and naltrexone hydrochloride (EMBEDA)	Other	Phase PHASE4	Chronic Disease	ClinicalTrials.gov
PF-04523655 low	Other	Phase PHASE2	Diabetic Retinopathy	ClinicalTrials.gov
PF-04523655 middle	Other	Phase PHASE2	Diabetic Retinopathy	ClinicalTrials.gov
PF-04523655 high	Other	Phase PHASE2	Diabetic Retinopathy	ClinicalTrials.gov
Laser Treatment	Drug	Phase PHASE2	Diabetic Retinopathy	ClinicalTrials.gov
mFOLFOX6	Other	Phase PHASE2	Colorectal Neoplasms	ClinicalTrials.gov
1 mg PF-04523655	Other	Phase PHASE2	Age Related Macular Degeneration	ClinicalTrials.gov
3 mg PF-04523655	Other	Phase PHASE2	Age Related Macular Degeneration	ClinicalTrials.gov
0.5 mg ranibizumab	Other	Phase PHASE2	Age Related Macular Degeneration	ClinicalTrials.gov
7vPnC	Other	Phase PHASE3	Vaccines, Pneumococcal	ClinicalTrials.gov
Tranexamic acid	Other	Phase PHASE2	Gastric Cancer	ClinicalTrials.gov
Randomized diabetes therapy	Drug	Preclinical	Diabetes Mellitus	ClinicalTrials.gov
Interferon Alfa and CCI-779	Other	Phase PHASE3	Carcinoma, Renal Cell	ClinicalTrials.gov
CCI-779	Other	Phase PHASE3	Carcinoma, Renal Cell	ClinicalTrials.gov
Interferon Alfa	Other	Phase PHASE3	Carcinoma, Renal Cell	ClinicalTrials.gov
PF-04691502	Other	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
sulphasalazine (SSZ)	Other	Phase PHASE4	Ankylosing Spondylitis	ClinicalTrials.gov
Macugen	Other	Preclinical	Macular Degeneration	ClinicalTrials.gov
tofacitinib modified-release (MR) formulation	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
vaccine-13vPnC	Other	Phase PHASE3	Pneumococcal Infections	ClinicalTrials.gov
moroctocog alfa (AF-CC)	Other	Phase PHASE1	Hemophilia A	ClinicalTrials.gov
Atorvastatin 10mg versus 40mg.	Other	Phase PHASE4	Coronary Disease	ClinicalTrials.gov
no voriconazole (Vfend)	Other	Preclinical	Non-Melanoma Skin Carcinoma	ClinicalTrials.gov
cholecalciferol	Other	Phase PHASE1	Vitamin D Deficiency	ClinicalTrials.gov
PF-06282999	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
BeneFIX (coagulation factor IX (recombinant))	Other	Preclinical	Hemophilia B	ClinicalTrials.gov
Idoform Plus	Other	Phase PHASE4	Diarrhoea	ClinicalTrials.gov
ziprasidone (Geodon)	Other	Phase PHASE4	Bipolar Disorder	ClinicalTrials.gov
ProNutrients Probiotic	Other	Phase PHASE4	Fecal Analysis	ClinicalTrials.gov
CP-751,871	Other	Phase PHASE1	Advanced Non-Hematologic Malignancies	ClinicalTrials.gov
methotrexate (MTX)	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
PF-06305591	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Intravenous Formulation of PD-0332991	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Oral Drug Formulation of PD-0332991	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
[14C]-PD-0332991	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Sutent (sunitinib)	Other	Phase PHASE2	Metastatic Melanoma	ClinicalTrials.gov
Risperdal	Other	Phase PHASE2	Diabetes	ClinicalTrials.gov
Zyprexa	Other	Phase PHASE2	Diabetes	ClinicalTrials.gov
Other cultures per Clinical routine practice	Other	Preclinical	Streptococcus Pneumoniae	ClinicalTrials.gov
Blood culture	Other	Preclinical	Streptococcus Pneumoniae	ClinicalTrials.gov
Fesoterodine 4mg	Other	Phase PHASE4	Overactive Bladder	ClinicalTrials.gov
Fesoterodine 8mg	Other	Phase PHASE4	Overactive Bladder	ClinicalTrials.gov
latanoprost 0.005%	Other	Preclinical	Glaucoma	ClinicalTrials.gov
dual-chamber syringe	Other	Phase EARLY_PHASE1	Healthy	ClinicalTrials.gov
PF-06342674 Dose J	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06342674 Dose I	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06342674 Dose H	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06342674 Dose F	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06342674 Dose G	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06342674 Dose E	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06342674 Dose D	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06342674 Dose C	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06342674 Dose B	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06342674 Dose A	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib plus itraconazole	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib Alone	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Non-interventional	Other	Preclinical	Renal Cell Carcinoma	ClinicalTrials.gov
Naproxen + PH-797804	Other	Phase PHASE2	Osteoarthritis	ClinicalTrials.gov
Laboratory tests	Other	Phase PHASE4	Hemophilia A	ClinicalTrials.gov
moroctocog alfa (AF-CC) (ReFacto AF)	Other	Phase PHASE4	Hemophilia A	ClinicalTrials.gov
Etanercept (genetical recombination)	Other	Preclinical	Juvenile Idiopathic Arthritis	ClinicalTrials.gov
PF-06372865	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo tofacitinib plus Methotrexate	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Tofacitinib plus placebo methotrexate	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Tasocitinib plus Methotrexate	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Prevenar (13v)	Other	Preclinical	Infants	ClinicalTrials.gov
CE-326,597 5mg QD	Other	Phase PHASE2	Weight Management	ClinicalTrials.gov
CE-326,597 25 mg QD	Other	Phase PHASE2	Weight Management	ClinicalTrials.gov
CE-326,597 50 mg QD	Other	Phase PHASE2	Weight Management	ClinicalTrials.gov
CE-326,597 100 mg QD	Other	Phase PHASE2	Weight Management	ClinicalTrials.gov
Low Calorie Diet	Other	Phase PHASE3	Obesity	ClinicalTrials.gov
Non-pharmacological weight loss program (NPP)	Other	Phase PHASE3	Obesity	ClinicalTrials.gov
CP-945,598 Treatment A	Drug	Phase PHASE3	Obesity	ClinicalTrials.gov
CP-945,598 Treatment B	Drug	Phase PHASE3	Obesity	ClinicalTrials.gov
UK-390,957	Other	Phase PHASE2	Ejaculation	ClinicalTrials.gov
PD-0332991	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
human interferon beta 1a (Rebif)	Other	Phase EARLY_PHASE1	Multiple Sclerosis	ClinicalTrials.gov
mycophenolate mofetil (Cellcept)	Other	Phase EARLY_PHASE1	Multiple Sclerosis	ClinicalTrials.gov
questionnaire	Other	Preclinical	Arthritis, Psoriatic	ClinicalTrials.gov
Pneumococcal 7-valent conjugate vaccine Prevnar	Other	Preclinical	Invasive Pneumococcal Disease	ClinicalTrials.gov
Pathogen detection by blood culture	Other	Phase PHASE4	Hematologic Diseases	ClinicalTrials.gov
Detection of microbial DNA in blood by SeptiFast Test	Other	Phase PHASE4	Hematologic Diseases	ClinicalTrials.gov
Test formulation administered with 40% ethanol	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Test formulation administered with 20% ethanol	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Test formulation administered with water	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Atorvastatin Placebo	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Herceptin	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05280014	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Active Caspofungin	Other	Phase PHASE3	Fungemia	ClinicalTrials.gov
Active Anidulafungin	Other	Phase PHASE3	Fungemia	ClinicalTrials.gov
CP-690,550 30 mg BID	Other	Phase PHASE1	Kidney Transplant	ClinicalTrials.gov
CP-690,550 15 mg BID	Other	Phase PHASE1	Kidney Transplant	ClinicalTrials.gov
CP-690,550 5 mg BID	Other	Phase PHASE1	Kidney Transplant	ClinicalTrials.gov
CP-690-550	Other	Phase PHASE2	Arthritis, Rheumatoid	ClinicalTrials.gov
Adalimumab	Other	Phase PHASE2	Arthritis, Rheumatoid	ClinicalTrials.gov
Somatotropin growth hormone recombinant human	Other	Phase PHASE4	Idiopathic Short Stature	ClinicalTrials.gov
Placebo + Methotrexate	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
CP-690,550 + methotrexate	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
sorafenib	Other	Phase PHASE3	Carcinoma, Hepatocellular	ClinicalTrials.gov
Biologic TNFi	Other	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
CP 690,550	Other	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
Letter to physician/discharge summary	Other	Approved	Cardiovascular Disease	ClinicalTrials.gov
Routine discharge counseling	Other	Approved	Cardiovascular Disease	ClinicalTrials.gov
informing physician if patient has stopped a medication	Drug	Approved	Cardiovascular Disease	ClinicalTrials.gov
Medication use evaluations by community pharmacist	Drug	Approved	Cardiovascular Disease	ClinicalTrials.gov
sharing information with community pharmacist	Other	Approved	Cardiovascular Disease	ClinicalTrials.gov
pocket medication card	Drug	Approved	Cardiovascular Disease	ClinicalTrials.gov
pill box	Other	Approved	Cardiovascular Disease	ClinicalTrials.gov
oral education & written tips for remembering medications	Drug	Approved	Cardiovascular Disease	ClinicalTrials.gov
CP-690,550 (tasocitinib)	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
Menitorix	Other	Phase PHASE3	Vaccines, Pneumococcal	ClinicalTrials.gov
NeisVac-C	Other	Phase PHASE3	Vaccines, Pneumococcal	ClinicalTrials.gov
Pediacel	Other	Phase PHASE3	Vaccines, Pneumococcal	ClinicalTrials.gov
Vardenafil	Other	Phase PHASE4	AIDS	ClinicalTrials.gov
Parecoxib 40mg	Other	Phase PHASE4	Pain	ClinicalTrials.gov
Ketoprofen 100mg	Other	Phase PHASE4	Pain	ClinicalTrials.gov
desvenlafaxine succinate SR	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Risperidone 4mg/day	Other	Phase PHASE2	Schizophrenia	ClinicalTrials.gov
SCA-136 300mg/day	Other	Phase PHASE2	Schizophrenia	ClinicalTrials.gov
SCA-136 150 mg/day	Other	Phase PHASE2	Schizophrenia	ClinicalTrials.gov
SCA-136 50mg/day	Other	Phase PHASE2	Schizophrenia	ClinicalTrials.gov
Epidemiological Non interventional	Other	Preclinical	Hemophilia	ClinicalTrials.gov
SAM-531 5.0 mg	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
SAM-531 3.0 mg	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
SAM-531 1.5 mg	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
zileuton	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
CP-690,550 (tofacitinib)	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
As per routinary clinical care	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
Unintentional exposure in utero	Other	Preclinical	Infant Developmental Assessment	ClinicalTrials.gov
Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg	Other	Phase PHASE3	Contraception	ClinicalTrials.gov
vancomycin with aztreonam	Other	Phase PHASE3	Skin Diseases, Infectious	ClinicalTrials.gov
Pantoprazole for approximately 9 weeks	Other	Phase PHASE3	Gastroesophageal Reflux	ClinicalTrials.gov
Torisel	Other	Phase PHASE1	Adenocarcinoma	ClinicalTrials.gov
Recombinant Human Interleukin-11 (rhIL-11)	Other	Phase PHASE2	Crohn Disease	ClinicalTrials.gov
BDDrFVII	Other	Approved	Hemophilia A	ClinicalTrials.gov
REBETOL	Other	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
Peg-Intron	Other	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
HCV 796	Other	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
risperidone	Other	Phase PHASE3	Schizophrenia	ClinicalTrials.gov
cytarabine.	Other	Phase PHASE2	Acute Myeloid Leukemia	ClinicalTrials.gov
7vPnc pneumococcal conjugate vaccine	Other	Phase PHASE3	Vaccines, Pneumococcal	ClinicalTrials.gov
Dalteparin sodium injection	Other	Phase PHASE4	Deep-Vein Thrombosis	ClinicalTrials.gov
Methotrexate plus ENBREL or ENBREL alone	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
EAA-090	Other	Phase PHASE2	Diabetes Mellitus	ClinicalTrials.gov
CAP: Ceftriaxone, plus if applicable oral clarithromycin	Other	Phase PHASE3	Community Acquired Bacterial Pneumonia	ClinicalTrials.gov
cIAI: Ceftriaxone with metronidazole, plus if applicable aminoglycoside	Other	Phase PHASE3	Community Acquired Bacterial Pneumonia	ClinicalTrials.gov
BMP-655/ACS+Standard of care or Standard of care	Other	Phase PHASE1	Rotator Cuff Tear	ClinicalTrials.gov
Buckwheat Honey	Other	Approved	Infection	ClinicalTrials.gov
Guaifenesin	Other	Approved	Infection	ClinicalTrials.gov
Etoposide	Other	Phase PHASE2	Small Cell Lung Carcinoma	ClinicalTrials.gov
Cisplatin (Or Carboplatin)	Other	Phase PHASE2	Small Cell Lung Carcinoma	ClinicalTrials.gov
figitumumab	Other	Phase PHASE2	Small Cell Lung Carcinoma	ClinicalTrials.gov
Placebo of SAM-760	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
SAM-760	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ceftriaxone plus metronidazole	Other	Phase PHASE4	Appendicitis	ClinicalTrials.gov
ceftriaxone sodium + metronidazole	Other	Phase PHASE4	Appendicitis	ClinicalTrials.gov
DTaP	Other	Phase PHASE4	Healthy Subjects	ClinicalTrials.gov
diphtheria, tetanus, and acellular pertussis vaccine (DTaP)	Other	Phase PHASE4	Healthy Subjects	ClinicalTrials.gov
7-pneumococcal conjugate vaccine (7vPnC)	Other	Phase PHASE4	Healthy Subjects	ClinicalTrials.gov
Sodium chloride solution 0.9% (saline)	Other	Phase PHASE1	Pain	ClinicalTrials.gov
Sodium lauryl sulfate 0.1%	Other	Phase PHASE1	Pain	ClinicalTrials.gov
Topical gel vehicle	Other	Phase PHASE1	Pain	ClinicalTrials.gov
Sodium lauryl sulfate 0.2%	Other	Phase PHASE1	Pain	ClinicalTrials.gov
Ibuprofen 5% topical gel	Other	Phase PHASE1	Pain	ClinicalTrials.gov
surgical intervention alone	Other	Phase PHASE2	Fractures	ClinicalTrials.gov
Maintenance on tacrolimus	Other	Phase PHASE4	Kidney Transplant	ClinicalTrials.gov
Conversion from Tacrolimus to Sirolimus	Other	Phase PHASE4	Kidney Transplant	ClinicalTrials.gov
TBC3711	Other	Phase PHASE2	Resistant Hypertension	ClinicalTrials.gov
Toviaz(fesoterodine) without educational materials	Other	Preclinical	Urinary Bladder, Overactive	ClinicalTrials.gov
Toviaz(fesoterodine) plus educational materials	Other	Preclinical	Urinary Bladder, Overactive	ClinicalTrials.gov
PF-00337210	Other	Phase PHASE1	Neoplasm	ClinicalTrials.gov
Temsirolimus (CCI-779)	Other	Phase PHASE2	Advanced Renal Cell Carcinoma	ClinicalTrials.gov
PF-04895162	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Enbrel 50 mg Autoinjector	Other	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
Enbrel 50 mg Prefilled Syringe	Other	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
PF-06291874	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
biodmards	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
tDMARDs	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
CP-690,550 Vehicle	Other	Phase PHASE1	Dry Eye Syndromes	ClinicalTrials.gov
PF-04449913, ketoconazole	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Bazedoxifene Acetate	Other	Phase PHASE3	Osteoporosis	ClinicalTrials.gov
CP-751,871 + carboplatin + paclitaxel	Other	Phase PHASE1	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
Propofol	Other	Phase PHASE1	Brain Injury	ClinicalTrials.gov
CP- 690 550	Other	Phase PHASE2	Ulcerative Colitis	ClinicalTrials.gov
FOLFOX (oxaliplatin, leucovorin, 5-fluorouracil [5FU])	Other	Phase PHASE2	Colorectal Neoplasms	ClinicalTrials.gov
Bevacizumab (avastin)	Other	Phase PHASE2	Colorectal Neoplasms	ClinicalTrials.gov
FOLFIRI (irinotecan, leucovorin, 5-fluorouracil [5FU])	Other	Phase PHASE2	Colorectal Neoplasms	ClinicalTrials.gov
Sitagliptin 100 mg	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
300 mg PF-04991532	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
150 mg PF-04991532	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
75 mg PF-04991532	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
25 mg PF-04991532	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
iSONEP (sonepcizumab/LT1009)	Other	Phase PHASE1	Pigment Epithelial Detachment	ClinicalTrials.gov
Treatment Optimization Program (educational material)	Drug	Phase PHASE4	Impotence	ClinicalTrials.gov
Sodium Hyaluronate	Other	Phase PHASE2	Dry Eye Syndromes	ClinicalTrials.gov
CP-690,550 Eye drops-vehicle	Other	Phase PHASE2	Dry Eye Syndromes	ClinicalTrials.gov
CP-690,550 Eye drops	Other	Phase PHASE2	Dry Eye Syndromes	ClinicalTrials.gov
CP-751,871, moxifloxacin, saline	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Aldazide	Other	Preclinical	Hypertension	ClinicalTrials.gov
CP-751, 871	Other	Phase PHASE2	Colorectal Neoplasm	ClinicalTrials.gov
Period 3	Other	Phase PHASE1	TTR Cardiomyopathy	ClinicalTrials.gov
Smoking cessation	Other	Preclinical	Smoking Cessation	ClinicalTrials.gov
Tolterodine extended-release (ER) 4mg	Other	Phase PHASE4	Overactive Bladder	ClinicalTrials.gov
PF-04191834 placebo	Other	Phase PHASE2	Osteoarthritis, Knee	ClinicalTrials.gov
Naproxen placebo	Other	Phase PHASE2	Osteoarthritis, Knee	ClinicalTrials.gov
rapamycin	Other	Phase EARLY_PHASE1	Solid Tumors	ClinicalTrials.gov
UK-432,097	Other	Phase PHASE2	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
vitamin B6 (pyridoxine)	Other	Phase PHASE3	Coronary Artery Disease	ClinicalTrials.gov
folic acid, vitamin B12 (cyanocobalamin)	Other	Phase PHASE3	Coronary Artery Disease	ClinicalTrials.gov
folic acid, vitamin B12 (cyanocobalamin), vitamin B6 (pyridoxine)	Other	Phase PHASE3	Coronary Artery Disease	ClinicalTrials.gov
sham rTMS- repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and active venlafaxine	Other	Phase PHASE3	Unipolar Depression	ClinicalTrials.gov
active rTMS -repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed and sham venlafaxine	Other	Phase PHASE3	Unipolar Depression	ClinicalTrials.gov
active venlafaxine and active rTMS-repetitive transcranial magnetic stimulator, Inomed and Alpine Biomed	Other	Phase PHASE3	Unipolar Depression	ClinicalTrials.gov
CP 751,871 (Figitumumab)	Other	Phase PHASE3	Carcinoma, Large Cell	ClinicalTrials.gov
750 mg PF-04991532	Other	Phase PHASE2	Diabetes, Type 2	ClinicalTrials.gov
450 mg PF-04991532	Other	Phase PHASE2	Diabetes, Type 2	ClinicalTrials.gov
Interferon beta -1b	Other	Phase PHASE3	Relapsing Remitting Multiple Sclerosis (RRMS)	ClinicalTrials.gov
New Formulation of rebif - human interferon beta-1a	Other	Phase PHASE3	Relapsing Remitting Multiple Sclerosis (RRMS)	ClinicalTrials.gov
sham injection	Other	Phase PHASE3	Macular Edema	ClinicalTrials.gov
PF-00868554	Other	Phase PHASE2	Hepatitis C	ClinicalTrials.gov
Palbociclib Formulation Test	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib Formulation Reference	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PD 0332991	Other	Phase PHASE1	Relapsed Acute Leukemia	ClinicalTrials.gov
MSIR	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ALO-01	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)	Other	Phase PHASE3	Osteoarthritis	ClinicalTrials.gov
ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride ER)	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Oxycodone + Naltrexone	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Maraviroc (UK-427,857) + Zidovudine/Lamivudine	Other	Phase PHASE3	HIV-1	ClinicalTrials.gov
Efavirenz + Zidovudine/Lamivudine	Other	Phase PHASE3	HIV-1	ClinicalTrials.gov
Maraviroc + Zidovudine/Lamivudine	Other	Phase PHASE3	HIV-1	ClinicalTrials.gov
Placebo or sugar pill	Other	Phase PHASE4	Ischemic Heart Disease	ClinicalTrials.gov
PET Scan	Other	Approved	Hepatocellular Carcinoma	ClinicalTrials.gov
PF-0499132	Other	Phase PHASE1	Diabetes Mellitus, Type 2	ClinicalTrials.gov
DVS SR	Other	Phase PHASE3	Depressive Disorder, Major	ClinicalTrials.gov
bapineuzumab	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
Enbrel group	Other	Preclinical	Pediatric Psoriasis	ClinicalTrials.gov
Temsirolimus (Torisel)	Other	Phase PHASE1	Brain Neoplasms	ClinicalTrials.gov
SBI-087	Other	Phase PHASE2	Active Rheumatoid Arthritis	ClinicalTrials.gov
AG-013726	Other	Phase PHASE1	Colorectal Neoplasms	ClinicalTrials.gov
2 x 15 mg/mL pegvisomant	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
1 x 30 mg/mL pegvisomant	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
HAI conventional chemotherapy	Drug	Phase PHASE2	Metastatic Colorectal Cancer	ClinicalTrials.gov
HAI chronomodulated chemotherapy	Drug	Phase PHASE2	Metastatic Colorectal Cancer	ClinicalTrials.gov
IV cetuximab	Other	Phase PHASE2	Metastatic Colorectal Cancer	ClinicalTrials.gov
Palbociclib administered Fed moderate calorie	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib administered Fed low calorie	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib administered Fed high calorie	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib administered Fasted	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
dacomitinib+antacid	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
dacomitinib fed	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
dacomitinib fasted	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
dacomitinib	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Non Interventional	Other	Preclinical	Renal Cell Carcinoma	ClinicalTrials.gov
CE 0.45 mg/MPA 1.5mg	Other	Phase PHASE3	Endometrial Hyperplasia	ClinicalTrials.gov
tiotropium bromide 1.25µg once daily	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
tiotropium bromide high dose once daily	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
Tiotropium matching Placebo once daily	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
tiotropium bromide 2.5µg once daily	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
Placebo Tiotropium	Other	Phase PHASE4	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
Placebo Salmeterol	Other	Phase PHASE4	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
Tiotropium bromide	Other	Phase PHASE4	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
tiotropium 18 mcg	Other	Phase PHASE4	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
Bapineuzumab 1.0 m/kg	Other	Phase PHASE3	Alzheimer Disease	ClinicalTrials.gov
Bapineuzumab 0.5 mg/kg	Other	Phase PHASE3	Alzheimer Disease	ClinicalTrials.gov
PF-868554	Other	Phase PHASE1	HEPATITIS C (HCV)	ClinicalTrials.gov
Remicade	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06438179	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
CP-751,871 (Figitumumab)	Other	Phase PHASE3	Carcinoma, Squamous Cell	ClinicalTrials.gov
CVD risk profile	Other	Approved	Obesity	ClinicalTrials.gov
Small Molecule Agent (PF-868554)	Other	Phase PHASE1	Hepatitis, Chronic	ClinicalTrials.gov
Pravastatin, midazolam, losartan, omeprazole, caffeine and PF-05089771	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib capsule: ICH	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib capsule: phase 3 studies	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
palbociclib capsule: phase 1 and 2 studies	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
desvenlafaxine succinate sustained-release 100 mg/day	Other	Phase PHASE4	Major Depressive Disorder	ClinicalTrials.gov
desvenlafaxine succinate sustained-release 50 mg/day	Other	Phase PHASE4	Major Depressive Disorder	ClinicalTrials.gov
Ceftriaxone sodium	Other	Phase PHASE3	Intra-abdominal Infections	ClinicalTrials.gov
Metronidazole	Other	Phase PHASE3	Intra-abdominal Infections	ClinicalTrials.gov
EFV +TVA	Other	Phase PHASE2	HIV-1	ClinicalTrials.gov
UK-453, 061	Other	Phase PHASE2	HIV-1	ClinicalTrials.gov
PD-0360324	Other	Phase PHASE1	Cutaneous Lupus Erythematosus	ClinicalTrials.gov
Temsirolimus and capecitabine	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Humira (adalimumab-US)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Humira (adalimumab-EU)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06410293	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Does not apply	Other	Preclinical	Esophagitis	ClinicalTrials.gov
Paracetamol	Other	Phase PHASE4	Pneumococcal Vaccines	ClinicalTrials.gov
HIV therapy	Drug	Phase PHASE4	HIV	ClinicalTrials.gov
C. difficile vaccine +adjuvant	Other	Phase PHASE1	Clostridium Difficile Associated Disease	ClinicalTrials.gov
C. difficile vaccine	Other	Phase PHASE1	Clostridium Difficile Associated Disease	ClinicalTrials.gov
Conventional Mother Care	Other	Phase PHASE3	Low Birth Weight Among Neonates	ClinicalTrials.gov
Kangaroo Mother Care	Other	Phase PHASE3	Low Birth Weight Among Neonates	ClinicalTrials.gov
Ziprasidone, Olanzapine	Other	Approved	Schizophrenia	ClinicalTrials.gov
palbociclib commercial free base capsule	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
palbociclib isethionate (phase 1 and 2 studies)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Xiapex	Other	Phase PHASE3	Dupuytren's Contracture	ClinicalTrials.gov
Genotropin (Recombinant Human Growth Hormone)	Other	Phase PHASE1	Allogeneic Stem Cell Transplantation	ClinicalTrials.gov
Patient Education	Other	Approved	Cardiovascular Risk Factors	ClinicalTrials.gov
PF-06649751	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Glaucoma Educational Intervention	Other	Approved	Glaucoma Medication Adherence	ClinicalTrials.gov
PF-06678552 or Placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06412562 TBD mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
25 mg PF-06412562	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
10 mg PF-06412562	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
3 mg PF-06412562	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
CP-690,550 or Placebo	Other	Phase PHASE1	Arthritis, Rheumatoid	ClinicalTrials.gov
PF-04605412	Other	Phase PHASE1	Advanced Non-Hematologic Malignancies	ClinicalTrials.gov
conjugated estrogens 0.45 mg/ medroxyprogesterone acetate 1.5 mg	Other	Phase PHASE3	Menopause	ClinicalTrials.gov
bazedoxifene 20 mg	Other	Phase PHASE3	Menopause	ClinicalTrials.gov
bazedoxifene 20 mg/ conjugated estrogens 0.625 mg	Other	Phase PHASE3	Menopause	ClinicalTrials.gov
bazedoxifene 20 mg/ conjugated estrogens 0.45 mg	Other	Phase PHASE3	Menopause	ClinicalTrials.gov
BZA 20 mg/CE 0.625 mg	Other	Preclinical	Osteoporosis	ClinicalTrials.gov
BZA 20 mg/CE 0.45 mg	Other	Preclinical	Osteoporosis	ClinicalTrials.gov
crizotinib oral solution	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
crizotinib capsule	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
crizotinib prototype microsphere 0.420 mg/mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
crizotinib prototype microsphere 0.470 mg/mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
crizotinib prototype microsphere 0.529 mg/mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-03654746	Other	Phase PHASE2	Allergic Rhinitis	ClinicalTrials.gov
13-valent Pneumoccocal Conjugate Vaccine	Other	Phase PHASE3	Pneumococcal Conjugate Vaccine	ClinicalTrials.gov
Colonization swab samples	Other	Phase PHASE1	Bacterial Infections	ClinicalTrials.gov
Placebo with no booster in stage 2	Other	Phase PHASE1	Bacterial Infections	ClinicalTrials.gov
SA3Ag with no booster in stage 2	Other	Phase PHASE1	Bacterial Infections	ClinicalTrials.gov
SA3Ag followed by Placebo	Other	Phase PHASE1	Bacterial Infections	ClinicalTrials.gov
SA3Ag vaccine	Other	Phase PHASE1	Bacterial Infections	ClinicalTrials.gov
Cognitive Behavioural Therapy	Drug	Phase PHASE3	Depression	ClinicalTrials.gov
Study Drug	Drug	Preclinical	Parkinson's Disease	ClinicalTrials.gov
10 mg cetirizine	Other	Phase PHASE1	Migraine	ClinicalTrials.gov
360 mg MR PF-05180999	Other	Phase PHASE1	Migraine	ClinicalTrials.gov
120 mg MR PF-05180999	Other	Phase PHASE1	Migraine	ClinicalTrials.gov
Fragmin, 5-Fluorouracil, Folinic Acid, irinotecan, bevacizumab	Other	Phase PHASE2	Colorectal Cancer	ClinicalTrials.gov
irinotecan, cisplatin, celecoxib	Other	Phase PHASE2	Esophageal Cancer	ClinicalTrials.gov
PF-05180999 Tablets	Other	Phase PHASE1	Migraine	ClinicalTrials.gov
Placebo Tablets	Other	Phase PHASE1	Migraine	ClinicalTrials.gov
PF-06412562	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Spiriva HandiHaler	Other	Phase PHASE4	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
FLUOROQUINOLONE	Other	Phase PHASE2	Hip Prosthetic Joint Infection	ClinicalTrials.gov
SULFAMETHOXAZOLE AND TRIMETHOPRIM (CO-TRIMOXAZOLE)	Other	Phase PHASE2	Hip Prosthetic Joint Infection	ClinicalTrials.gov
CEFTRIAXONE	Other	Phase PHASE2	Hip Prosthetic Joint Infection	ClinicalTrials.gov
Liposomal amphotericin B	Other	Phase PHASE4	Liver Disease	ClinicalTrials.gov
efavirenz	Other	Phase PHASE2	HIV-1	ClinicalTrials.gov
50 mcg salmeterol HFA MDI	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
tiotropium Respimat® high dose	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
tiotropium Respimat® low dose	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
Prevenar13	Other	Phase PHASE2	IgG Deficiency	ClinicalTrials.gov
antacid	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
palbociclib commercial free base	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
famotidine	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04965842	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib 125mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib 100mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib 75mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
bosutinib or bosutinib + aprepitant	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Quillivant Oral Suspension XR	Other	Phase PHASE3	Attention Deficit Hyperactivity Disorder	ClinicalTrials.gov
Artemether-lumefantrine	Other	Phase PHASE2	Malaria, Falciparum	ClinicalTrials.gov
Enbrel treatment	Drug	Preclinical	Plaque Psoriasis Patients	ClinicalTrials.gov
Growth hormone treatment	Drug	Approved	Obese	ClinicalTrials.gov
Tiotropium Respimat	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
Placebo Respimat	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
Neratinib	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
reference drugs	Drug	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
RIN 150	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-06263726	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Minnesota Living with Heart Failure Questionnaire	Other	Approved	Congenital Heart Disease	ClinicalTrials.gov
Six minute walk test	Other	Approved	Congenital Heart Disease	ClinicalTrials.gov
SU011248 & Irinotecan	Other	Phase PHASE1	Glioblastoma	ClinicalTrials.gov
[14C] PF-04449913	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Ibuprofen Sodium	Other	Phase PHASE3	Pain	ClinicalTrials.gov
PF-06678552	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Benzonatate 800 mg	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Benzonatate 200 mg	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
No drug will be administered	Drug	Phase PHASE2	HIV-1	ClinicalTrials.gov
non-biologic anti-rheumatic drugs	Drug	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
PF-04691502 in combination with Letrozole	Other	Phase PHASE2	Early Breast Cancer (Phase 2)	ClinicalTrials.gov
lyrica	Other	Phase PHASE3	Post-operative Pain	ClinicalTrials.gov
Tiotropium 2.5 mcg bid	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
Tiotropium 5 mcg qd	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
PF-06439535	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF- 04965842	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06372865 or Placebo or Lorazepam	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06372865 or Placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
tiotropium 5mcg/day	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
Temodar and Irinotecan	Other	Phase PHASE2	Glioblastoma	ClinicalTrials.gov
Haloperidol	Other	Phase PHASE2	Affective Disorders	ClinicalTrials.gov
PF-05212384	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
tiotropium Respimat high dose	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
tiotropium Respimat low dose	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
BP Monitor	Other	Approved	Cardiovascular Diseases	ClinicalTrials.gov
Nurse administered	Other	Approved	Cardiovascular Diseases	ClinicalTrials.gov
ART intensification (maraviroc)	Other	Phase PHASE2	HIV Infection	ClinicalTrials.gov
ART intensification (raltegravir)	Other	Phase PHASE2	HIV Infection	ClinicalTrials.gov
DNA + HIV-rAd5 vaccine	Other	Phase PHASE2	HIV Infection	ClinicalTrials.gov
100 mg PF-05231023	Other	Phase PHASE1	Type 2 Diabetes Mellitus (T2DM)	ClinicalTrials.gov
Placebo/CP-690,550	Other	Phase PHASE3	Psoriasis	ClinicalTrials.gov
PF-06252616	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06252161	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
CP-195,543	Other	Phase PHASE2	Arthritis, Rheumatoid	ClinicalTrials.gov
No Avatar group	Other	Approved	Overactive Bladder	ClinicalTrials.gov
Avatar group	Other	Approved	Overactive Bladder	ClinicalTrials.gov
480 mg PF-06473871	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
320 mg PF-06473871	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
160 mg PF-06473871	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
80 mg PF-06473871	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
VACCINE: 13-valent pneumococcal conjugate vaccine	Other	Phase PHASE4	Pneumonia, Pneumococcal	ClinicalTrials.gov
VACCINE: placebo	Other	Phase PHASE4	Pneumonia, Pneumococcal	ClinicalTrials.gov
Casodex (bicalutamide)	Other	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
tiotropium low dose	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
tiotropium high dose	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
Group A SLE prospective study	Other	Phase PHASE1	Systemic Lupus Erythematosus	ClinicalTrials.gov
Blood drawing only Group C	Other	Phase PHASE1	Systemic Lupus Erythematosus	ClinicalTrials.gov
Group B SLE one blood donation	Other	Phase PHASE1	Systemic Lupus Erythematosus	ClinicalTrials.gov
PF-06427878	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PH797804	Other	Phase PHASE1	Pain	ClinicalTrials.gov
Lithium	Other	Phase PHASE1	Generalized Anxiety Disease	ClinicalTrials.gov
magnetic resonance spectroscopic imaging	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
pharmacological study	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
laboratory biomarker analysis	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
imaging biomarker analysis	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
Sitaxsentan and Sildenafil	Other	Phase PHASE3	Pulmonary Arterial Hypertension	ClinicalTrials.gov
RN6G	Other	Phase PHASE1	Age-Related Maculopathy	ClinicalTrials.gov
SA4Ag vaccine	Other	Phase PHASE1	Staphylococcal Infections	ClinicalTrials.gov
Adalimumab-EU	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Adalimumab-US	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
tiotropium 5 mcg	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
tiotropium 2.5 mcg	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
Combined Diphtheria-Tetanus-acellular Pertussis (DTPa), Hepatitis B, Poliovirus and Haemophilus influenzae type b vaccine	Other	Phase PHASE3	Neisseria Meningitidis	ClinicalTrials.gov
Pneumococcal 13-valent conjugate vaccine	Other	Phase PHASE3	Neisseria Meningitidis	ClinicalTrials.gov
Meningococcal group C polysaccharide conjugate vaccine	Other	Phase PHASE3	Neisseria Meningitidis	ClinicalTrials.gov
Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT)	Other	Phase PHASE3	Neisseria Meningitidis (Bacterial Meningitis)	ClinicalTrials.gov
7-valent Pneumococcal CRM197-conjugate vaccine (PCV7)	Other	Phase PHASE3	Neisseria Meningitidis (Bacterial Meningitis)	ClinicalTrials.gov
Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT) vaccine and 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7)	Other	Phase PHASE3	Neisseria Meningitidis (Bacterial Meningitis)	ClinicalTrials.gov
Glasdegib	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
ADL5747	Other	Phase PHASE2	Postherpetic Neuralgia	ClinicalTrials.gov
Tofacitinib MR 22 mg (Fasted)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tofacitinib MR 22 mg (Fed)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Intravitreal Pegaptanib	Other	Approved	Myopic Choroidal Neovascular Membrane	ClinicalTrials.gov
dacomitinib intravenous	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
dacomitinib oral	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-06473871	Other	Phase PHASE2	Reduction of Hypertrophic Skin Scarring	ClinicalTrials.gov
Genotropin (somatropin)	Other	Phase PHASE4	Short Stature Born Small for Gestational Age (SGA)	ClinicalTrials.gov
PF-06410293 PFP	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
PF-06410293 PFS	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
EU-approved Neulasta	Other	Phase PHASE1	Neutropenia	ClinicalTrials.gov
US-approved Neulasta	Other	Phase PHASE1	Neutropenia	ClinicalTrials.gov
HSP-130	Other	Phase PHASE1	Neutropenia	ClinicalTrials.gov
Intravenous infusions of Xyntha	Other	Phase PHASE1	Hemophilia A	ClinicalTrials.gov
Vanquix Auto-Injector (Diazepam Injection)	Other	Phase PHASE3	Seizures	ClinicalTrials.gov
LGX818	Other	Phase PHASE2	Melanoma	ClinicalTrials.gov
PF-06342674 6.0 mg/kg	Other	Phase PHASE1	Multiple Sclerosis	ClinicalTrials.gov
PF-06342674 1.5 mg/kg	Other	Phase PHASE1	Multiple Sclerosis	ClinicalTrials.gov
PF-06342674 0.25 mg/kg	Other	Phase PHASE1	Multiple Sclerosis	ClinicalTrials.gov
Observational	Other	Preclinical	Otitis Media	ClinicalTrials.gov
Nose/throat swab	Other	Preclinical	Otitis Media	ClinicalTrials.gov
Tympanocentesis	Other	Preclinical	Otitis Media	ClinicalTrials.gov
PF-06700841 tablet	Other	Phase PHASE1	Plaque Psoriasis	ClinicalTrials.gov
PF-06700841 oral solution/suspension	Other	Phase PHASE1	Plaque Psoriasis	ClinicalTrials.gov
Local radiotherapy	Drug	Phase PHASE2	Lymphoma, Non-Hodgkin	ClinicalTrials.gov
Epogen	Other	Phase PHASE1	Chronic Renal Failure	ClinicalTrials.gov
Epoetin Hospira	Other	Phase PHASE1	Chronic Renal Failure	ClinicalTrials.gov
Antibacterial agent for the treatment of febrile neutropenia	Drug	Preclinical	Febrile Neutropenia	ClinicalTrials.gov
Ointment Vehicle	Other	Phase PHASE2	Psoriasis	ClinicalTrials.gov
AN2728 ointment, 2%	Other	Phase PHASE2	Psoriasis	ClinicalTrials.gov
CVX-096	Other	Phase PHASE1	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Sulbactam Sodium/Ampicillin Sodium	Other	Preclinical	Pneumonia	ClinicalTrials.gov
Placebo , Oxaliplatin	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Pregabalin, Oxaliplatin	Other	Phase PHASE3	Pain	ClinicalTrials.gov
CP690,550	Other	Phase PHASE3	Ulcerative Colitis	ClinicalTrials.gov
Anti-CTLA4 monoclonal antibody and HDI	Other	Phase PHASE2	Melanoma	ClinicalTrials.gov
Ibuprofen 600 mg Immediate Release/Extended Release Caplet	Other	Phase PHASE3	Analgesia	ClinicalTrials.gov
meropenem	Other	Phase PHASE4	Pancreatitis, Acute Necrotizing	ClinicalTrials.gov
MERREM I.V. 500 mg as a 3 hour infusion every 8 hours	Other	Phase PHASE3	Pneumonia	ClinicalTrials.gov
MERREM I.V. 1g as a 30 minute infusion every 8 hours	Other	Phase PHASE3	Pneumonia	ClinicalTrials.gov
tobramycin I.V. 5 mg/kg every 24 hours	Other	Phase PHASE3	Pneumonia	ClinicalTrials.gov
vancomycin I.V. 1 g every 12 hours	Other	Phase PHASE3	Pneumonia	ClinicalTrials.gov
MERREM I.V. 2g as a 3 hour infusion every 8 hours	Other	Phase PHASE3	Pneumonia	ClinicalTrials.gov
ACR/EULAR criteria	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
US power doppler	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Palbociclib 75 mg Capsule	Other	Phase PHASE1	Healthy, Hepatic Insufficiency	ClinicalTrials.gov
Travatan Z	Other	Phase PHASE4	Glaucoma	ClinicalTrials.gov
Xalatan	Other	Phase PHASE4	Glaucoma	ClinicalTrials.gov
Bococizumab (PF-04950615; RN316)	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
4 Pillars Toolkit	Other	Approved	Adolescent HPV Vaccine	ClinicalTrials.gov
PF-06669571	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
CP-601,927	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Enhanced Assessment and Education	Other	Approved	Venous Thromboembolism	ClinicalTrials.gov
Oral Methylprednisolone Tablets	Other	Preclinical	Asthma	ClinicalTrials.gov
non-intervention	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
Non Intervention	Other	Preclinical	Pneumococcal Disease	ClinicalTrials.gov
PF-06651600	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Four Conversations	Other	Approved	Breast Cancer	ClinicalTrials.gov
Best Supportive Care	Other	Phase PHASE2	Hepatocellular Carcinoma	ClinicalTrials.gov
Colonization swab sample	Other	Phase PHASE1	Staphylococcal Infections	ClinicalTrials.gov
SA4Ag vaccine high dose	Other	Phase PHASE1	Staphylococcal Infections	ClinicalTrials.gov
SA4Ag vaccine mid dose	Other	Phase PHASE1	Staphylococcal Infections	ClinicalTrials.gov
SA4Ag vaccine low dose	Other	Phase PHASE1	Staphylococcal Infections	ClinicalTrials.gov
bococizumab (PF-04950615)	Other	Phase PHASE3	Cardiovascular Disease	ClinicalTrials.gov
Not applicable - blood tests/tissue specimen tests will be undertaken	Other	Preclinical	Carcinoma, Renal Cell	ClinicalTrials.gov
Tramadol hydrochloride 37.5 mg/Paracetamol 325 mg tablets - tablet (Pfizer)	Other	Phase PHASE4	Healthy	ClinicalTrials.gov
Ultracet Tablets	Other	Phase PHASE4	Healthy	ClinicalTrials.gov
Desvenlafaxine succinate 50mg	Other	Phase PHASE4	Hot Flashes	ClinicalTrials.gov
Desvenlafaxine succinate 100mg	Other	Phase PHASE4	Hot Flashes	ClinicalTrials.gov
Sayana Press	Other	Phase PHASE4	Contraception	ClinicalTrials.gov
CT-P13	Other	Preclinical	Inflammatory Bowel Diseases	ClinicalTrials.gov
Pneumo-23	Other	Phase PHASE4	Chronic Obstructive Pulmonary Disease	ClinicalTrials.gov
Prevenar-13	Other	Phase PHASE4	Chronic Obstructive Pulmonary Disease	ClinicalTrials.gov
Tools & Education	Other	Approved	Stasis Dermatitis	ClinicalTrials.gov
Motivational Interviewing training for home health aides	Other	Approved	Stasis Dermatitis	ClinicalTrials.gov
Order set	Other	Approved	Stasis Dermatitis	ClinicalTrials.gov
Avelumab	Other	Phase PHASE3	Ovarian Cancer	ClinicalTrials.gov
ARRY-614, p38/Tie2 inhibitor; oral	Other	Phase PHASE1	Myelodysplastic Syndromes	ClinicalTrials.gov
Paclitaxel, mitotic inhibitor; intravenous	Other	Phase PHASE1	Epithelial Ovarian Cancer	ClinicalTrials.gov
MEK162, MEK inhibitor; oral	Other	Phase PHASE1	Epithelial Ovarian Cancer	ClinicalTrials.gov
amphotericin-B	Other	Phase PHASE4	Blastomycosis	ClinicalTrials.gov
MEK162	Other	Phase PHASE1	Advanced Solid Tumor	ClinicalTrials.gov
BKM120 + MEK162	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
ARRY-502	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ARRY-371797, p38 inhibitor; oral	Other	Phase PHASE2	Ankylosing Spondylitis	ClinicalTrials.gov
PF-06649751 high dose (15 mg QD)	Other	Phase PHASE2	Parkinson Disease	ClinicalTrials.gov
PF-06649751 middle dose 2 (7 mg QD)	Other	Phase PHASE2	Parkinson Disease	ClinicalTrials.gov
PF-06649751 middle dose 1 (3 mg QD)	Other	Phase PHASE2	Parkinson Disease	ClinicalTrials.gov
PF-06649751 low dose (1 mg QD)	Other	Phase PHASE2	Parkinson Disease	ClinicalTrials.gov
PF-05221304	Other	Phase PHASE2	Nonalcoholic Fatty Liver Disease	ClinicalTrials.gov
PF-06647020 combined with Avelumab	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
PF-06647020 Q2W	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
PF-06647020 Q3W	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Staphylococcus aureus 4-Antigen (SA4Ag) Vaccine	Other	Phase PHASE2	Staphylococcal Vaccine	ClinicalTrials.gov
PF-06700841 MR3	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06700841 MR2	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06700841 MR1	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06700841 IR	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Intravenous infusion of bosutinib	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Oral Bosutinib	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Control-no treatment	Drug	Phase PHASE3	Infant, Small for Gestational Age	ClinicalTrials.gov
Genotropin (PN-180,307) Somatropin	Other	Phase PHASE3	Infant, Small for Gestational Age	ClinicalTrials.gov
Maraviroc Placebo	Other	Phase PHASE2	Arthritis, Rheumatoid	ClinicalTrials.gov
20 mg PF-02545920	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
23-valent Pneumococcal Polysaccharide Vaccine (23vPS)	Other	Phase PHASE3	HIV Infections	ClinicalTrials.gov
Anrukinzumab	Other	Phase PHASE2	Colitis, Ulcerative	ClinicalTrials.gov
IMA-638 is a biologic	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
Desvenlafaxine succinate sustained release 25 mg	Other	Phase PHASE3	Major Depressive Disorder	ClinicalTrials.gov
Desvenlafaxine succinate sustained release 50 mg	Other	Phase PHASE3	Major Depressive Disorder	ClinicalTrials.gov
rLP2086	Other	Phase PHASE2	Healthy	ClinicalTrials.gov
Routine age appropriate childhood vaccines	Other	Phase PHASE2	Meningitis, Meningococcal	ClinicalTrials.gov
meningococcal B rLP2086 vaccine	Other	Phase PHASE2	Meningitis, Meningococcal	ClinicalTrials.gov
Education	Other	Preclinical	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
Latanoprost SR insert	Other	Phase PHASE1	Primary Open Angle Glaucoma (POAG)	ClinicalTrials.gov
Arm 2	Other	Phase PHASE1	Primary Open Angle Glaucoma (POAG)	ClinicalTrials.gov
Latanoprost	Other	Phase PHASE1	Primary Open Angle Glaucoma (POAG)	ClinicalTrials.gov
Toviaz	Other	Phase PHASE1	Overactive Bladder	ClinicalTrials.gov
PF-06372865 (15mg)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06372865 (65mg)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
30 mg PF-06412562	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ACC-001	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
Intravitreal injection of pegaptanib sodium	Other	Phase PHASE4	Diabetic Macular Oedema	ClinicalTrials.gov
Ethambutol	Other	Phase PHASE2	Pulmonary Tuberculosis Without Resistance to Rifampicin	ClinicalTrials.gov
ACC-001 (vanutide cridificar)	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
PF-06459988	Other	Phase PHASE2	Advanced EGFRm (Del 19 or L858R +/- T790M) NSCLC	ClinicalTrials.gov
PF-05231023	Other	Phase PHASE1	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Trimethobenzamide Hydrochloride	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Fesoterodine SR4 (sprinkle)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Fesoterodine ER (fed)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Fesoterodine SR4 (fed)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Fesoterodine SR4 (fasted)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Fesoterodine ER (fasted)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Fesoterodine SR3 (sprinkle)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Fesoterodine SR3 (fed)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Fesoterodine SR3 (fasted)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06743649	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
CVX-060	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Radiation Therapy (RT)	Drug	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
Casodex	Other	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
Goserelin	Other	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
Leuprolide	Other	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
Empiric antifungal therapy based on physician discretion.	Drug	Approved	Invasive Candidiasis	ClinicalTrials.gov
Preemptive Therapy with Anidulafungin	Drug	Approved	Invasive Candidiasis	ClinicalTrials.gov
150 mg PF-05231023	Other	Phase PHASE1	Diabetes Melliuts, Type 2	ClinicalTrials.gov
50 mg PF-05231023	Other	Phase PHASE1	Diabetes Melliuts, Type 2	ClinicalTrials.gov
25 mg PF-05231023	Other	Phase PHASE1	Diabetes Melliuts, Type 2	ClinicalTrials.gov
SC anti-TNF	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
Sedline	Other	Phase PHASE4	Anesthesia, General	ClinicalTrials.gov
Palbociclib plus pioglitazone	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib plus Modafinil	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Sitaxsentan alone	Other	Phase PHASE1	Pulmonary Arterial Hypertension	ClinicalTrials.gov
rLP2086 vaccine	Other	Phase PHASE3	Meningitis, Meningococcal	ClinicalTrials.gov
PF-04856884	Other	Phase PHASE2	Glioblastoma	ClinicalTrials.gov
S-1	Other	Phase PHASE1	Stomach Neoplasms	ClinicalTrials.gov
Saline injection	Other	Phase PHASE3	Tube Feeding	ClinicalTrials.gov
Imedeen	Other	Phase PHASE4	Photodamaged Skin	ClinicalTrials.gov
Parent's group	Other	Approved	Obesity	ClinicalTrials.gov
Parents and children group	Other	Approved	Obesity	ClinicalTrials.gov
CE/BZA	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Smoking Cessation Decision Aids	Other	Approved	Cigarette Smoking	ClinicalTrials.gov
levo- leucovorin	Other	Phase PHASE3	Metastatic Colorectal Cancer	ClinicalTrials.gov
Gemcitabine + Cisplatin	Other	Phase PHASE3	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
Paclitaxel + Carboplatin	Other	Phase PHASE3	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
PF-3512676 + Paclitaxel + Carboplatin	Other	Phase PHASE3	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
Investigator's choice	Other	Phase PHASE3	Lymphoma	ClinicalTrials.gov
Fluad	Other	Phase PHASE4	Influenza	ClinicalTrials.gov
Fluad and Prevenar13	Other	Phase PHASE4	Influenza	ClinicalTrials.gov
non-interventional trial	Other	Preclinical	HIV	ClinicalTrials.gov
varencline	Other	Phase PHASE1	Nicotine Dependence	ClinicalTrials.gov
(CP-690,550) Tofacitinib	Other	Phase PHASE2	Plaque Psoriasis	ClinicalTrials.gov
(CP-6890,550) Tofacitinib	Other	Phase PHASE2	Plaque Psoriasis	ClinicalTrials.gov
normal saline (placebo)	Other	Phase PHASE2	Meningitis, Meningococcal	ClinicalTrials.gov
meningococcal B rLP2086 vaccine.	Other	Phase PHASE2	Meningitis, Meningococcal	ClinicalTrials.gov
High dose of dialysis	Other	Phase PHASE3	Acute Renal Failure	ClinicalTrials.gov
Standard dose of dialysis	Other	Phase PHASE3	Acute Renal Failure	ClinicalTrials.gov
Control cohort	Other	Preclinical	Low Back Pain	ClinicalTrials.gov
painPREMIER cohort	Other	Preclinical	Low Back Pain	ClinicalTrials.gov
Idarubicin	Other	Preclinical	Acute Myeloid Leukemia	ClinicalTrials.gov
Varenicline Immediate Release 1 mg	Other	Phase PHASE2	Smoking Cessation	ClinicalTrials.gov
Varenicline Controlled Release 2.4 mg	Other	Phase PHASE2	Smoking Cessation	ClinicalTrials.gov
Varenicline Controlled Release 1.8 mg	Other	Phase PHASE2	Smoking Cessation	ClinicalTrials.gov
Varenicline Controlled Release 1.2 mg	Other	Phase PHASE2	Smoking Cessation	ClinicalTrials.gov
post GH treatment observational study	Drug	Preclinical	Infant, Small for Gestational Age	ClinicalTrials.gov
CP-742,033	Other	Phase PHASE1	Obesity	ClinicalTrials.gov
ibuprofen 600 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
pregabalin 300 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05089771 300 mg + pregabalin 300 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05089771 300mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
12 mg/kg every 8 weeks	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
8 mg/kg every 8 weeks	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
4 mg/kg every 8 weeks	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
4 mg/kg every 4 weeks	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
2 mg/kg every 4 weeks	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
1 mg/kg every 2 weeks	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
ARM C : single epoietin zeta	Other	Phase PHASE4	Solid Cancer Metastatic Disease	ClinicalTrials.gov
ARM B: IV iron + epoietin zeta sequence	Other	Phase PHASE4	Solid Cancer Metastatic Disease	ClinicalTrials.gov
ARM A : IV iron + epoietin zeta	Other	Phase PHASE4	Solid Cancer Metastatic Disease	ClinicalTrials.gov
sunitinib: observational study	Other	Preclinical	Metastatic Renal Cell Carcinoma	ClinicalTrials.gov
bazedoxifene/conjugated estrogens combination tablet	Other	Phase PHASE1	Postmenopause	ClinicalTrials.gov
Incentives to improve DTP/HepB/MMR/Var/PCV/Hib/IPV coverage	Other	Approved	Immunization	ClinicalTrials.gov
QI support to improve DTP/Hep B/MMR/Var/PCV/Hib/IPV coverage	Other	Approved	Immunization	ClinicalTrials.gov
AG-014699	Other	Phase PHASE2	Diabetes Mellitus	ClinicalTrials.gov
PN-152,243)/PN-196,444	Other	Phase PHASE3	Sarcoma	ClinicalTrials.gov
GH treatment	Drug	Phase PHASE3	Chronic Disease	ClinicalTrials.gov
Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)	Other	Phase PHASE4	Encephalitis, Tick-Borne	ClinicalTrials.gov
Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl	Other	Preclinical	Encephalitis, Tick-borne	ClinicalTrials.gov
Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine (GCMP-TT)	Other	Phase PHASE3	Meningitis, Meningococcal	ClinicalTrials.gov
FSME-IMMUN NEW 0.25 ml	Other	Phase PHASE3	Tick-borne Encephalitis	ClinicalTrials.gov
Tick-borne encephalitis vaccine	Other	Phase PHASE2	Tick-borne Encephalitis	ClinicalTrials.gov
FSME-IMMUN 0.5ml	Other	Phase PHASE4	Tick-borne Encephalitis	ClinicalTrials.gov
Abbreviated HIV test counseling	Other	Approved	HIV Infections	ClinicalTrials.gov
Palbociclib + Rabeprazole	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Standard management - Control group	Other	Phase PHASE3	Psoriatic Arthritis	ClinicalTrials.gov
Intensive management or Tight control	Other	Phase PHASE3	Psoriatic Arthritis	ClinicalTrials.gov
sertraline (Zoloft)	Other	Phase PHASE3	Major Depressive Disorder	ClinicalTrials.gov
Ropivicaine 0.5%	Other	Phase PHASE4	Osteoarthritis	ClinicalTrials.gov
Placebo saline injection	Other	Phase PHASE4	Osteoarthritis	ClinicalTrials.gov
Nonacog alfa	Other	Phase PHASE3	Hemophilia B	ClinicalTrials.gov
PF-06648671	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
sulfadoxine-pyrimethamine	Other	Phase PHASE3	Intermittent Preventive Treatment In Pregnancy (IPTp)	ClinicalTrials.gov
Acute Exercise	Other	Approved	Elderly	ClinicalTrials.gov
tiotropium-bromide	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
1.5 mg PF-06649751 in healthy Japanese subjects	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
8.0 mg PF-06649751	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
5.0 mg PF-06649751	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
3.0 mg PF-06649751	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
1.5 mg PF-06649751 21 Days	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
1.5 mg PF-06649751	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
0.5 mg PF-06649751	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
0.15 mg PF-06649751	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Matched control	Other	Phase PHASE3	Optic Nerve Diseases	ClinicalTrials.gov
Zyvox - linezolid	Other	Phase PHASE3	Optic Nerve Diseases	ClinicalTrials.gov
Placebo Pill.	Other	Phase PHASE3	Depression	ClinicalTrials.gov
Supervised Aerobic Exercise	Other	Phase PHASE3	Depression	ClinicalTrials.gov
Correlative studies	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
PF-06650833	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PPV23 vaccination or PCV13 vaccination	Other	Phase PHASE4	Chronic Kidney Failure	ClinicalTrials.gov
CT-011	Other	Phase PHASE2	Metastatic Colorectal Cancer	ClinicalTrials.gov
sunitinib + FOLFOX	Other	Phase PHASE1	Colorectal Neoplasms	ClinicalTrials.gov
Interferon-beta-1a FBS-free/HSA-free	Other	Phase PHASE3	Multiple Sclerosis	ClinicalTrials.gov
Resection as clinical care	Other	Phase PHASE2	Glioblastoma	ClinicalTrials.gov
PD 0332991 (pre-surgery)	Procedure	Phase PHASE2	Glioblastoma	ClinicalTrials.gov
PF-06409577 or Placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Insulin Glargine (Lantus®)	Other	Phase PHASE4	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Midazolam Injection	Other	Phase PHASE4	Mechanically Ventilated and Intubated Subjects	ClinicalTrials.gov
Dexmedetomidine HCL Injection	Other	Phase PHASE4	Mechanically Ventilated and Intubated Subjects	ClinicalTrials.gov
DA-9501	Other	Phase PHASE3	Sedation	ClinicalTrials.gov
etanercept (Enbrel®)	Other	Preclinical	Psoriasis	ClinicalTrials.gov
Nivestim®	Other	Preclinical	Solid Tumors	ClinicalTrials.gov
Evidence summaries endorsed by local opinion leaders	Other	Phase PHASE4	Coronary Disease	ClinicalTrials.gov
PF-04856883	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
rLP2086 vaccine or control	Other	Phase PHASE1	Meningitis, Meningococcal	ClinicalTrials.gov
CP-690, 550	Other	Phase PHASE3	Psoriasis	ClinicalTrials.gov
Fentanyl/Morphine	Other	Phase PHASE2	Sedation	ClinicalTrials.gov
Oxycodone CR	Other	Phase PHASE2	Osteoarthritis of the Knee	ClinicalTrials.gov
ADL5859	Other	Phase PHASE2	Osteoarthritis of the Knee	ClinicalTrials.gov
Xyntha : coagulation factor IIIV (recombinant)	Other	Preclinical	Hemophilia A	ClinicalTrials.gov
diclofenac 50 milligrams	Other	Phase PHASE4	Ankylosing Spondylitis	ClinicalTrials.gov
Celecoxib 400 milligrams	Other	Phase PHASE4	Ankylosing Spondylitis	ClinicalTrials.gov
Celecoxib 200 milligrams	Other	Phase PHASE4	Ankylosing Spondylitis	ClinicalTrials.gov
Irinotecan&Temsirolimus:Arm 2, Level 1	Other	Phase PHASE1	Sarcoma	ClinicalTrials.gov
Irinotecan&Temsirolimus:Arm 1, Level 2	Other	Phase PHASE1	Sarcoma	ClinicalTrials.gov
Irinotecan&Temsirolimus:Arm1, Level 1	Other	Phase PHASE1	Sarcoma	ClinicalTrials.gov
Calcium/Vit D	Other	Phase PHASE4	Osteoporosis, Postmenopausal	ClinicalTrials.gov
Artificial Tears (Methyl cellulose drops)	Other	Approved	Primary Open Angle Glaucoma	ClinicalTrials.gov
ketorolac 0.5%	Other	Approved	Primary Open Angle Glaucoma	ClinicalTrials.gov
prednisolone 1%	Other	Approved	Primary Open Angle Glaucoma	ClinicalTrials.gov
Oncovir poly IC:LC	Other	Phase PHASE1	Melanoma	ClinicalTrials.gov
Peptides	Other	Phase PHASE1	Melanoma	ClinicalTrials.gov
CP 870,893	Other	Phase PHASE1	Melanoma	ClinicalTrials.gov
PF-03084014	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Tamoxifen 20 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PD-0332991 combination	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tamoxifen 60 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PD-0332991 alone	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Advil Allergy and Congestion Relief	Other	Phase PHASE3	Common Cold	ClinicalTrials.gov
Advil Congestion Relief	Other	Phase PHASE3	Common Cold	ClinicalTrials.gov
Methylnaltrexone Bromide (MNTX)	Other	Phase PHASE4	Colonic Inertia	ClinicalTrials.gov
Placebo ointment (Vehicle)	Other	Phase PHASE2	Dermatitis, Atopic	ClinicalTrials.gov
Tofacitinib ointment 20mg/g	Other	Phase PHASE2	Dermatitis, Atopic	ClinicalTrials.gov
GBP Group - Non-diabetics intending to undergo Gastric Bypass surgery	Procedure	Approved	Branched-chain Amino Acid Metabolism	ClinicalTrials.gov
Pre-Diabetes Group - 6-mo Aerobic and Resistance combined exercise training	Other	Approved	Branched-chain Amino Acid Metabolism	ClinicalTrials.gov
Background NSAID	Other	Phase PHASE3	Spondylitis, Ankylosing	ClinicalTrials.gov
PF-03446962	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Toviaz treatment	Drug	Preclinical	Overactive Bladder	ClinicalTrials.gov
Anidulafungin/Fluconazole	Other	Phase PHASE3	Candidemia	ClinicalTrials.gov
PF-03758309	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
tamoxifen + exemestane	Other	Phase PHASE3	Breast Neoplasms	ClinicalTrials.gov
PF-06427878 600 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06427878 10 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
[11C]PF-06427878	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Standard-of-Care	Other	Phase PHASE3	Endotracheal Intubation	ClinicalTrials.gov
Standard-of-Care plus Dexmedetomidine	Other	Phase PHASE3	Endotracheal Intubation	ClinicalTrials.gov
10 mg PF-06412562 IR tablets	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
2 x 15 mg PF-06412562 MR tablets_Fed	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
2 x 15 mg PF-06412562 MR tablets_Fasted	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
3 mg PF-06412562 MR tablets_Fasted	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
10% Arginine Hydrochloride-R-Gene 10	Other	Phase PHASE1	Type 2 Diabetes	ClinicalTrials.gov
18F-AV-133	Other	Phase PHASE1	Type 2 Diabetes	ClinicalTrials.gov
PF00299804	Other	Phase PHASE2	Advanced Gastric Cancer	ClinicalTrials.gov
CVX-241	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
CVX-060 + sunitinib	Other	Phase PHASE2	Solid Tumor	ClinicalTrials.gov
Individual smoking cessation counseling	Other	Phase PHASE4	Smoking	ClinicalTrials.gov
Vfend - voriconazole	Other	Phase PHASE3	Antifungal Prophylaxis of Invasive Fungal Infections	ClinicalTrials.gov
tofacitinib ointment 10 mg/g	Other	Phase PHASE2	Psoriasis Vulgaris	ClinicalTrials.gov
tofacitinib ointment 20 mg/g	Other	Phase PHASE2	Psoriasis Vulgaris	ClinicalTrials.gov
Trabeculectomy with mitomycin C	Other	Approved	Glaucoma	ClinicalTrials.gov
Baerveldt implant	Other	Approved	Glaucoma	ClinicalTrials.gov
[14C] PF-06463922	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Inotuzumab Ozogamicin (CMC-544)	Other	Phase PHASE1	Lymphoma, B-Cell	ClinicalTrials.gov
Sunitinib Malate (Sutent)	Other	Phase PHASE2	Renal Cell Carcinoma	ClinicalTrials.gov
Decision support	Other	Approved	Pharmacogenetics	ClinicalTrials.gov
Radiation Therapy	Drug	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
QS-21	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
PBS	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
Diluent: Phosphate Buffered Saline	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
ACC-001 + QS-21	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
Placebo: Phosphate buffered saline	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
Diazepam	Other	Preclinical	Alcohol Withdrawal Syndrome	ClinicalTrials.gov
placebo for maraviroc	Other	Phase PHASE3	HIV-1	ClinicalTrials.gov
placebo for emtricitabine/tenofovir	Other	Phase PHASE3	HIV-1	ClinicalTrials.gov
darunavir/ritonavir 800/100 mg	Other	Phase PHASE3	HIV-1	ClinicalTrials.gov
Emtricitabine/tenofovir	Other	Phase PHASE3	HIV-1	ClinicalTrials.gov
PF03512676	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Merocel pack	Other	Approved	Epistaxis	ClinicalTrials.gov
Thrombin-JMI	Other	Approved	Epistaxis	ClinicalTrials.gov
Phase 1: Conventiaonal DMARD	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Phase 1: Methotrexate	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Phase 2: Optional ETN, SSZ, HCQ, MTX	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Phase 1: Etanercept	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
7-valent vaccine injection	Other	Preclinical	Pneumococcal Vaccine	ClinicalTrials.gov
PF-04236921 SC injection	Other	Phase PHASE2	Crohn's Disease	ClinicalTrials.gov
NIC7-003	Other	Phase PHASE1	Smoking	ClinicalTrials.gov
NIC7-001	Other	Phase PHASE1	Smoking	ClinicalTrials.gov
Tiotropium low dose mcg	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
Vitamin E	Other	Phase PHASE4	Fatty Liver	ClinicalTrials.gov
NWP09	Other	Phase PHASE3	Attention Deficit Hyperactivity Disorder	ClinicalTrials.gov
E Group	Other	Phase PHASE2	Nosocomial Pneumonia	ClinicalTrials.gov
C Group	Other	Phase PHASE2	Nosocomial Pneumonia	ClinicalTrials.gov
OIS (Oxaliplatin, Irinotecan, S-1)	Other	Phase PHASE1	Gastrointestinal Neoplasms	ClinicalTrials.gov
High Dose PF-03635659	Other	Phase PHASE2	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
Mid Dose PF-03635659	Other	Phase PHASE2	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
Low Dose PF-03635659	Other	Phase PHASE2	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
active comparator	Other	Phase PHASE2	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
Placebo capsules	Other	Phase PHASE2	Attention Deficit Hyperactivity Disorder	ClinicalTrials.gov
Health Education	Other	Approved	Fibromyalgia	ClinicalTrials.gov
Mindfulness Emotion Regulation	Other	Approved	Fibromyalgia	ClinicalTrials.gov
Placebo- Phosphate buffered saline (PBS)	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
ACC-001 10 μg/ QS-21 50 μg	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
ACC-001 3 μg/ QS-21 50 μg	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
Selective Laser trabeculoplasty	Other	Approved	Glaucoma	ClinicalTrials.gov
PF-04937319 MR 3	Other	Phase PHASE1	Type 2 Diabetes Mellitus	ClinicalTrials.gov
PF-04937319 MR 2	Other	Phase PHASE1	Type 2 Diabetes Mellitus	ClinicalTrials.gov
PF-04937319 MR 1	Other	Phase PHASE1	Type 2 Diabetes Mellitus	ClinicalTrials.gov
PF-04937319 IR MST	Other	Phase PHASE1	Type 2 Diabetes Mellitus	ClinicalTrials.gov
bococizumab PFP	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
bococizumab PFS: BIP	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
bococizumab PFS:Pfizer	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
blood specimen	Other	Preclinical	Hemophilia	ClinicalTrials.gov
Ceftriaxone and amoxicillin/clavulanate	Other	Phase PHASE2	Pneumonia, Bacterial	ClinicalTrials.gov
Sulopenem and PF-03709270	Other	Phase PHASE2	Pneumonia, Bacterial	ClinicalTrials.gov
tacrolimus, sirolimus and steroid	Other	Approved	Absence; Kidney	ClinicalTrials.gov
rapamune, mycophenolate mofetil and steroid	Other	Approved	Absence; Kidney	ClinicalTrials.gov
CP-70,429 and PF-03709270	Other	Phase PHASE1	Pneumonia	ClinicalTrials.gov
PF-04937319 low dose	Other	Phase PHASE1	Type 2 Diabetes Mellitus	ClinicalTrials.gov
PF-04937319 high dose	Other	Phase PHASE1	Type 2 Diabetes Mellitus	ClinicalTrials.gov
Providers of Usual Care	Other	Approved	Chronic Noncancer Pain	ClinicalTrials.gov
Providers of Novel Care	Other	Approved	Chronic Noncancer Pain	ClinicalTrials.gov
ACC-001+QS-21 (30mcg)	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
ACC-001 (10 mcg) + QS-21	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
ACC-001+ QS21 (3mcg)	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
consultation 10 days later	Other	Approved	Depression	ClinicalTrials.gov
Triazolam	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Radical Cystectomy	Other	Phase PHASE2	Transitional Cell Carcinoma of the Bladder	ClinicalTrials.gov
Placebo for PF-05230907	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05230907	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Temsirolimus (Non-Interventional Study)	Other	Preclinical	Carcinoma, Renal Cell	ClinicalTrials.gov
Interferon-Alfa 9MU	Other	Phase PHASE3	Renal Cell Carcinoma	ClinicalTrials.gov
sunitinib and rapamycin (Drug will be held)	Drug	Phase PHASE1	Non-Small Cell Lung Cancer	ClinicalTrials.gov
US-approved Neupogen®	Other	Phase PHASE1	Neutropenia (Low White Blood Cell Count)	ClinicalTrials.gov
Filgrastim Hospira (US)	Other	Phase PHASE1	Neutropenia (Low White Blood Cell Count)	ClinicalTrials.gov
Computer intervention & reduction of financial barrier	Other	Phase PHASE4	Hypertension	ClinicalTrials.gov
Reduction in financial barrier	Other	Phase PHASE4	Hypertension	ClinicalTrials.gov
Computer	Other	Phase PHASE4	Hypertension	ClinicalTrials.gov
PF-06463922	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Bupivacaine Block	Other	Phase PHASE4	Pain, Postoperative	ClinicalTrials.gov
Rituximab, CMC544, Gemcitabine and Oxaliplatine	Other	Phase PHASE1	Diffuse Large B-Cell Lymphoma	ClinicalTrials.gov
Simple chest tube drainage	Other	Phase PHASE3	Complicated Parapneumonic Effusion	ClinicalTrials.gov
Medical thoracoscopy	Other	Phase PHASE3	Complicated Parapneumonic Effusion	ClinicalTrials.gov
Placebo three times daily	Other	Phase PHASE3	Ankle Injuries	ClinicalTrials.gov
Topical IBU three times daily	Other	Phase PHASE3	Ankle Injuries	ClinicalTrials.gov
Placebo twice daily	Other	Phase PHASE3	Ankle Injuries	ClinicalTrials.gov
Topical IBU twice daily	Other	Phase PHASE3	Ankle Injuries	ClinicalTrials.gov
written asthma action plan (WAAP)	Other	Approved	Asthma	ClinicalTrials.gov
electronic asthma action plan (eAAP)	Other	Approved	Asthma	ClinicalTrials.gov
Ibuprofen 400 mg caplet	Other	Phase PHASE3	Patient Compliance	ClinicalTrials.gov
Adjuvant Chemotherapy	Drug	Phase PHASE2	Rectal Cancer	ClinicalTrials.gov
Surgery	Procedure	Phase PHASE2	Rectal Cancer	ClinicalTrials.gov
Preoperative Radiation	Other	Phase PHASE2	Rectal Cancer	ClinicalTrials.gov
Neoadjuvant Chemotherapy	Drug	Phase PHASE2	Rectal Cancer	ClinicalTrials.gov
EUS	Other	Phase PHASE2	Rectal Cancer	ClinicalTrials.gov
Clinical Trial educational materials	Other	Approved	Cancer	ClinicalTrials.gov
Daivonex Ointment	Other	Phase PHASE1	Psoriasis Vulgaris	ClinicalTrials.gov
Daivonex	Other	Phase PHASE1	Psoriasis Vulgaris	ClinicalTrials.gov
Vehicle	Other	Phase PHASE1	Psoriasis Vulgaris	ClinicalTrials.gov
2%Tofacitinib Ointment	Other	Phase PHASE1	Psoriasis Vulgaris	ClinicalTrials.gov
PF06263276	Other	Phase PHASE1	Psoriasis Vulgaris	ClinicalTrials.gov
Tofacitinib 2 mg	Other	Phase PHASE2	Ankylosing Spondylitis	ClinicalTrials.gov
Nicotine Replacement Therapy Patch	Drug	Phase PHASE4	Smoking Cessation	ClinicalTrials.gov
bupropion hydrochloride	Other	Phase PHASE4	Smoking Cessation	ClinicalTrials.gov
vinorelbine ditartrate	Other	Phase PHASE1	Extensive Stage Small Cell Lung Cancer	ClinicalTrials.gov
Havrix (HAV)	Other	Phase PHASE3	Meningococcal Vaccine	ClinicalTrials.gov
Bodystudio ATBM (Automatic Total Body Mapping)	Other	Approved	Psoriasis	ClinicalTrials.gov
flow cytometry	Other	Phase PHASE1	Esophageal Cancer	ClinicalTrials.gov
PF-06266047	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Seasonal Inactivated Influenza Vaccine	Other	Phase PHASE4	PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE	ClinicalTrials.gov
Blood sample collection	Other	Phase PHASE4	Prevention of Pneumonia and Invasive Disease Caused by the Serotypes in 13vPnC	ClinicalTrials.gov
Yoga Classes	Other	Approved	Breast Cancer	ClinicalTrials.gov
Questionnaires	Other	Approved	Breast Cancer	ClinicalTrials.gov
IGE-2	Other	Phase PHASE1	Allergic Rhinitis	ClinicalTrials.gov
IGE-1	Other	Phase PHASE1	Allergic Rhinitis	ClinicalTrials.gov
Tiotropium high dose QD	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
Tiotropium low dose QD	Other	Phase PHASE3	Asthma	ClinicalTrials.gov
Maraviroc (Celsentri)	Other	Phase PHASE3	HIV-1 Infection	ClinicalTrials.gov
U.S.-approved Neupogen®	Other	Phase PHASE1	Neutropenia (Low White Blood Cell Count)	ClinicalTrials.gov
Temsirolimus (pre surgery)	Procedure	Approved	Renal Cell Carcinoma	ClinicalTrials.gov
LPS	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06741086	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Large volume blood draw	Other	Approved	Healthy	ClinicalTrials.gov
Prospective TDM Arm	Other	Phase PHASE4	Fungal Infection	ClinicalTrials.gov
pelvic CT-scan	Other	Preclinical	Structural Sacro-iliitis	ClinicalTrials.gov
pelvic MRI	Other	Preclinical	Structural Sacro-iliitis	ClinicalTrials.gov
pelvic radiography	Other	Preclinical	Structural Sacro-iliitis	ClinicalTrials.gov
Absorptive filters	Other	Approved	Glaucoma	ClinicalTrials.gov
Telescopes, telemicroscopes and microscopes	Other	Approved	Glaucoma	ClinicalTrials.gov
portable CCTV	Other	Approved	Glaucoma	ClinicalTrials.gov
Efficient	Other	Approved	Human Papillomavirus	ClinicalTrials.gov
Participatory	Other	Approved	Human Papillomavirus	ClinicalTrials.gov
LEE011	Other	Phase PHASE1	Locally Advanced Metastatic BRAF Mutant Melanoma	ClinicalTrials.gov
PF-00489791	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
SR verapamil	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
diltiazem	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-06651600 or Placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Sitagliptin once-daily	Other	Phase PHASE1	Type 2 Diabetes Mellitus	ClinicalTrials.gov
PF-04937319 split-dose	Other	Phase PHASE1	Type 2 Diabetes Mellitus	ClinicalTrials.gov
PF-04937319 once-daily	Other	Phase PHASE1	Type 2 Diabetes Mellitus	ClinicalTrials.gov
Dimebon (latrepirdine)	Other	Phase PHASE3	Moderate to Severe Alzheimer	ClinicalTrials.gov
Baseline serum vitamin D level at or above 50 nmol/l	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
Baseline serum vitamin D level below 50 nmol/l	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
Masked Sham Therapy	Drug	Phase PHASE2	Macular Edema, Diabetic	ClinicalTrials.gov
Ranibizumab	Other	Phase PHASE2	Macular Edema, Diabetic	ClinicalTrials.gov
Pristiq	Other	Phase PHASE4	Social Anxiety Disorder	ClinicalTrials.gov
triazolam tablets	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
triazolam liquid oral drops	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Gemcitabine, Cisplatin, Sunitinib	Other	Phase PHASE2	Urothelial Cancer	ClinicalTrials.gov
Chloral hydrate	Other	Phase PHASE2	Procedural Sedation	ClinicalTrials.gov
PF-06687234	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
13-valent conjugate pneumococcal vaccine	Other	Phase PHASE4	End Stage Renal Disease	ClinicalTrials.gov
oxycodone HCl and naltrexone HCl extended-release capsules	Other	Phase PHASE3	Chronic Noncancer Pain	ClinicalTrials.gov
three different perimeters: HFA, Octopus, MATRIX	Other	Preclinical	Glaucoma	ClinicalTrials.gov
PF-06372865.	Other	Phase PHASE2	Generalized Anxiety Disorder	ClinicalTrials.gov
Pregabalin Placebo Capsules	Other	Phase PHASE4	Schizophrenia	ClinicalTrials.gov
Liver biopsy	Other	Preclinical	Side Effects of Calcineurin Inhibitors	ClinicalTrials.gov
conventional text message reminders	Other	Approved	Vaccination	ClinicalTrials.gov
educational text message reminders	Other	Approved	Vaccination	ClinicalTrials.gov
Clostridium difficile vaccine	Other	Phase PHASE2	Clostridium Difficile Associated Disease	ClinicalTrials.gov
Prevenar 13	Other	Preclinical	Pneumococcal Disease	ClinicalTrials.gov
Placebo (for sunitinib)	Other	Phase PHASE2	Carcinoid Tumors	ClinicalTrials.gov
Lanreotide	Other	Phase PHASE2	Carcinoid Tumors	ClinicalTrials.gov
Glimepiride	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
PF-04937319 100 mg	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
PF-04937319 50 mg	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
PF-04937319 10 mg	Other	Phase PHASE2	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Sitagliptin - 100mg	Other	Phase PHASE2	Type 2 Diabetes Mellitus	ClinicalTrials.gov
PF-04937319 - 100mg	Other	Phase PHASE2	Type 2 Diabetes Mellitus	ClinicalTrials.gov
PF-04937319 - 50mg	Other	Phase PHASE2	Type 2 Diabetes Mellitus	ClinicalTrials.gov
PF-04937319 - 20mg	Other	Phase PHASE2	Type 2 Diabetes Mellitus	ClinicalTrials.gov
PF-04937319 - 3mg	Other	Phase PHASE2	Type 2 Diabetes Mellitus	ClinicalTrials.gov
E-blast and Webinars	Other	Approved	Tobacco Use	ClinicalTrials.gov
Provider and Patient Tools	Other	Approved	Tobacco Use	ClinicalTrials.gov
Training	Other	Approved	Tobacco Use	ClinicalTrials.gov
Voriconazole high dose	Other	Phase PHASE4	Healthy	ClinicalTrials.gov
Voriconazole low dose	Other	Phase PHASE4	Healthy	ClinicalTrials.gov
Moroctocog alfa ( AF-CC)	Other	Phase PHASE4	Hemophilia A	ClinicalTrials.gov
13-valent pneumococcal vaccine	Other	Preclinical	Healthy	ClinicalTrials.gov
US-Approved Neupogen	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Filgrastim Hospira	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Intravitreal Celecoxib	Other	Phase PHASE1	Inflammation	ClinicalTrials.gov
AAB-003 (PF-05236812)	Other	Phase PHASE1	Alzheimer's Disease	ClinicalTrials.gov
Sulfasalazine	Other	Phase PHASE4	Arthritis, Juvenile Rheumatoid	ClinicalTrials.gov
Cyclophosphamide.	Other	Phase PHASE1	Neoplasms, Advanced	ClinicalTrials.gov
Valproic acid	Other	Phase PHASE1	Neoplasms, Advanced	ClinicalTrials.gov
metronidazole and azithromycin	Other	Phase PHASE4	Bacterial Vaginosis	ClinicalTrials.gov
Matching vehicle control	Other	Phase PHASE3	Dermatitis, Atopic	ClinicalTrials.gov
AN2728 Topical Ointment, 2%	Other	Phase PHASE3	Dermatitis, Atopic	ClinicalTrials.gov
AN2728 Topical Ointment, 0.5% BID	Other	Phase PHASE2	Dermatitis, Atopic	ClinicalTrials.gov
AN2728 Topical Ointment, 2% BID	Other	Phase PHASE2	Dermatitis, Atopic	ClinicalTrials.gov
AN2728 Topical Ointment, 0.5% QD	Other	Phase PHASE2	Dermatitis, Atopic	ClinicalTrials.gov
AN2728 Topical Ointment, 2% QD	Other	Phase PHASE2	Dermatitis, Atopic	ClinicalTrials.gov
AN2728 Ointment Vehicle	Other	Phase PHASE2	Psoriasis	ClinicalTrials.gov
AN2728	Other	Phase PHASE2	Psoriasis	ClinicalTrials.gov
modest blood pressure lowering	Other	Phase PHASE4	Brain Ischemia	ClinicalTrials.gov
Aggressive BP lowering	Other	Phase PHASE4	Brain Ischemia	ClinicalTrials.gov
perifosine + temsirolimus	Other	Phase PHASE1	Pediatric Solid Tumors	ClinicalTrials.gov
PF-00734200	Other	Phase PHASE1	Renal Insufficiency, Chronic	ClinicalTrials.gov
IV levofloxacin	Other	Phase PHASE4	Community-Acquired Pneumonia (CAP)	ClinicalTrials.gov
oral levofloxacin	Other	Phase PHASE4	Community-Acquired Pneumonia (CAP)	ClinicalTrials.gov
oral azithromycin	Other	Phase PHASE4	Community-Acquired Pneumonia (CAP)	ClinicalTrials.gov
IV azithromycin	Other	Phase PHASE4	Community-Acquired Pneumonia (CAP)	ClinicalTrials.gov
Neulasta (Amgen)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Pegfilgrastim Hospira	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Mayne Glucagon	Other	Phase PHASE1	Hypoglycemia	ClinicalTrials.gov
Glucagen	Other	Phase PHASE1	Hypoglycemia	ClinicalTrials.gov
Iron Sucrose	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
maraviroc (Selzentry)	Other	Phase PHASE2	HIV Infections	ClinicalTrials.gov
somatotropin	Other	Approved	Turner Syndrome	ClinicalTrials.gov
[11C]PF-06809247	Other	Phase PHASE1	Neuroinflammation	ClinicalTrials.gov
Single drug references	Drug	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Myrin P Forte	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Control Arm	Other	Phase PHASE2	Growth Hormone Therapy	ClinicalTrials.gov
Cytoxan	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Dexmedetomidine, midazolam; fentanyl	Other	Phase PHASE2	Intubated and Mechanically Ventilated Pediatric Subjects	ClinicalTrials.gov
Darunavir/cobicistat (Part 2)	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Maraviroc (Part 2)	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Maraviroc (Part 1)	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Esomeprazole 20 mg	Other	Phase PHASE4	Heartburn	ClinicalTrials.gov
oprelvekin	Other	Phase PHASE2	Severe Thrombocytopenia	ClinicalTrials.gov
Arm Precaution	Other	Approved	Breast Cancer	ClinicalTrials.gov
The-Optimal-Lymph-Flow	Other	Approved	Breast Cancer	ClinicalTrials.gov
Placebo cream	Other	Phase PHASE4	Overactive Bladder	ClinicalTrials.gov
Azithromycin IV	Other	Preclinical	Pneumonia	ClinicalTrials.gov
Irinotecan hydrochloride trihydrate	Other	Phase PHASE2	Esophageal Cancer	ClinicalTrials.gov
PF-05089771 150 mg + Pregabalin 300 mg	Other	Phase PHASE2	Diabetic Neuropathy, Painful	ClinicalTrials.gov
Matched placebo for PF-05089771 150 mg and pregabalin 300 mg	Other	Phase PHASE2	Diabetic Neuropathy, Painful	ClinicalTrials.gov
PF-05089771 150 mg	Other	Phase PHASE2	Diabetic Neuropathy, Painful	ClinicalTrials.gov
Control group:	Other	Approved	Smoking	ClinicalTrials.gov
Smoking cessation counselling group	Other	Approved	Smoking	ClinicalTrials.gov
Champix	Other	Approved	Smoking	ClinicalTrials.gov
Radiation	Other	Phase PHASE2	Esophageal Cancer	ClinicalTrials.gov
Ziprasidone/Geodon	Other	Phase PHASE4	Bipolar Disorder	ClinicalTrials.gov
Ponezumab	Other	Phase PHASE2	Cerebral Amyloid Angiopathy	ClinicalTrials.gov
Bococizumab (PF-04950615;RN316)	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
IV methylprednisolone	Other	Phase PHASE3	Multiple Sclerosis	ClinicalTrials.gov
megadose oral methylprednisolone	Other	Phase PHASE3	Multiple Sclerosis	ClinicalTrials.gov
Rifabutin/rifampin	Other	Phase PHASE4	Mycobacterium Avium Complex	ClinicalTrials.gov
Placebo PF00299804	Other	Phase PHASE3	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Placebo erlotinib	Other	Phase PHASE3	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Active Comparator (erlotinib)	Other	Phase PHASE3	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Dacomitinib (PF-00299804)	Other	Phase PHASE3	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Arm 5: IVR call	Other	Approved	Influenza	ClinicalTrials.gov
Arm 3: No e-portal message with IVR call	Other	Approved	Influenza	ClinicalTrials.gov
Arm 2: E-portal message with no IVR call	Other	Approved	Influenza	ClinicalTrials.gov
Arm 1: E-portal message with IVR call	Other	Approved	Influenza	ClinicalTrials.gov
Ziprasidone 160 mg/d	Other	Phase PHASE3	Schizophrenia	ClinicalTrials.gov
Ziprasidone 80-160 mg/d	Other	Phase PHASE3	Schizophrenia	ClinicalTrials.gov
IV diphenhydramine	Other	Approved	Endometriosis	ClinicalTrials.gov
IV Lidocaine	Other	Approved	Endometriosis	ClinicalTrials.gov
Vitamin D	Other	Approved	Chronic Kidney Disease (CKD)	ClinicalTrials.gov
Dietary supplement	Other	Approved	Chronic Kidney Disease (CKD)	ClinicalTrials.gov
2-[18F]-fluro-3-[2(S)-2-azethidinylmethoxy]-pyridine	Other	Preclinical	Nicotine Addiction	ClinicalTrials.gov
atorvastatin matching placebo	Other	Phase PHASE1	Type 1 Diabetes	ClinicalTrials.gov
PF-06423264	Other	Phase PHASE1	Normal Healthy	ClinicalTrials.gov
smoking questionnaire	Other	Preclinical	Plaque Psoriasis	ClinicalTrials.gov
Bosulif	Other	Phase PHASE2	Chronic Myelogenous Leukaemia	ClinicalTrials.gov
Pillars4Life	Other	Approved	Breast Cancer	ClinicalTrials.gov
Tofacitinib 10 mg BID	Other	Phase PHASE3	Psoriatic Arthritis	ClinicalTrials.gov
Tofacitinib 5 mg BID	Other	Phase PHASE3	Psoriatic Arthritis	ClinicalTrials.gov
crushed oxycodone IR 30 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
oxycodone weight-matched placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
crushed ALO-02 30 mg/3.6 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
ALO-02 weight-matched placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo pill	Other	Approved	Tobacco Use Disorder	ClinicalTrials.gov
written materials	Other	Approved	Cardiovascular Diseases	ClinicalTrials.gov
Health Educator Visits	Other	Approved	Cardiovascular Diseases	ClinicalTrials.gov
Peer Coach Phone Calls	Other	Approved	Cardiovascular Diseases	ClinicalTrials.gov
PCV13	Other	Preclinical	COPD	ClinicalTrials.gov
PF-06751979	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
atorvastatin (Lipitor)	Other	Phase PHASE4	Aortic Valve Stenosis	ClinicalTrials.gov
BMN 673	Other	Phase PHASE1	Human Volunteers	ClinicalTrials.gov
PCIA analgesia	Other	Approved	Gastric Cancer	ClinicalTrials.gov
Multimodal analgesia	Other	Approved	Gastric Cancer	ClinicalTrials.gov
High Fat, High Calorie Meal	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
thermacare heat wraps	Other	Phase PHASE4	Heat	ClinicalTrials.gov
Moderate Dose Quillivant XR	Other	Phase PHASE4	ADHD	ClinicalTrials.gov
Low Dose Quillivant XR	Other	Phase PHASE4	ADHD	ClinicalTrials.gov
Very Low Dose Quillivant XR	Other	Phase PHASE4	ADHD	ClinicalTrials.gov
HEAD-US scoring system	Other	Approved	Moderate and Severe Haemophilia	ClinicalTrials.gov
Transient elastography	Other	Preclinical	Psoriasis Chronic	ClinicalTrials.gov
PF-06865571	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06412562 15mg BID	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06412562 3mg BID	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Acetaminophen 650 mg	Other	Phase PHASE3	Post-surgical Pain Following Extraction of Molar Teeth	ClinicalTrials.gov
Ibuprofen 250 mg	Other	Phase PHASE3	Post-surgical Pain Following Extraction of Molar Teeth	ClinicalTrials.gov
Ibuprofen 250 mg / Acetaminophen 500 mg	Other	Phase PHASE3	Post-surgical Pain Following Extraction of Molar Teeth	ClinicalTrials.gov
[14C]NXL104	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Ceftazidime	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Avibactam	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
CAZ104	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
NXL104	Other	Phase PHASE1	Healthy Male and Female Japanese Volunteers	ClinicalTrials.gov
Placebo Infusion	Other	Phase PHASE1	Healthy Male Volunteers	ClinicalTrials.gov
Ceftaroline	Other	Phase PHASE1	Healthy Male Volunteers	ClinicalTrials.gov
Imipenem-cilastatin	Other	Phase PHASE3	Skin Infection	ClinicalTrials.gov
0.9% Normal Saline	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
CAZ-AVI	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
CXL	Other	Phase PHASE1	Pharmacokinetics	ClinicalTrials.gov
600 mg Ceftaroline fosamil	Other	Phase PHASE1	Renal Disease	ClinicalTrials.gov
200 mg Ceftaroline fosamil	Other	Phase PHASE1	Renal Disease	ClinicalTrials.gov
Placebo in 100 ml infusion volume	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
600 mg ceftaroline in 100 ml infusion volume	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo in 250 ml infusion volume	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
600 ceftaroline fosamil in 250 ml infusion volume	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo in 50 ml infusion volume	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
600 mg ceftaroline fosamil in 50 ml infusion volume	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
CAZ-AVI + metronidazole	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06835919	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Aztreonam	Other	Phase PHASE3	Complicated Skin and Soft Tissue Infection	ClinicalTrials.gov
Ceftaroline fosamil	Other	Phase PHASE3	Complicated Skin and Soft Tissue Infection	ClinicalTrials.gov
meropenem (active comparator)	Other	Phase PHASE3	Nosocomial Pneumonia (NP)	ClinicalTrials.gov
ceftazidim-avibactam (CAZ-AVI, experimental product)	Other	Phase PHASE3	Nosocomial Pneumonia (NP)	ClinicalTrials.gov
Ceftazidime-avibactam	Other	Phase PHASE3	Complicated Intra-abdominal Infection	ClinicalTrials.gov
combination of Aztreonam - Avibactam (ATM-AVI)	Other	Phase PHASE1	Complicated Infection	ClinicalTrials.gov
Aztreonam (ATM)	Other	Phase PHASE1	Complicated Infection	ClinicalTrials.gov
Avibactam (AVI)	Other	Phase PHASE1	Complicated Infection	ClinicalTrials.gov
or switch to oral therapy: 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)	Drug	Phase PHASE3	Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis	ClinicalTrials.gov
Either switch to oral therapy: 500 mg of Ciprofloxacin (oral)	Drug	Phase PHASE3	Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis	ClinicalTrials.gov
Doripenem	Other	Phase PHASE3	Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis	ClinicalTrials.gov
Ceftazidime - Avibactam ( CAZ-AVI)	Other	Phase PHASE3	Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis	ClinicalTrials.gov
Temsirolimus, Rituximab, Bendamustin	Other	Phase PHASE1	Follicular Lymphoma	ClinicalTrials.gov
[14C]lorlatinib	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
lipitor	Other	Approved	Diabetes	ClinicalTrials.gov
Standard therapy	Drug	Phase PHASE4	Psychosis	ClinicalTrials.gov
Best Available Therapy	Drug	Phase PHASE3	Complicated Urinary Tract Infection	ClinicalTrials.gov
BYL719	Other	Phase PHASE1	Advanced and Selected Solid Tumors	ClinicalTrials.gov
Statin	Other	Phase PHASE2	Hypercholesterolemia	ClinicalTrials.gov
PF-04950615 (RN316)	Other	Phase PHASE2	Hypercholesterolemia	ClinicalTrials.gov
Satin	Other	Phase PHASE2	Hypercholesterolemia	ClinicalTrials.gov
PF-06667272	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Glasdegib IV infusion	Other	Phase PHASE1	Healthy Volunteer Study	ClinicalTrials.gov
Glasdegib Oral Tablet	Other	Phase PHASE1	Healthy Volunteer Study	ClinicalTrials.gov
PF06649751, Itraconazole	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib 200mg	Other	Phase PHASE2	Sarcoma	ClinicalTrials.gov
treatment	Drug	Phase PHASE3	Non Squamous Lung Cancer	ClinicalTrials.gov
Placebo injection SC/IV	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Bococizumab	Other	Phase PHASE3	Primary Hyperlipidemia or Mixed Dyslipidemia	ClinicalTrials.gov
PF-04950615	Other	Phase PHASE2	Hypercholesterolemia	ClinicalTrials.gov
PBO	Other	Phase PHASE2	Hypercholesterolemia	ClinicalTrials.gov
300mg PF-04950615 (RN316)	Other	Phase PHASE2	Hypercholesterolemia	ClinicalTrials.gov
200mg PF-04950615 (RN316)	Other	Phase PHASE2	Hypercholesterolemia	ClinicalTrials.gov
rituximab	Other	Phase PHASE2	Lymphoma, B-Cell	ClinicalTrials.gov
PF-06818883	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo for atorvastatin	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
Placebo for Bococizumab (PF-04950615;RN316)	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
PDE9i	Other	Phase PHASE1	Phase 1 Sickle Cell	ClinicalTrials.gov
placebo for PDE9i	Other	Phase PHASE1	Phase 1 Sickle Cell	ClinicalTrials.gov
Bococizumab 75mg placebo	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
Bococizumab 150mg placebo	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
Bococizumab 75mg	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
Bococizumab 150mg	Other	Phase PHASE3	Hyperlipidemia	ClinicalTrials.gov
1 year treatment with placebo followed by optional 3 years of GH treatment	Drug	Phase PHASE4	Idiopathic Short Stature	ClinicalTrials.gov
GH treatment (Genotropin)	Drug	Phase PHASE4	Idiopathic Short Stature	ClinicalTrials.gov
Absolute Bioavailability	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
behavioural intervention	Other	Approved	Smoking	ClinicalTrials.gov
nicotine replacement therapy	Drug	Approved	Smoking	ClinicalTrials.gov
Screening	Other	Phase PHASE4	Coronary Disease	ClinicalTrials.gov
Atorvastatin 80mg	Other	Phase PHASE4	Coronary Disease	ClinicalTrials.gov
Placebo Oral Tablet	Other	Phase PHASE4	Coronary Disease	ClinicalTrials.gov
fludarabine	Other	Phase PHASE3	Lymphoma, Follicular	ClinicalTrials.gov
prednisone/prednisolone	Other	Phase PHASE3	Lymphoma, Follicular	ClinicalTrials.gov
vincristine	Other	Phase PHASE3	Lymphoma, Follicular	ClinicalTrials.gov
10 mg dose MR formulations,10 mg dose of tofacitinib IR solution	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
MEK inhibitor MEK162	Other	Phase PHASE1	Recurrent Colon Cancer	ClinicalTrials.gov
Oprelvekin, Interleukin 11, IL-11	Other	Phase PHASE2	Von Willebrand Disease	ClinicalTrials.gov
Atorvastatin 80 mg/day	Other	Phase PHASE4	Dyslipidemia in Patients With Diabetes Mellitus	ClinicalTrials.gov
atovastatin 10 mg/day	Other	Phase PHASE4	Dyslipidemia in Patients With Diabetes Mellitus	ClinicalTrials.gov
PF-06852231	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-06664178	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
AN2690	Other	Phase PHASE2	Onychomycosis	ClinicalTrials.gov
AN2690, 7.5%	Other	Phase PHASE2	Distal, Subungual Onychomycosis	ClinicalTrials.gov
AN2690, 5%	Other	Phase PHASE2	Distal, Subungual Onychomycosis	ClinicalTrials.gov
AN2690, 2.5%	Other	Phase PHASE2	Distal, Subungual Onychomycosis	ClinicalTrials.gov
Mycophenolate acid	Other	Approved	BK Viremia	ClinicalTrials.gov
0.5 mg/kg	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
4 mg/kg	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
FDC IBU/APAP 250 mg/500 mg	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Blood Collection	Other	Approved	Healthy Subjects	ClinicalTrials.gov
untreated to atorvastatin treatment	Drug	Phase PHASE2	Relapsing Remitting Multiple Sclerosis	ClinicalTrials.gov
interferon beta treatment to add-on atorvastatin treatment	Drug	Phase PHASE2	Relapsing Remitting Multiple Sclerosis	ClinicalTrials.gov
PF-06882961	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Ibuprofen, brimonidine, latanoprost	Other	Approved	Glaucoma	ClinicalTrials.gov
ibuprofen, latanoprost, brimonidine	Other	Approved	Glaucoma	ClinicalTrials.gov
Disease-modifying antirheumatic drug	Drug	Phase PHASE3	Arthritis, Rheumatoid	ClinicalTrials.gov
Toviaz (Fesoterodine)	Other	Phase PHASE4	Bladder Outlet Obstruction	ClinicalTrials.gov
PF-04136309	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
somatropin [rDNA origin] for injection	Other	Phase PHASE2	Arthritis, Juvenile Rheumatoid	ClinicalTrials.gov
Tavaborole 5% Topical Solution	Other	Phase PHASE4	Onychomycosis	ClinicalTrials.gov
PF-06865571 Immediate release tablets	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06865571 Fast release MR tablets	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06865571 Slow release MR tablets	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06865571 Immediate release suspension	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
20 mg BID of PF-02545920	Other	Phase PHASE2	Huntington's Disease	ClinicalTrials.gov
Epoetin Hospira MDV	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Epoetin Hospira SDV	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06730512	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
NXL104/ceftazidime	Other	Phase PHASE2	Complicated Urinary Tract Infection	ClinicalTrials.gov
Infliximab	Other	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
Caduet Pill	Other	Phase PHASE4	Metabolic Syndrome	ClinicalTrials.gov
Therapeutic Lifestyle Change	Other	Phase PHASE4	Metabolic Syndrome	ClinicalTrials.gov
IV Iron	Other	Phase PHASE3	Chronic Kidney Disease (CKD)	ClinicalTrials.gov
Standard of Care Arm	Other	Phase PHASE3	Chronic Kidney Disease (CKD)	ClinicalTrials.gov
Epoetin Hospira Arm	Other	Phase PHASE3	Chronic Kidney Disease (CKD)	ClinicalTrials.gov
Adalimumab with methotrexate	Other	Phase PHASE4	Rhematoid Arthritis	ClinicalTrials.gov
Tofacitinib without methotrexate	Other	Phase PHASE4	Rhematoid Arthritis	ClinicalTrials.gov
Tofacitinib with methotrexate	Other	Phase PHASE4	Rhematoid Arthritis	ClinicalTrials.gov
Copaxone®	Other	Phase PHASE4	Relapsing-remitting Multiple Sclerosis	ClinicalTrials.gov
Rebif®	Other	Phase PHASE4	Relapsing-remitting Multiple Sclerosis	ClinicalTrials.gov
Combination therapy	Drug	Phase PHASE3	Type 1 Diabetes	ClinicalTrials.gov
ACE inhibitor	Other	Phase PHASE3	Type 1 Diabetes	ClinicalTrials.gov
Physical and Occupational Therapy	Drug	Phase PHASE4	Mechanical Ventilation	ClinicalTrials.gov
ceftazidime/NXL104 + metronidazole	Other	Phase PHASE2	Complicated Intra-abdominal Infections	ClinicalTrials.gov
Cefepime	Other	Phase PHASE2	Complicated Urinary Tract Infections	ClinicalTrials.gov
Ceftazidime -avibactam	Other	Phase PHASE2	Complicated Urinary Tract Infections	ClinicalTrials.gov
other intravenous chemotherapy drugs	Drug	Phase PHASE2	Colorectal Cancer	ClinicalTrials.gov
raltitrexed	Other	Phase PHASE2	Colorectal Cancer	ClinicalTrials.gov
ReFacto AF (Moroctocog alfa)	Other	Preclinical	Hemophilia A	ClinicalTrials.gov
PF-06882961 Immediate Release Solution	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
PF-06882961 Controlled Release Tablet (short)	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
PF-06882961 Controlled Release Tablet (long)	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
PF-06882961 Immediate Release Tablet	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Staphylococcus aureus 4-antigen vaccine	Other	Phase PHASE2	Staphylococcal Infections	ClinicalTrials.gov
Case Management and Self-Management Education	Other	Approved	Chronic Obstructive Pulmonary Disease	ClinicalTrials.gov
Fluoxetine	Other	Approved	Major Depressive Disorder	ClinicalTrials.gov
Venlafaxine ERT	Other	Approved	Major Depressive Disorder	ClinicalTrials.gov
Probiotic	Other	Approved	Probiotics	ClinicalTrials.gov
Epogen Amgen	Other	Phase PHASE3	Chronic Renal Failure	ClinicalTrials.gov
Varenicline 0.5mg BID	Other	Phase PHASE4	Smoking Cessation	ClinicalTrials.gov
Varenicline 1mg BID	Other	Phase PHASE4	Smoking Cessation	ClinicalTrials.gov
Ibuprofen 600 mg ER	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Temsirolimus and Sorafenib	Other	Phase PHASE2	Thyroid Cancer	ClinicalTrials.gov
PF-06881894	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Atorvastatin 10 mg daily	Other	Phase PHASE3	Saphenous Vein Graft Disease	ClinicalTrials.gov
Atorvastatin 80 mg daily	Other	Phase PHASE3	Saphenous Vein Graft Disease	ClinicalTrials.gov
Taliglucerase alfa	Other	Phase PHASE3	Gaucher Disease	ClinicalTrials.gov
Plant cell expressed recombinant glucocerebrosidase (prGCD)	Other	Preclinical	Gaucher Disease	ClinicalTrials.gov
Epogen (Amgen)	Other	Phase PHASE3	Chronic Kidney Disease	ClinicalTrials.gov
Tdap	Other	Phase PHASE1	Pneumococcal Infections	ClinicalTrials.gov
Multivalent	Other	Phase PHASE1	Pneumococcal Infections	ClinicalTrials.gov
Fesoterodine Oral Product	Other	Phase EARLY_PHASE1	Urinary Incontinence	ClinicalTrials.gov
Aminoglycoside	Other	Phase PHASE2	Late-onset Sepsis	ClinicalTrials.gov
Ampicillin	Other	Phase PHASE2	Late-onset Sepsis	ClinicalTrials.gov
Placebo multiple elderly dose	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
PF-06751979 multiple dose	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Placebo multiple ascending dose	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
PF-06751979 multiple ascending dose	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Placebo single dose	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
PF-06751979 single dose	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
PF-05221304 administered Day 7-14	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05221304 administered Day 1-14	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06865571 administered Day 1-14	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06865571 administered Day 7-14	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Exemestane and GnRH analogue	Other	Phase PHASE3	Male Breast Cancer	ClinicalTrials.gov
Tamoxifen and GnRH analogue	Other	Phase PHASE3	Male Breast Cancer	ClinicalTrials.gov
Refacto FusENGO	Other	Preclinical	Hemophilia A	ClinicalTrials.gov
Open Label Treatment Access: Maraviroc	Drug	Preclinical	Human Immunodeficiency Virus (HIV)	ClinicalTrials.gov
BLI-489	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06815345	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
Immediate-release reference drug	Drug	Preclinical	Healthy	ClinicalTrials.gov
Oxycodone controlled-release test formulation	Other	Preclinical	Healthy	ClinicalTrials.gov
ALO-02 (Oxycodone Naltrexone)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Inhaled Insulin (Exubera)	Other	Phase PHASE4	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Insulin glargine	Other	Phase PHASE4	Diabetes Mellitus, Type 2	ClinicalTrials.gov
Subcutaneous Insulin (subject's prescribed)	Other	Phase PHASE3	Diabetes Mellitus, Type 1	ClinicalTrials.gov
penicillin G benzathine	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06293620	Other	Phase PHASE1	Type 2 Diabetes Mellitus	ClinicalTrials.gov
crushed oxycodone IR 40 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
crushed ALO-02 40 mg/4.8 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
crushed oxycodone IR 60 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
crushed ALO-02 60 mg/7.2 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
intact ALO-02 60 mg/7.2 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
HR-pQCT	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
*CYP2D610 gene test**	Other	Phase PHASE3	CYP2D6 Polymorphism	ClinicalTrials.gov
ovarian function suppression/ablation	Other	Phase PHASE3	CYP2D6 Polymorphism	ClinicalTrials.gov
Exemestane Tablets	Other	Phase PHASE3	CYP2D6 Polymorphism	ClinicalTrials.gov
methylphenidate HCl ERCT	Other	Phase PHASE4	Attention Deficit Hyperactivity Disorder (ADHD)	ClinicalTrials.gov
Methylphenidate Hydrochloride (HCl) Extended Release Chewable Tablet (ERCT)	Other	Phase PHASE4	Attention Deficit Hyperactivity Disorder	ClinicalTrials.gov
Placebo multiple dose	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
PF-06751979 single ascending dose	Other	Phase PHASE1	Healthy Subjects	ClinicalTrials.gov
Intra Vaginal Estradiol Cream	Other	Approved	Overactive Bladder	ClinicalTrials.gov
Extended Release Tolterodine LA	Other	Approved	Overactive Bladder	ClinicalTrials.gov
PF-05212384 (also known as PKI-587)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
dose level 4	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
dose level 3	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
dose level 2	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
dose level 1	Other	Phase PHASE1	Rheumatoid Arthritis	ClinicalTrials.gov
PF-03382792 15 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-03382792 5 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-03382792 1.5 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-03382792 0.5mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Cognitive remediation	Other	Approved	Depression	ClinicalTrials.gov
Action based cognitive remediation	Other	Approved	Depression	ClinicalTrials.gov
PF-06260414 nanosuspension	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF 06260414 solid dose formulation	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06260414	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Scopolamine	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
AN2690 Solution, 7.5%	Other	Phase PHASE2	Onychomycosis	ClinicalTrials.gov
AN2690 Solution, 5.0%	Other	Phase PHASE2	Onychomycosis	ClinicalTrials.gov
vehicle for Tasocitinib	Other	Phase PHASE2	Keratoconjunctivitis Sicca	ClinicalTrials.gov
Tasocitinib	Other	Phase PHASE2	Keratoconjunctivitis Sicca	ClinicalTrials.gov
rofecoxib	Other	Phase PHASE4	Acute Pain	ClinicalTrials.gov
PF-04494700	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
[14C]PF-05221304	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
C. difficile vaccine with adjuvant	Other	Phase PHASE1	Clostridium Difficile	ClinicalTrials.gov
PF-05335810 Dose D	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
PF-05335810 Dose E	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
PF-05335810 Dose C	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
PF-04950615 Dose A	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
PF-05335810 Dose B	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
PF-05335810 Dose A	Other	Phase PHASE1	Hypercholesterolemia	ClinicalTrials.gov
Fesoterodine 8 mg	Other	Phase PHASE4	Urinary Bladder, Overactive	ClinicalTrials.gov
UK-396,082	Other	Phase PHASE1	Phase 1	ClinicalTrials.gov
Your Way	Other	Preclinical	Overactive Bladder	ClinicalTrials.gov
UK-453,061 Dose 2	Other	Phase PHASE2	HIV-1	ClinicalTrials.gov
UK-453,061 Dose 1	Other	Phase PHASE2	HIV-1	ClinicalTrials.gov
Tramadol	Other	Phase PHASE1	Osteoarthritis Thumbs	ClinicalTrials.gov
piroxicam	Other	Phase PHASE4	Dysmenorrhea	ClinicalTrials.gov
CE-224535	Other	Phase PHASE2	Osteoarthritis	ClinicalTrials.gov
olmesartan alone or in combination with hydrochlorothiazide	Other	Phase PHASE3	Essential Hypertension	ClinicalTrials.gov
Acetaminophen 500 mg	Other	Phase PHASE3	Fever	ClinicalTrials.gov
Uniject	Other	Preclinical	Volume Delivery	ClinicalTrials.gov
750 mg Tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
5 mg Tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
400 mg Tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
30 mg Tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
150 mg Tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
750 mg Suspension	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
5 mg Suspension	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
400 mg Suspension	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
30 mg Suspension	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
150 mg Suspension	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
desvenlafaxine succinate sustained release tablets	Other	Phase PHASE3	Major Depressive Disorder	ClinicalTrials.gov
Pelli-Robson Contrast Sensitivity Chart	Other	Approved	Glaucoma	ClinicalTrials.gov
Spaeth/Richman Contrast Sensitivity Test	Other	Approved	Glaucoma	ClinicalTrials.gov
CsA+MMF+CS	Other	Phase PHASE4	Inflammation	ClinicalTrials.gov
CsA+Rapamune+CS	Other	Phase PHASE4	Inflammation	ClinicalTrials.gov
AN2690 Solution Vehicle	Other	Phase PHASE2	Distal, Subungual Onychomycosis	ClinicalTrials.gov
Dexmedetomidine hydrochloride	Other	Phase PHASE3	ICU Sedation	ClinicalTrials.gov
FSME-IMMUN 0.25 mL Junior (1.2 µg TBE antigen/0.25 mL) or FSME-IMMUN 0.5 mL (2.4µg TBE antigen/0.5 mL)	Other	Phase PHASE4	Encephalitis, Tick-Borne	ClinicalTrials.gov
Inotuzumab ozogamicin [CMC-544]	Other	Phase PHASE1	Lymphoma, B-Cell	ClinicalTrials.gov
Gardasil	Other	Phase PHASE2	Vaccines	ClinicalTrials.gov
rLP2086 and Gardasil	Other	Phase PHASE2	Vaccines	ClinicalTrials.gov
Prospective Observational	Other	Preclinical	Left Ventricular Dysfunction Post Myocardial Infarction	ClinicalTrials.gov
Placebo for Fragmin/ Dalteparin Sodium	Other	Phase PHASE2	Diabetic Foot Ulcer	ClinicalTrials.gov
Fragmin/ Dalteparin Sodium	Other	Phase PHASE2	Diabetic Foot Ulcer	ClinicalTrials.gov
Tamsulosin	Other	Phase PHASE2	Prostatic Hyperplasia	ClinicalTrials.gov
aspirin	Other	Phase PHASE3	Atrial Fibrillation	ClinicalTrials.gov
indobufen	Other	Phase PHASE3	Atrial Fibrillation	ClinicalTrials.gov
QUESTIONNAIRE ON SMOKING HABITS	Other	Preclinical	Chronic Plaque Psoriasis	ClinicalTrials.gov
rLP2086 + saline	Other	Phase PHASE2	Vaccines	ClinicalTrials.gov
MCV4 + Tdap + saline	Other	Phase PHASE2	Vaccines	ClinicalTrials.gov
rLP2086 + MCV4 + Tdap	Other	Phase PHASE2	Vaccines	ClinicalTrials.gov
Viviant	Other	Preclinical	Osteoporosis	ClinicalTrials.gov
Etanercept 50 mg	Other	Phase PHASE3	Psoriasis	ClinicalTrials.gov
CP 690,550 10 mg	Other	Phase PHASE3	Psoriasis	ClinicalTrials.gov
CP 690,550 5 mg	Other	Phase PHASE3	Psoriasis	ClinicalTrials.gov
Tablet Methylprednisolone (4 or 16 mg)	Other	Preclinical	Dermatitis, Contact	ClinicalTrials.gov
Paraplatin®	Other	Phase PHASE3	Early Breast Cancer	ClinicalTrials.gov
Taxotere®	Other	Phase PHASE3	Early Breast Cancer	ClinicalTrials.gov
Trastuzumab-EU	Other	Phase PHASE3	Early Breast Cancer	ClinicalTrials.gov
rituximab +bendamustine	Other	Phase PHASE3	Lymphoma, Non-Hodgkin	ClinicalTrials.gov
rituximab + gemcitabine	Other	Phase PHASE3	Lymphoma, Non-Hodgkin	ClinicalTrials.gov
PF-06263507	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
cytarabine and mitoxantrone	Other	Phase PHASE3	Acute Lymphoblastic Leukemia	ClinicalTrials.gov
HIDAC (high dose cytarabine)	Other	Phase PHASE3	Acute Lymphoblastic Leukemia	ClinicalTrials.gov
FLAG (fludarabine, cytarabine and G-CSF)	Other	Phase PHASE3	Acute Lymphoblastic Leukemia	ClinicalTrials.gov
Alclometasone cream	Other	Phase PHASE2	Non Small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
Doxycycline	Other	Phase PHASE2	Non Small Cell Lung Cancer (NSCLC)	ClinicalTrials.gov
New oral anticoagulant pharmacodynamic analysis (blood level assesment)	Other	Preclinical	Atrial Fibrillation and Flutter	ClinicalTrials.gov
Glasdegib (PF-04449913)	Other	Phase PHASE2	Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis	ClinicalTrials.gov
Axitinib plus Lomustine	Other	Phase PHASE2	Glioblastoma Multiforme	ClinicalTrials.gov
Rituximab-US + Rituximab-Pfizer x 2 Courses	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Rituximab-EU+ Rituximab-Pfizer x 2 Courses	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Rituximab-Pfizer (PF-05280586) x 3 courses	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Period 2: Cohort 2: Fluconazole & PF-04965842	Other	Phase PHASE1	Dermatitis, Atopic	ClinicalTrials.gov
Period 2: Cohort 1: Fluvoxamine & PF-04965842	Other	Phase PHASE1	Dermatitis, Atopic	ClinicalTrials.gov
Period 1 - Day 1: PF-04965842 administered	Other	Phase PHASE1	Dermatitis, Atopic	ClinicalTrials.gov
Trofile Assay and HIV RNA quantification assay	Other	Phase PHASE1	HIV Infections	ClinicalTrials.gov
Internet Medical Model	Other	Approved	Hypertension	ClinicalTrials.gov
PF - 00610355	Other	Phase PHASE2	Asthma, Bronchial	ClinicalTrials.gov
PF-06412562 45mg BID	Other	Phase PHASE1	Schizophrenia	ClinicalTrials.gov
PF-06412562 9mg BID	Other	Phase PHASE1	Schizophrenia	ClinicalTrials.gov
PF- 00610355	Other	Phase PHASE2	Pulmonary Disease, Chronic Obstructive	ClinicalTrials.gov
Bevacizumab-EU	Other	Phase PHASE3	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Bevacizumab-Pfizer	Other	Phase PHASE3	Non-Small Cell Lung Cancer	ClinicalTrials.gov
MK-3475	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
PF-05082566	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Overall satisfaction questionnaires of home use of Nivestim	Other	Preclinical	Non-Interventional Study	ClinicalTrials.gov
PF-03654764 5mg plus fexofenadine 60mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-03654764 2.5mg plus fexofenadine 60mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Azacitidine	Other	Phase PHASE1	Acute Myeloid Leukemia (AML)	ClinicalTrials.gov
Azithromycin Tablet manufactured in US	Other	Phase PHASE1	Bioequivalence	ClinicalTrials.gov
Azithromycin Tablet manufactured in China	Other	Phase PHASE1	Bioequivalence	ClinicalTrials.gov
AN2898 ointment vehicle	Other	Phase PHASE2	Dermatitis, Atopic	ClinicalTrials.gov
AN2898 ointment, 1%	Other	Phase PHASE2	Dermatitis, Atopic	ClinicalTrials.gov
Solution Vehicle	Other	Phase PHASE3	Onychomycosis of Toenails	ClinicalTrials.gov
AN2690 Topical Solution, 5%	Other	Phase PHASE3	Onychomycosis of Toenails	ClinicalTrials.gov
Protopic® Ointment, 0.1 %	Other	Phase PHASE1	Psoriasis	ClinicalTrials.gov
Betnesol®-V Creme, 0.1%	Other	Phase PHASE1	Psoriasis	ClinicalTrials.gov
AN2728 Ointment, 0.5%	Other	Phase PHASE1	Psoriasis	ClinicalTrials.gov
AN2728 Ointment, 5%	Other	Phase PHASE1	Psoriasis	ClinicalTrials.gov
Benadryl demand	Other	Phase PHASE4	Sedation	ClinicalTrials.gov
Fentanyl demand	Other	Phase PHASE4	Sedation	ClinicalTrials.gov
Midazolam demand	Other	Phase PHASE4	Sedation	ClinicalTrials.gov
Ketamine maintenance	Other	Phase PHASE4	Sedation	ClinicalTrials.gov
Dexmedetomidine maintenance	Other	Phase PHASE4	Sedation	ClinicalTrials.gov
Fentanyl load	Other	Phase PHASE4	Sedation	ClinicalTrials.gov
Midazolam load	Other	Phase PHASE4	Sedation	ClinicalTrials.gov
Ketamine load	Other	Phase PHASE4	Sedation	ClinicalTrials.gov
Dexmedetomidine load	Other	Phase PHASE4	Sedation	ClinicalTrials.gov
KW-0761	Other	Phase PHASE1	Advanced/Metastatic Solid Tumors	ClinicalTrials.gov
AN2728 Cream Vehicle	Other	Phase PHASE1	Psoriasis	ClinicalTrials.gov
AN2728 Cream, 0.3%	Other	Phase PHASE1	Psoriasis	ClinicalTrials.gov
AN2728 Cream, 1%	Other	Phase PHASE1	Psoriasis	ClinicalTrials.gov
AN2728 Cream, 2%	Other	Phase PHASE1	Psoriasis	ClinicalTrials.gov
Crisaborole ointment 2%	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PET Scan with PF-03654746	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Positron Emission tomography	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PSG	Other	Preclinical	Nonrestorative Sleep	ClinicalTrials.gov
AN2728 Vehicle	Other	Phase PHASE1	Plaque-type Psoriasis	ClinicalTrials.gov
AN2728 Ointment	Other	Phase PHASE1	Plaque-type Psoriasis	ClinicalTrials.gov
AN3365	Other	Phase PHASE1	Gram-negative Bacterial Infection	ClinicalTrials.gov
IV 14C-labeled PF-06700841	Other	Phase PHASE1	Healthy Male Subjects	ClinicalTrials.gov
Oral unlabeled PF-06700841	Other	Phase PHASE1	Healthy Male Subjects	ClinicalTrials.gov
Oral PF-06700841 containing 14C microtracer	Other	Phase PHASE1	Healthy Male Subjects	ClinicalTrials.gov
temsirolimus plus liposomal doxorubicin	Other	Phase PHASE1	Sarcoma	ClinicalTrials.gov
Regorafenib	Other	Phase PHASE1	Colorectal Cancer	ClinicalTrials.gov
Rituximab (Rituxan)	Other	Phase PHASE1	Lymphoma, B-Cell	ClinicalTrials.gov
Workshop	Other	Approved	Pelvic Floor Disorders	ClinicalTrials.gov
sunitinib malate dose escalation	Other	Phase PHASE2	Gastrointestinal Stromal Tumors	ClinicalTrials.gov
PF-06650808	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
PF-06835919 High Dose	Other	Phase PHASE2	Non-alcoholic Fatty Liver Disease	ClinicalTrials.gov
PF-06835919 Low Dose	Other	Phase PHASE2	Non-alcoholic Fatty Liver Disease	ClinicalTrials.gov
Ibuprofen/Caffeine	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Ethinyl estradiol (EE) and levonogestrel (LN)	Other	Phase PHASE1	Healthy Females	ClinicalTrials.gov
Sodium Lauryl Sulfate, 0.5%	Other	Phase PHASE1	Onychomycosis	ClinicalTrials.gov
AN2690 Solution, Vehicle	Other	Phase PHASE1	Onychomycosis	ClinicalTrials.gov
15 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD	Other	Phase PHASE2	Parkinson's Disease With Motor Fluctuations	ClinicalTrials.gov
7 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)	Other	Phase PHASE2	Parkinson's Disease With Motor Fluctuations	ClinicalTrials.gov
3 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study)	Other	Phase PHASE2	Parkinson's Disease With Motor Fluctuations	ClinicalTrials.gov
1 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study)	Other	Phase PHASE2	Parkinson's Disease With Motor Fluctuations	ClinicalTrials.gov
15 mg QD PF-06649751	Other	Phase PHASE2	Parkinson's Disease With Motor Fluctuations	ClinicalTrials.gov
7 mg QD to 15 mg QD PF-06649751	Other	Phase PHASE2	Parkinson's Disease With Motor Fluctuations	ClinicalTrials.gov
3 mg QD to 15 mg QD PF-06649751	Other	Phase PHASE2	Parkinson's Disease With Motor Fluctuations	ClinicalTrials.gov
1 mg QD to 15 mg QD PF-06649751	Other	Phase PHASE2	Parkinson's Disease With Motor Fluctuations	ClinicalTrials.gov
Sodium Lauryl Sulfate	Other	Phase PHASE1	Tinea Pedis	ClinicalTrials.gov
AN2718	Other	Phase PHASE1	Tinea Pedis	ClinicalTrials.gov
PNU-165442G; [S,S]-reboxetine	Other	Phase PHASE2	Attention Deficit Hyperactivity Disorder	ClinicalTrials.gov
PF-06647263	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
light microscopy	Other	Phase PHASE2	Recurrent Bladder Cancer	ClinicalTrials.gov
TdT-mediated dUTP nick end labeling assay	Other	Phase PHASE2	Recurrent Bladder Cancer	ClinicalTrials.gov
immunohistochemistry staining method	Other	Phase PHASE2	Recurrent Bladder Cancer	ClinicalTrials.gov
Normal follow-up	Other	Approved	Type 1 Diabetes	ClinicalTrials.gov
Intensive treatment	Drug	Approved	Type 1 Diabetes	ClinicalTrials.gov
Rosuvastatin	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Glasdegib 100 mg single oral dose	Other	Phase PHASE1	Hepatic Impairment	ClinicalTrials.gov
Medroxyprogesterone 17-Acetate	Other	Approved	Contraception	ClinicalTrials.gov
PF-06700841 Modified release tablets	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06700841 Immediate release tablets	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
OGTT	Other	Approved	Acromegaly	ClinicalTrials.gov
Gadolinium	Other	Approved	Acromegaly	ClinicalTrials.gov
CMRI	Other	Approved	Acromegaly	ClinicalTrials.gov
Hemophilia A extended half-life	Other	Preclinical	Hemophilia A	ClinicalTrials.gov
Hemophilia A standard half-life	Other	Preclinical	Hemophilia A	ClinicalTrials.gov
Hemophilia B extended half-life	Other	Preclinical	Hemophilia A	ClinicalTrials.gov
Hemophilia B standard half-life	Other	Preclinical	Hemophilia A	ClinicalTrials.gov
White petrolatum	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06700841 cream	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Blood sampling for genomics; harvesting of a sample of intercostal muscle for proteomics (thoracotomies only)	Other	Preclinical	Neuropathic Pain	ClinicalTrials.gov
Vaginal Heat Wash-Out Device	Device	Phase PHASE1	Sexual Dysfunction, Physiological	ClinicalTrials.gov
Prazosin Hydrochloride	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Bitrex solution	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06651600 20 mg	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Ritalin	Other	Preclinical	Healthy	ClinicalTrials.gov
Prototype (AN0128 Toothpaste)	Other	Phase PHASE1	Dental Plaque	ClinicalTrials.gov
Positive Control (anti-plaque/anti-bacterial toothpaste)	Other	Phase PHASE1	Dental Plaque	ClinicalTrials.gov
Negative Control (Regular Toothpaste)	Other	Phase PHASE1	Dental Plaque	ClinicalTrials.gov
Meningococcal vaccine GSK134612	Other	Phase PHASE3	Infections, Meningococcal	ClinicalTrials.gov
Placebo comparator: control group	Other	Approved	Haemophilia	ClinicalTrials.gov
Psychology and Physiotherapy group	Drug	Approved	Haemophilia	ClinicalTrials.gov
multivalent pneumococcal conjugate formulation 2	Other	Phase PHASE1	Pneumococcal Infections	ClinicalTrials.gov
multivalent pneumococcal conjugate formulation 1	Other	Phase PHASE1	Pneumococcal Infections	ClinicalTrials.gov
Prevnar 13	Other	Phase PHASE1	Pneumococcal Infections	ClinicalTrials.gov
MabThera®	Other	Phase PHASE3	Follicular Lymphoma	ClinicalTrials.gov
PF-05280586	Other	Phase PHASE3	Follicular Lymphoma	ClinicalTrials.gov
Within-Subject Active vs. Placebo Topical Applications	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Within-Subject Active vs Placebo Topical Applications	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
VistaO2	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Temsirolimus + Weekly Paclitaxel + Carboplatin	Other	Phase PHASE1	Squamous Cell Cancer	ClinicalTrials.gov
Itraconazole Solution 200 mg	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06651600 10 mg tablets	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
As per clinical practice	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
PF 06835919	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
14C-PF-06651600 IV	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
14C-PF-06651600	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Liraglutide	Other	Phase PHASE1	Obesity	ClinicalTrials.gov
Oxybutynin XL	Other	Phase PHASE3	Overactive Bladder	ClinicalTrials.gov
Standard of Care Placebo	Other	Phase PHASE1	Parkinson Disease	ClinicalTrials.gov
inotuzumab ozogamicin+rituximab+gemcitabine+cisplatinum+dexamethasone	Other	Phase PHASE1	Lymphoma, B-Cell	ClinicalTrials.gov
inotuzumab ozogamicin+rituximab +cyclophosphamide+vincristine+prednisone	Other	Phase PHASE1	Lymphoma, B-Cell	ClinicalTrials.gov
70 mg/dL	Other	Approved	Ischemic Stroke	ClinicalTrials.gov
Target : 100 mg/dL (+/-10 mg/dL)	Other	Approved	Ischemic Stroke	ClinicalTrials.gov
Crisaborole ointment 2% BID	Other	Phase PHASE2	Dermatitis, Atopic	ClinicalTrials.gov
Antibody Drug Conjugate Chemotherapeutic	Drug	Preclinical	CD33 Positive Acute Myelogenous Leukemia	ClinicalTrials.gov
No drug name provided by Sponsor; drug referenced as PD 0332334	Drug	Phase PHASE3	Anxiety Disorders	ClinicalTrials.gov
Glasdegib single 100 mg dose in severe renal impairment subjects	Other	Phase PHASE1	Renal Impairment	ClinicalTrials.gov
Glasdegib single 100 mg dose in moderate renal impairment subjects	Other	Phase PHASE1	Renal Impairment	ClinicalTrials.gov
Glasdegib single 100 mg dose in normal healthy subjects	Other	Phase PHASE1	Renal Impairment	ClinicalTrials.gov
Placebo Control	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Positive Control (Moxifloxacin)	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Glasdegib Supra-therapeutic Exposure	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Glasdegib Therapeutic Exposure	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Crizotinib (Xalkori)	Other	Preclinical	Non-small Cell Lung Cancer	ClinicalTrials.gov
Subcutaneous depot medroxyprogesterone acetate	Other	Phase PHASE4	Contraception	ClinicalTrials.gov
Elelyso 60 units/kg	Other	Phase PHASE4	Type 1 Gaucher Disease	ClinicalTrials.gov
Precedex	Other	Phase PHASE4	Liver Transplantation	ClinicalTrials.gov
Duloxetine hydrochloride capsule	Other	Phase PHASE4	Healthy	ClinicalTrials.gov
Cymbalta capsule	Other	Phase PHASE4	Healthy	ClinicalTrials.gov
Duloxetine Hydrochloride Capsules	Other	Phase PHASE4	Healthy	ClinicalTrials.gov
Cymbalta Capsules	Other	Phase PHASE4	Healthy	ClinicalTrials.gov
Gedatolisib	Other	Phase PHASE1	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Probenecid	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
novel treatment	Drug	Phase PHASE4	HIV	ClinicalTrials.gov
standard care	Other	Phase PHASE4	HIV	ClinicalTrials.gov
call center	Other	Preclinical	Metastatic/Advanced Renal Cell Carcinoma	ClinicalTrials.gov
PF-06946860	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Ethinyl estradiol (EE) and levonorgestrel(LN)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Treatment H	Drug	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
BCG and CP-675,206	Other	Phase PHASE1	Bladder Cancer	ClinicalTrials.gov
MabThera	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
erlotinib, sunitinib	Other	Phase PHASE1	Non Small Cell Lung Cancer	ClinicalTrials.gov
Non Interventional Study	Other	Preclinical	Growth Hormone Deficiency	ClinicalTrials.gov
Decitabine	Other	Phase PHASE1	Acute Myeloid Leukemia	ClinicalTrials.gov
Daunorubicin	Other	Phase PHASE1	Acute Myeloid Leukemia	ClinicalTrials.gov
Cytarabine	Other	Phase PHASE1	Acute Myeloid Leukemia	ClinicalTrials.gov
PF-06747143	Other	Phase PHASE1	Acute Myeloid Leukemia	ClinicalTrials.gov
Bicalutamide, CP-675,206	Other	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
Bicalutamide, CP-675,206 (Tremelimumab)	Other	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
Bicalutamide and CP-675,206 (Tremelimumab)	Other	Phase PHASE1	Prostate Cancer	ClinicalTrials.gov
PF-06865571 400 mg MR in Fasted State	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06865571 400 mg MR in Fed State	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06865571 50 mg Modified Release (MR) in Fed State	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06865571 400 mg Immediate Release (IR) in Fed State	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Tolterodine 6	Other	Phase PHASE4	Overactive Bladder	ClinicalTrials.gov
LHRHa	Other	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Abiraterone Acetate	Other	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
PF-04965842 200 mg	Other	Phase PHASE3	Dermatitis, Atopic	ClinicalTrials.gov
PF-04965842 100 mg	Other	Phase PHASE3	Dermatitis, Atopic	ClinicalTrials.gov
[S,S]-Reboxetine + Pregabalin	Other	Phase PHASE2	Pain	ClinicalTrials.gov
PPSV23	Other	Phase PHASE2	Pneumococcal Infections	ClinicalTrials.gov
CELSENTRI® Tablets	Other	Preclinical	CCR5-tropic HIV-1 Infection	ClinicalTrials.gov
Normal Saline for injection	Other	Phase PHASE2	Pulmonary Sarcoidosis	ClinicalTrials.gov
Comm-Fed	Other	Phase PHASE1	Dermatitis, Atopic	ClinicalTrials.gov
Vari-Fast	Other	Phase PHASE1	Dermatitis, Atopic	ClinicalTrials.gov
Comm-Fast	Other	Phase PHASE1	Dermatitis, Atopic	ClinicalTrials.gov
P3-Fast	Other	Phase PHASE1	Dermatitis, Atopic	ClinicalTrials.gov
Tanezumab 5 mg	Other	Phase PHASE3	Chronic Pain	ClinicalTrials.gov
Tanezumab 2.5 mg	Other	Phase PHASE3	Chronic Pain	ClinicalTrials.gov
NSAID	Other	Phase PHASE3	Chronic Pain	ClinicalTrials.gov
Tofacitinib Oral Solution	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tofacitinib tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Lorlatinib 100 mg	Other	Phase PHASE1	Adult	ClinicalTrials.gov
Lorlatinib 75 mg	Other	Phase PHASE1	Adult	ClinicalTrials.gov
Lorlatinib 50 mg	Other	Phase PHASE1	Adult	ClinicalTrials.gov
PF-06688992	Other	Phase PHASE1	Melanoma	ClinicalTrials.gov
PF-06840003	Other	Phase PHASE1	Oligodendroglioma	ClinicalTrials.gov
Oral Contraceptive (OC)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06826647	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Nilotinib	Other	Phase PHASE1	Leukemia	ClinicalTrials.gov
MEK-162	Other	Phase PHASE1	Leukemia	ClinicalTrials.gov
Oxybutynin	Other	Phase PHASE2	Overactive Bladder	ClinicalTrials.gov
Comprehensive Geriatric Assessment	Other	Approved	Metastatic Breast Cancer	ClinicalTrials.gov
Didactic session	Other	Approved	Metastatic Breast Cancer	ClinicalTrials.gov
Low dose ARA-C (LDAC)	Other	Phase PHASE2	Acute Myeloid Leukemia	ClinicalTrials.gov
PF-04449913	Other	Phase PHASE2	Acute Myeloid Leukemia	ClinicalTrials.gov
SL-ECG	Other	Preclinical	ECG	ClinicalTrials.gov
Health education intervention (HEI)	Other	Approved	Overactive Bladder	ClinicalTrials.gov
bisphosphonates, calcium, and vitamin D	Other	Phase PHASE2	Osteoporosis	ClinicalTrials.gov
rhBMP-2/CPM injection and bisphosphonates, calcium, and vitamin D (oral bisphosphonate therapy)	Drug	Phase PHASE2	Osteoporosis	ClinicalTrials.gov
Ethinyl estradiol (EE) and levonorgestrel (LN)	Other	Phase PHASE1	Healthy Females	ClinicalTrials.gov
PF-07081532	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
bivalent rLP2086	Other	Phase PHASE3	Meningococcal Infection	ClinicalTrials.gov
Placebo oral solution/suspension	Other	Phase PHASE1	Plaque Psoriasis	ClinicalTrials.gov
PF-06826647 oral suspension	Other	Phase PHASE1	Plaque Psoriasis	ClinicalTrials.gov
PF-06826647 tablet	Other	Phase PHASE1	Plaque Psoriasis	ClinicalTrials.gov
The Control Group	Other	Preclinical	Pneumonia	ClinicalTrials.gov
The Pneumonia Group	Other	Preclinical	Pneumonia	ClinicalTrials.gov
Hydroxychloroquine (HCQ)	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
PF-06671008	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
ARRY-380, HER2 inhibitor; oral	Other	Phase PHASE1	Cancer	ClinicalTrials.gov
PF-07038124 or vehicle	Other	Phase PHASE1	Dermatitis Atopic	ClinicalTrials.gov
PF-07038124 and Vehicle	Other	Phase PHASE1	Dermatitis Atopic	ClinicalTrials.gov
Gemcitabine, Nab-Paclitaxel, and hydroxychloroquine	Other	Phase PHASE2	Pancreatic Cancer Resectable	ClinicalTrials.gov
Gemcitabine, Nab-Paclitaxel, hydroxychloroquine and Avelumab	Other	Phase PHASE2	Pancreatic Cancer Resectable	ClinicalTrials.gov
Ibuprofen/acetaminophen	Other	Phase PHASE2	Pain	ClinicalTrials.gov
PF-05221304 Formulation B	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-05221304 Formulation A	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06650833 together with PF-06651600	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06651600 alone	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06650833 alone	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo Methotrexate	Other	Phase PHASE3	Arthritis, Psoriatic	ClinicalTrials.gov
tofacitinib IR 5 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
tofacitinib MR 11 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
TA-46	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
polysaccharide	Other	Phase PHASE2	Pneumococcal Infections	ClinicalTrials.gov
Questionnaire Administration	Other	Phase PHASE1	Recurrent Childhood Anaplastic Large Cell Lymphoma	ClinicalTrials.gov
SPK-9001	Other	Phase PHASE2	Hemophilia B	ClinicalTrials.gov
Betamethasone	Other	Phase PHASE1	Psoriasis	ClinicalTrials.gov
Calcipotriene/calcipotriol	Other	Phase PHASE1	Psoriasis	ClinicalTrials.gov
PF-06763809	Other	Phase PHASE1	Psoriasis	ClinicalTrials.gov
Shear wave elastography	Other	Approved	Amyloidosis	ClinicalTrials.gov
lecozotan SR (SRA-333)	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
bosutinib capsules high flavour	Other	Phase PHASE1	CML	ClinicalTrials.gov
bosutinib capsules low flavour	Other	Phase PHASE1	CML	ClinicalTrials.gov
bosutinib capsules high sweet	Other	Phase PHASE1	CML	ClinicalTrials.gov
Bosutinib capsules in low sweet	Other	Phase PHASE1	CML	ClinicalTrials.gov
bosutinib capsules in water	Other	Phase PHASE1	CML	ClinicalTrials.gov
Bosutinib capsules in yogurt	Other	Phase PHASE1	CML	ClinicalTrials.gov
bosutinib capsules in applesauce	Other	Phase PHASE1	CML	ClinicalTrials.gov
bosutinib high flavour	Other	Phase PHASE1	CML	ClinicalTrials.gov
bosutinib taste low flavour	Other	Phase PHASE1	CML	ClinicalTrials.gov
bosutinib in mannitol high sweet	Other	Phase PHASE1	CML	ClinicalTrials.gov
bosutinib in mannitol low sweet	Other	Phase PHASE1	CML	ClinicalTrials.gov
Bosutinib Mannitol	Other	Phase PHASE1	CML	ClinicalTrials.gov
bosunitib sorbitol	Other	Phase PHASE1	CML	ClinicalTrials.gov
200 Mg capsules of bosutinib in Water solution	Other	Phase PHASE1	CML	ClinicalTrials.gov
ages 12-17	Other	Phase PHASE4	Moderate-severe Pain	ClinicalTrials.gov
Ages 7-11	Other	Phase PHASE4	Moderate-severe Pain	ClinicalTrials.gov
TH-302 + Sunitinib	Other	Phase PHASE2	Neuroendocrine Tumors	ClinicalTrials.gov
Methotrexate - Delay	Other	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
Methotrexate - Immediate	Other	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
Pneumo23 / Pneumovax	Other	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
maximum tolerated dose of anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody	Other	Phase PHASE1	Melanoma (Skin)	ClinicalTrials.gov
SU011248, Sutent	Other	Phase PHASE2	Papillary Thyroid Cancer	ClinicalTrials.gov
Placebo for tanezumab	Other	Phase PHASE3	Low Back Pain	ClinicalTrials.gov
Placebo for celecoxib	Other	Phase PHASE3	Low Back Pain	ClinicalTrials.gov
Tanezumab 10 mg	Other	Phase PHASE3	Low Back Pain	ClinicalTrials.gov
'WeChat WeQuit' smoking cessation training program	Other	Approved	Smoking Cessation Intervention	ClinicalTrials.gov
Ruxolitinib	Other	Phase PHASE1	Acute Lymphoblastic Leukemia, in Relapse	ClinicalTrials.gov
Doxorubicin	Other	Phase PHASE1	Acute Lymphoblastic Leukemia, in Relapse	ClinicalTrials.gov
Dasatinib	Other	Phase PHASE1	Acute Lymphoblastic Leukemia, in Relapse	ClinicalTrials.gov
Intrathecal Triple Therapy	Drug	Phase PHASE1	Acute Lymphoblastic Leukemia, in Relapse	ClinicalTrials.gov
Palbociclib Oral Capsule	Other	Phase PHASE1	Acute Lymphoblastic Leukemia, in Relapse	ClinicalTrials.gov
Sumatriptan	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Avelumab (MSB0010718C)	Other	Phase PHASE1	Carcinoma, Hepatocellular	ClinicalTrials.gov
FLARE Intervention Group	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
PRO data not utilized	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
PRO data utilized	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous	Other	Phase PHASE2	Advanced Multiple Myeloma	ClinicalTrials.gov
Dexamethasone, steroid; oral or intravenous	Other	Phase PHASE2	Advanced Multiple Myeloma	ClinicalTrials.gov
Filanesib, KSP(Eg5) inhibitor; intravenous	Other	Phase PHASE2	Advanced Multiple Myeloma	ClinicalTrials.gov
Carfilzomib, proteasome inhibitor; intravenous	Other	Phase PHASE2	Advanced Multiple Myeloma	ClinicalTrials.gov
AEB071	Other	Phase PHASE1	Uveal Melanoma	ClinicalTrials.gov
ARRY-438162 (MEK162), MEK inhibitor; oral	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
ARRY-382, cFMS inhibitor; oral	Other	Phase PHASE1	Metastatic Cancer	ClinicalTrials.gov
PF-05221304 and PF-06865571 Combination	Other	Phase PHASE2	Non-Alcoholic Fatty Liver Disease (NAFLD)	ClinicalTrials.gov
PF-06865571 Monotherapy	Drug	Phase PHASE2	Non-Alcoholic Fatty Liver Disease (NAFLD)	ClinicalTrials.gov
PF-05221304 Monotherapy	Drug	Phase PHASE2	Non-Alcoholic Fatty Liver Disease (NAFLD)	ClinicalTrials.gov
ARRY-520, KSP(Eg5) inhibitor; intravenous	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Placebo for 12 weeks	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Methotrexate plus ERB-041 for 12 weeks	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Prophylactic growth factors; subcutaneous	Other	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
Docetaxel, mitotic inhibitor; intravenous	Other	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
ARRY-300, MEK inhibitor; oral	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Capecitabine, 5-fluorouracil prodrug; oral	Drug	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
BEZ235 + MEK162	Other	Phase PHASE1	Unspecified Adult Solid Tumor, Protocol Specific	ClinicalTrials.gov
MenACWY-TT	Other	Phase PHASE3	Meningococcal ACWY Disease	ClinicalTrials.gov
Oxycodone hydrochloride (HCl) extended release (ER), opioid agonist; oral	Other	Phase PHASE2	Osteoarthritis of the Knee	ClinicalTrials.gov
PF 06252616	Other	Phase PHASE1	LGMD2I	ClinicalTrials.gov
Filanesib, KSP (Eg5) inhibitor; intravenous	Other	Phase PHASE2	Advanced Multiple Myeloma	ClinicalTrials.gov
Dexamethasone, steroid; oral	Other	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Brompheniramine maleate	Other	Phase PHASE1	Allergic Reactions	ClinicalTrials.gov
Chlorpheniramine	Other	Phase PHASE1	Allergic Reactions	ClinicalTrials.gov
Licensed pediatric hepatits A vaccine	Other	Phase PHASE2	MENINGOCOCCAL INFECTION	ClinicalTrials.gov
Bivalent rLP2086 Vaccine	Other	Phase PHASE2	MENINGOCOCCAL INFECTION	ClinicalTrials.gov
tofacitinib modified release (MR)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Switch	Other	Phase PHASE4	Schizophrenia	ClinicalTrials.gov
OAP-189	Other	Phase PHASE1	Diabetes Mellitus	ClinicalTrials.gov
[124I]IB PF 06687234	Other	Phase PHASE1	Inflammatory Bowel Disease	ClinicalTrials.gov
PF 06687234	Other	Phase PHASE1	Inflammatory Bowel Disease	ClinicalTrials.gov
Extended Individual Counseling - Relapse Prevention Model	Other	Phase PHASE3	Nicotine Dependence	ClinicalTrials.gov
Extended Individual Counseling - Health Model	Other	Phase PHASE3	Nicotine Dependence	ClinicalTrials.gov
Check-ins with medical staff	Other	Phase PHASE3	Nicotine Dependence	ClinicalTrials.gov
Initial Individual counseling	Other	Phase PHASE3	Nicotine Dependence	ClinicalTrials.gov
diagnostic algorithm	Other	Preclinical	Cardiac Amyloidosis	ClinicalTrials.gov
20vPnC	Other	Phase PHASE3	Pneumococcal Disease	ClinicalTrials.gov
Bupropion	Other	Phase PHASE2	Nicotine Dependence	ClinicalTrials.gov
PF-06882961, 50 mg and [14C]PF-06882961, 100 ug	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
[14C]PF-06882961, 50 mg	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Pre treatment Recurrence Score:26-100 Letrozole + Palbociclib	Drug	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Pre treatment Recurrence Score:18-25 Letrozole + Palbociclib	Drug	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Laboratory Assessments	Other	Phase EARLY_PHASE1	Smoking Cessation	ClinicalTrials.gov
Counseling and Support Materials	Other	Phase EARLY_PHASE1	Smoking Cessation	ClinicalTrials.gov
Fesoterodine BIC 4 mg	Other	Phase PHASE3	Urinary Bladder, Neurogenic	ClinicalTrials.gov
Fesoterodine BIC 2 mg	Other	Phase PHASE3	Urinary Bladder, Neurogenic	ClinicalTrials.gov
Fesoterodine PR 8 mg	Other	Phase PHASE3	Urinary Bladder, Neurogenic	ClinicalTrials.gov
Fesoterodine PR 4 mg	Other	Phase PHASE3	Urinary Bladder, Neurogenic	ClinicalTrials.gov
ARRY-438162, MEK inhibitor; oral	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
NB-UVB Phototherapy	Drug	Approved	Psoriasis	ClinicalTrials.gov
Sorafenib:	Other	Phase PHASE2	Hepatocellular Carcinoma	ClinicalTrials.gov
Pemetrexed/Carboplatin	Other	Phase PHASE3	NSCLC (Non-small Cell Lung Cancer)	ClinicalTrials.gov
Pemetrexed/Cisplatin	Other	Phase PHASE3	NSCLC (Non-small Cell Lung Cancer)	ClinicalTrials.gov
AMG 479	Other	Phase PHASE1	Metastatic Pancreatic Adenocarcinoma	ClinicalTrials.gov
PF-6826647 400 mg QD	Other	Phase PHASE2	Ulcerative Colitis	ClinicalTrials.gov
PF-06826647 600 mg QD	Other	Phase PHASE2	Ulcerative Colitis	ClinicalTrials.gov
PF-06826647 300 mg QD	Other	Phase PHASE2	Ulcerative Colitis	ClinicalTrials.gov
PF-06826647 100 mg QD	Other	Phase PHASE2	Ulcerative Colitis	ClinicalTrials.gov
Utomilumab	Other	Phase PHASE3	Diffuse Large B-Cell Lymphoma	ClinicalTrials.gov
Vupanorsen	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Meloxicam	Other	Approved	Osteoarthritis of the Knee	ClinicalTrials.gov
Placebo Vehicle	Other	Phase PHASE2	Psoriasis	ClinicalTrials.gov
PF-07304814	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Vehicle 2	Other	Phase PHASE2	Psoriasis	ClinicalTrials.gov
CP-690,550 Ointment 2	Other	Phase PHASE2	Psoriasis	ClinicalTrials.gov
Vehicle 1	Other	Phase PHASE2	Psoriasis	ClinicalTrials.gov
CP-690,550 Ointment 1	Other	Phase PHASE2	Psoriasis	ClinicalTrials.gov
Injectable Placebo	Other	Phase PHASE3	Dermatitis	ClinicalTrials.gov
Oral Placebo	Other	Phase PHASE3	Dermatitis	ClinicalTrials.gov
Dupilumab	Other	Phase PHASE3	Dermatitis	ClinicalTrials.gov
therapeutic conventional surgery	Procedure	Phase PHASE2	Melanoma	ClinicalTrials.gov
FSME-IMMUN 0.5 ml	Other	Phase PHASE4	Tick-borne Encephalitis (TBE)	ClinicalTrials.gov
Fesoterodine PR	Other	Phase PHASE3	Urinary Bladder, Neurogenic	ClinicalTrials.gov
Amyloid Cardiomyopathy	Other	Preclinical	Amyloid Cardiomyopathy	ClinicalTrials.gov
Celecoxib, COX-2 inhibitor; oral	Other	Phase PHASE2	Dental Pain	ClinicalTrials.gov
Fesoterodine BIC SR4 fed (Treatment E in Part B)	Drug	Phase PHASE1	Neurogenic Detrusor Overactivity	ClinicalTrials.gov
Fesoterodine BIC SR7 on apple sauce (Treatment D in Part A)	Drug	Phase PHASE1	Neurogenic Detrusor Overactivity	ClinicalTrials.gov
Fesoterodine BIC SR7 fed (Treatment C in Part A, Treatment F in Part B)	Drug	Phase PHASE1	Neurogenic Detrusor Overactivity	ClinicalTrials.gov
Fesoterodine BIC SR7 fasted (Treatment B in Part A, Treatment H in Part B)	Drug	Phase PHASE1	Neurogenic Detrusor Overactivity	ClinicalTrials.gov
Fesoterodine BIC SR4 fasted (Treatment A in Part A, Treatment G in Part B)	Drug	Phase PHASE1	Neurogenic Detrusor Overactivity	ClinicalTrials.gov
RSV Vaccine	Other	Phase PHASE2	Respiratory Tract Infection	ClinicalTrials.gov
Observational study of the surgical outcome	Other	Preclinical	Rotator Cuff	ClinicalTrials.gov
Donepezil and experimenter-administered memory training	Other	Phase PHASE1	Stroke	ClinicalTrials.gov
Donepezil and self-generated memory training	Other	Phase PHASE1	Stroke	ClinicalTrials.gov
Panitumumab	Other	Phase PHASE1	Metastatic Colorectal Cancer	ClinicalTrials.gov
14C-PF-06826647 100 ug IV	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06826647 600 mg PO	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
14C-PF-06826647-LR 600 mg PO	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-04383119 (tanezumab)	Other	Phase PHASE2	Osteoarthritis, Knee	ClinicalTrials.gov
Crisaborole 2% Top Oint	Other	Phase PHASE4	Atopic Dermatitis	ClinicalTrials.gov
Probiotic, Omega-3, Vitamin D supplement	Other	Approved	Inflammation	ClinicalTrials.gov
IV placebo	Other	Phase PHASE3	Osteoarthritis	ClinicalTrials.gov
Inflectra	Other	Preclinical	Inflammatory Bowel Disease (IBD)	ClinicalTrials.gov
Tafamidis meglumine capsule	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tafamidis free acid tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Group Apixaban	Other	Phase PHASE3	Complication	ClinicalTrials.gov
Group Hydroxychloroquine and apixaban	Other	Phase PHASE3	Complication	ClinicalTrials.gov
Group Hydroxychloroquine	Other	Phase PHASE3	Complication	ClinicalTrials.gov
Control group (standard hospital treatment)	Drug	Phase PHASE3	Complication	ClinicalTrials.gov
TNO155	Other	Phase PHASE1	Lung Cancer	ClinicalTrials.gov
Behavioral Therapy	Drug	Phase PHASE4	Nicotine Dependence	ClinicalTrials.gov
Placebo (for Varenicline)	Other	Phase PHASE4	Nicotine Dependence	ClinicalTrials.gov
Varinecline (Chantix)	Other	Phase PHASE4	Nicotine Dependence	ClinicalTrials.gov
Caffeine	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
99mTc-PYP	Other	Phase EARLY_PHASE1	Heart Failure With Preserved Ejection Fraction	ClinicalTrials.gov
Stereotactic radiotherapy	Drug	Phase PHASE2	Clear Cell Metastatic Renal Cell Carcinoma	ClinicalTrials.gov
ACC-001(30µg) + QS21	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
ACC-001(10µg) + QS21	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
ACC-001(3µg) + QS21	Other	Phase PHASE2	Alzheimer Disease	ClinicalTrials.gov
Vehicle (Placebo)	Other	Phase PHASE2	Atopic Dermatitis	ClinicalTrials.gov
Tanezumab 2.5mg/5mg	Other	Phase PHASE3	Osteoarthritis, Knee	ClinicalTrials.gov
Nicotine Adaptive Protocol	Other	Phase PHASE2	Nicotine Dependence	ClinicalTrials.gov
Varenicline Adaptive Protocol	Other	Phase PHASE2	Nicotine Dependence	ClinicalTrials.gov
Nicotine Patch Standard Protocol	Other	Phase PHASE2	Nicotine Dependence	ClinicalTrials.gov
Varenicline Standard Protocol	Other	Phase PHASE2	Nicotine Dependence	ClinicalTrials.gov
Blood for detection of circulating tumor cells	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Research blood for germline DNA	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Research blood sample	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Research bone marrow (OPTIONAL)	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Research tumor biopsy	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Breast surgery	Procedure	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
standard follow-up	Other	Phase PHASE3	Renal Cell Carcinoma Metastatic	ClinicalTrials.gov
KidneyPRO	Other	Phase PHASE3	Renal Cell Carcinoma Metastatic	ClinicalTrials.gov
remission prevalence of generalized anxiety disorder	Other	Preclinical	Anxiety Disorders	ClinicalTrials.gov
Lip Salivary Gland Biopsy	Other	Preclinical	Amyloidosis	ClinicalTrials.gov
Dupilumab 300 mg	Other	Phase PHASE3	Atopic Dermatitis	ClinicalTrials.gov
Abrocitinib 200 mg	Other	Phase PHASE3	Atopic Dermatitis	ClinicalTrials.gov
Chemotherapy + bevacizumab followed by bevacizumab	Drug	Phase PHASE3	Ovarian Cancer	ClinicalTrials.gov
Chemotherapy followed by talazoparib maintenance	Drug	Phase PHASE3	Ovarian Cancer	ClinicalTrials.gov
Chemotherapy + avelumab followed by avelumab + talazoparib	Drug	Phase PHASE3	Ovarian Cancer	ClinicalTrials.gov
voxelotor	Other	Phase PHASE3	Sickle Cell Disease	ClinicalTrials.gov
PF-07321332	Other	Phase PHASE2	COVID-19	ClinicalTrials.gov
Tazemetostat	Other	Phase PHASE1	Metastatic Prostate Cancer	ClinicalTrials.gov
epirubicin/cyclophosphamide	Other	Phase PHASE2	Breast Cancer Stage II	ClinicalTrials.gov
doxorubicin/cyclophosphamide	Other	Phase PHASE2	Breast Cancer Stage II	ClinicalTrials.gov
Docetaxel / cyclophosphamide	Other	Phase PHASE2	Breast Cancer Stage II	ClinicalTrials.gov
PF-06835375	Other	Phase PHASE2	Primary Immune Thrombocytopenia	ClinicalTrials.gov
PF-06838435 (formerly SPK-9001)	Other	Phase PHASE2	Hemophilia B	ClinicalTrials.gov
MEK162 and mFOLFIRI	Other	Phase PHASE1	Advanced KRAS Positive Metastatic Colorectal Cancer	ClinicalTrials.gov
Diagnosis of TTR amyloidosis cardiomyopathy	Other	Preclinical	Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)	ClinicalTrials.gov
Oxbryta® (voxelotor) 500-mg Tablets	Other	Preclinical	Sickle Cell Disease	ClinicalTrials.gov
PF-07265803	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
RV521	Other	Phase PHASE1	Respiratory Syncytial Virus Infections	ClinicalTrials.gov
Placebo for RV521	Other	Phase PHASE1	Respiratory Syncytial Virus Infections	ClinicalTrials.gov
Rifampicin	Other	Phase PHASE1	Respiratory Syncytial Virus Infections	ClinicalTrials.gov
Stereotactic Body Radiation Therapy (SBRT)	Drug	Phase PHASE2	Mucosal Melanoma	ClinicalTrials.gov
Nivolumab and/or Ipilimumab	Other	Phase PHASE2	Mucosal Melanoma	ClinicalTrials.gov
Crisaborole	Other	Phase PHASE2	Morphea	ClinicalTrials.gov
Anti-NGF AB	Other	Phase PHASE2	Neoplasms	ClinicalTrials.gov
PF-06651600 30 mg	Other	Phase PHASE1	Hepatic Impairment	ClinicalTrials.gov
PF-06865571 100 mg	Other	Phase PHASE1	Hepatic Impairment	ClinicalTrials.gov
Menopause educational secure messaging	Other	Approved	Menopause	ClinicalTrials.gov
Clopidogrel 75mg	Other	Phase PHASE3	Critical Limb Ischemia	ClinicalTrials.gov
ASA	Other	Phase PHASE3	Critical Limb Ischemia	ClinicalTrials.gov
cediranib	Other	Phase PHASE1	Endometrial Cancer	ClinicalTrials.gov
Tanezumab 20 mg	Other	Phase PHASE2	Low Back Pain	ClinicalTrials.gov
pregabalin (Lyrica)	Other	Phase EARLY_PHASE1	Essential Tremor	ClinicalTrials.gov
bevacizumab - EU	Other	Phase PHASE1	Pharmacokinetics	ClinicalTrials.gov
PF-06439535 (CN)	Other	Phase PHASE1	Pharmacokinetics	ClinicalTrials.gov
Triamcinolone Acetonide 0.1% Ointment	Other	Preclinical	Atopic Dermatitis	ClinicalTrials.gov
Crisaborole 2% Topical Application Ointment [EUCRISA]	Other	Preclinical	Atopic Dermatitis	ClinicalTrials.gov
Cough recording device	Device	Phase PHASE4	Cough	ClinicalTrials.gov
Dextromethorphan Hydrobromide	Other	Phase PHASE4	Cough	ClinicalTrials.gov
Brief Cognitive-Behavioral Pain Management Training	Other	Preclinical	Sickle Cell Disease	ClinicalTrials.gov
Reference formulation	Other	Phase PHASE1	Hypogonadism	ClinicalTrials.gov
Test formulation	Other	Phase PHASE1	Hypogonadism	ClinicalTrials.gov
Pexidartinib	Other	Phase PHASE1	Gastrointestinal Stromal Tumor (GIST)	ClinicalTrials.gov
Atorvastatin - Cholestyramine - Sitosterol	Other	Approved	Symptomatic Carotid Stenosis	ClinicalTrials.gov
PF-04217329 - Vehicle	Other	Phase PHASE2	Primary Open-Angle Glaucoma	ClinicalTrials.gov
PF-04217329 - High Dose	Other	Phase PHASE2	Primary Open-Angle Glaucoma	ClinicalTrials.gov
PF-04217329 - Middle Dose	Other	Phase PHASE2	Primary Open-Angle Glaucoma	ClinicalTrials.gov
PF-04217329 - Low Dose	Other	Phase PHASE2	Primary Open-Angle Glaucoma	ClinicalTrials.gov
Latanoprost Vehicle	Other	Phase PHASE2	Primary Open-Angle Glaucoma	ClinicalTrials.gov
PF-4217329 - Highest Dose	Other	Phase PHASE2	Primary Open-Angle Glaucoma	ClinicalTrials.gov
PF-04217329 - High Middle Dose	Other	Phase PHASE2	Primary Open-Angle Glaucoma	ClinicalTrials.gov
PF-04217329 - Lowest Dose	Other	Phase PHASE2	Primary Open-Angle Glaucoma	ClinicalTrials.gov
Moroctocog-alfa (AF-CC)	Other	Phase PHASE4	Hemophilia A	ClinicalTrials.gov
PF-04217329	Other	Phase PHASE2	Glaucoma, Open-Angle	ClinicalTrials.gov
Laboratory and instrumental examination	Device	Preclinical	Covid19	ClinicalTrials.gov
Placebo SC	Other	Phase PHASE3	Osteoarthritis	ClinicalTrials.gov
Tanezumab IV	Other	Phase PHASE3	Osteoarthritis	ClinicalTrials.gov
Placebo IV	Other	Phase PHASE3	Osteoarthritis	ClinicalTrials.gov
Tanezumab SC	Other	Phase PHASE3	Osteoarthritis	ClinicalTrials.gov
Azithromycin Capsule	Other	Phase PHASE3	COVID-19	ClinicalTrials.gov
8 mg fesoterodine ER tablet from Freiburg	Other	Phase PHASE1	Neurogenic Detrusor Overactivity	ClinicalTrials.gov
8 mg fesoterodine ER tablet from Zwickau	Other	Phase PHASE1	Neurogenic Detrusor Overactivity	ClinicalTrials.gov
4 mg fesoterodine ER tablet from Freiburg	Other	Phase PHASE1	Neurogenic Detrusor Overactivity	ClinicalTrials.gov
4 mg Fesoterodine ER tablet from Zwickau	Other	Phase PHASE1	Neurogenic Detrusor Overactivity	ClinicalTrials.gov
PF-04383119	Other	Phase PHASE2	Cystitis, Interstitial	ClinicalTrials.gov
Abexinostat Tosylate	Other	Phase PHASE1	Anatomic Stage III Breast Cancer AJCC v8	ClinicalTrials.gov
Antimicrobial	Other	Preclinical	Osteomyelitis	ClinicalTrials.gov
Shear-wave elastography	Other	Approved	Fabry Disease	ClinicalTrials.gov
RN624	Other	Phase PHASE2	Neuralgia, Postherpetic	ClinicalTrials.gov
SABER-Placebo	Other	Phase PHASE3	Postoperative Pain	ClinicalTrials.gov
Bupivacaine HCl	Other	Phase PHASE3	Postoperative Pain	ClinicalTrials.gov
SABER-Bupivacaine	Other	Phase PHASE3	Postoperative Pain	ClinicalTrials.gov
PF-06747775	Other	Phase PHASE1	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Fesoterodine (Toviaz)	Other	Preclinical	Overactive Bladder (OAB)	ClinicalTrials.gov
IV Placebo for tanezumab	Other	Phase PHASE2	Neoplasm Metastasis	ClinicalTrials.gov
Tanezumab 10 mg IV	Other	Phase PHASE2	Neoplasm Metastasis	ClinicalTrials.gov
Axitinib Oral Tablet	Other	Phase PHASE2	Renal Cell Carcinoma	ClinicalTrials.gov
PF-299804 (Dacomitinib)	Other	Phase PHASE2	Glioblastoma	ClinicalTrials.gov
Placebo for naproxen	Other	Phase PHASE2	Low Back Pain	ClinicalTrials.gov
Tanezumab 5 mg IV	Other	Phase PHASE2	Low Back Pain	ClinicalTrials.gov
Tanezumab 20 mg IV	Other	Phase PHASE2	Low Back Pain	ClinicalTrials.gov
PF-04383119 (RN624)	Other	Phase PHASE2	Low Back Pain	ClinicalTrials.gov
Tofacitinib 5 mg twice daily	Other	Phase PHASE1	Cutaneous Sarcoidosis	ClinicalTrials.gov
Fluconazole 150mg Capsule Localized Originator	Other	Phase PHASE1	Bioequivalence	ClinicalTrials.gov
Fluconazole 150mg Capsule Originator	Other	Phase PHASE1	Bioequivalence	ClinicalTrials.gov
EXC 001	Other	Phase PHASE2	Scar Prevention	ClinicalTrials.gov
pregabalin/PF-00489791	Other	Phase PHASE2	Postherpetic Neuralgia	ClinicalTrials.gov
Crisaborole 2%	Other	Phase PHASE3	Atopic Dermatitis	ClinicalTrials.gov
EXC 001 (currently called PF-06473871)	Other	Phase PHASE2	Reduction in Severity of Skin Scarring	ClinicalTrials.gov
Amlodipine + Olmesartan medoxomil	Other	Preclinical	Hypertension	ClinicalTrials.gov
NSA-789 at 2 different doses	Other	Phase PHASE1	Schizophrenia	ClinicalTrials.gov
Formulation C	Other	Phase PHASE2	Respiratory Tract Infection	ClinicalTrials.gov
Formulation B	Other	Phase PHASE2	Respiratory Tract Infection	ClinicalTrials.gov
Formulation A	Other	Phase PHASE2	Respiratory Tract Infection	ClinicalTrials.gov
PF-06826647 or Placebo	Other	Phase PHASE2	Psoriasis	ClinicalTrials.gov
Patient Control	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Patient Educational Intervention	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
LYFE MD app	Other	Approved	Crohn Disease	ClinicalTrials.gov
Chemoradiation	Other	Phase PHASE3	Squamous Cell Carcinoma of the Head and Neck	ClinicalTrials.gov
NicodermCQ	Other	Phase PHASE4	Smoking Cessation	ClinicalTrials.gov
Behavioral Counseling Sessions	Other	Phase PHASE4	Smoking Cessation	ClinicalTrials.gov
Chantix	Other	Phase PHASE4	Smoking Cessation	ClinicalTrials.gov
Pediatric HAV vaccine	Other	Phase PHASE2	Meningococcal B Disease	ClinicalTrials.gov
Support, management, educational, counselling, follow-up	Other	Approved	Cardiovascular Disease	ClinicalTrials.gov
Placebo TID	Other	Phase PHASE3	Pain	ClinicalTrials.gov
IBU TID	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Placebo BID	Other	Phase PHASE3	Pain	ClinicalTrials.gov
IBU BID	Other	Phase PHASE3	Pain	ClinicalTrials.gov
Prevenar 13™	Other	Phase PHASE3	Infections, Meningococcal	ClinicalTrials.gov
Busulfan	Other	Phase PHASE3	Acute Myeloid Leukaemia	ClinicalTrials.gov
Liposomal daunorubicin	Other	Phase PHASE3	Acute Myeloid Leukaemia	ClinicalTrials.gov
Group B streptoccous 6-valent polysaccharide conjugate vaccine (GBS6)	Other	Phase PHASE2	Group B Streptococcal Infections	ClinicalTrials.gov
DIC075V (intravenous diclofenac sodium)	Other	Phase PHASE3	Pain, Postoperative	ClinicalTrials.gov
Activity Monitor	Other	Preclinical	Duchenne Muscular Dystrophy (DMD)	ClinicalTrials.gov
IV ketorolac	Other	Phase PHASE3	Postoperative Pain	ClinicalTrials.gov
IV Diclofenac	Other	Phase PHASE3	Postoperative Pain	ClinicalTrials.gov
Sulfamethoxazole-Trimethoprim	Other	Phase PHASE2	Bacterial Infections	ClinicalTrials.gov
Atovaquone	Other	Phase PHASE2	Bacterial Infections	ClinicalTrials.gov
Trimix combination (Papavarine 30mg/mL Phentholamine 1mg/mL Prostaglandin E1 10 mcg/mmL) and questionnaires	Other	Approved	Penile Cancer	ClinicalTrials.gov
Sildenafil and questionnaire	Other	Approved	Penile Cancer	ClinicalTrials.gov
Placebo QHS and sildenafil and questionnaires	Other	Approved	Penile Cancer	ClinicalTrials.gov
Acipimox	Other	Approved	Type 2 Diabetes	ClinicalTrials.gov
Relative Bioavailability	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06842874	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Exercise, insulin infusion	Other	Approved	Insulin Resistance	ClinicalTrials.gov
Recifercept	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Crisaborole Vehicle	Other	Phase PHASE4	Atopic Dermatitis	ClinicalTrials.gov
Pimecrolimus cream, 1%	Other	Phase PHASE4	Atopic Dermatitis	ClinicalTrials.gov
Hydrocortisone butyrate cream, 0.1%	Other	Phase PHASE4	Atopic Dermatitis	ClinicalTrials.gov
Crisaborole ointment, 2%	Other	Phase PHASE4	Atopic Dermatitis	ClinicalTrials.gov
Physician's-Choice	Other	Phase PHASE3	Breast Neoplasms	ClinicalTrials.gov
Tofacitinib citrate	Other	Phase EARLY_PHASE1	Discoid Lupus Erythematosus	ClinicalTrials.gov
Vincristine Sulfate Liposome	Other	Phase PHASE1	Allogeneic Hematopoietic Stem Cell Transplantation Recipient	ClinicalTrials.gov
Quality-of-Life Assessment	Other	Phase PHASE1	Allogeneic Hematopoietic Stem Cell Transplantation Recipient	ClinicalTrials.gov
[14C]PF-07321332	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PD-0332991 and T-DM1	Other	Phase PHASE1	Advanced Breast Cancer	ClinicalTrials.gov
Bosutinib tablet	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Bosutinib capsule	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Tofacitinib 5mg [Xeljanz] 1 year open-label extension	Other	Phase PHASE1	Sarcoidosis, Pulmonary	ClinicalTrials.gov
Corticosteroid	Other	Phase PHASE1	Sarcoidosis, Pulmonary	ClinicalTrials.gov
Laboratory testing	Other	Phase PHASE1	Sarcoidosis, Pulmonary	ClinicalTrials.gov
RNA Sequencing	Other	Phase PHASE1	Sarcoidosis, Pulmonary	ClinicalTrials.gov
Spirometry	Other	Phase PHASE1	Sarcoidosis, Pulmonary	ClinicalTrials.gov
Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial	Other	Phase PHASE1	Sarcoidosis, Pulmonary	ClinicalTrials.gov
PF-06651600 Maintenance Dose #3	Other	Phase PHASE2	Alopecia Areata	ClinicalTrials.gov
PF-06651600 Maintenance Dose #2	Other	Phase PHASE2	Alopecia Areata	ClinicalTrials.gov
PF-06651600 Maintenance Dose #1	Other	Phase PHASE2	Alopecia Areata	ClinicalTrials.gov
PF-06651600 Induction Dose	Other	Phase PHASE2	Alopecia Areata	ClinicalTrials.gov
Naloxone Hydrochloride Injection, USP	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
NaxRedy ™	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Duavee	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Fluorouracile	Other	Phase PHASE2	Neoadjuvant Operable Breast Cancer	ClinicalTrials.gov
narrow-band UVB phototherapy	Drug	Phase PHASE2	Active Non-segmental Vitiligo	ClinicalTrials.gov
PF06700841	Other	Phase PHASE2	Active Non-segmental Vitiligo	ClinicalTrials.gov
ARRY-371797, p38 inhibitor, oral	Other	Phase PHASE2	LMNA-Related Dilated Cardiomyopathy	ClinicalTrials.gov
PF-06882961 100 mg	Other	Phase PHASE1	Overweight and/or Obesity	ClinicalTrials.gov
Mammography	Other	Approved	Breast Cancer	ClinicalTrials.gov
Breast ultrasound	Other	Approved	Breast Cancer	ClinicalTrials.gov
Clinical Breast Examination	Other	Approved	Breast Cancer	ClinicalTrials.gov
iBreast device	Device	Approved	Breast Cancer	ClinicalTrials.gov
PF04965842	Other	Phase PHASE3	Atopic Dermatitis	ClinicalTrials.gov
Oncotype DX Breast Recurrence Score	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
PF-04518600 plus PF-05082566	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
PF-04518600	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
PF-06462700	Other	Phase PHASE3	Aplastic Anemia	ClinicalTrials.gov
Afib 2gether TM Mobile Application	Other	Approved	Atrial Fibrillation New Onset	ClinicalTrials.gov
vehicle ointment	Other	Phase PHASE2	Stasis Dermatitis	ClinicalTrials.gov
crisaborole ointment	Other	Phase PHASE2	Stasis Dermatitis	ClinicalTrials.gov
YouTube Video	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
GAP-486	Other	Phase PHASE2	Arrhythmias	ClinicalTrials.gov
Double-blind investigational anti-arrhythmic	Other	Phase PHASE2	Arrhythmias	ClinicalTrials.gov
Urinary antigen detection assay	Other	Preclinical	Community-acquired Pneumonia	ClinicalTrials.gov
DMARDS	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Etanercept + Methotrexate	Other	Phase PHASE4	Rheumatoid Arthritis	ClinicalTrials.gov
Placebo for PF-06817024	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06817024	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Trainings application	Other	Approved	Haemophilia	ClinicalTrials.gov
Crisaborole Placebo Vehicle	Other	Phase PHASE3	Atopic Dermatitis	ClinicalTrials.gov
Placebo Colesevelam	Other	Phase PHASE4	Coronary Artery Disease	ClinicalTrials.gov
Placebo Niacin	Other	Phase PHASE4	Coronary Artery Disease	ClinicalTrials.gov
Colesevelam	Other	Phase PHASE4	Coronary Artery Disease	ClinicalTrials.gov
Niacin	Other	Phase PHASE4	Coronary Artery Disease	ClinicalTrials.gov
Bupivacaine TTS (Bupivacaine Patch)	Other	Phase PHASE2	Chronic Low Back Pain	ClinicalTrials.gov
Moroctocog alfa	Other	Phase PHASE3	Hemophilia A	ClinicalTrials.gov
ARRY-382	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Routine Care	Other	Approved	Catastrophization	ClinicalTrials.gov
Cognitive Therapy	Drug	Approved	Catastrophization	ClinicalTrials.gov
Group 1 (PMS Treatment)	Drug	Approved	Back Pain	ClinicalTrials.gov
Group 2 (PCP Treatment)	Drug	Approved	Back Pain	ClinicalTrials.gov
Eribulin Mesylate	Other	Phase PHASE1	Metastatic Urothelial Cell Cancer	ClinicalTrials.gov
immunosuppression	Other	Phase PHASE2	Patients Receiving Mismatched Allogeneic HCT	ClinicalTrials.gov
Influenza vaccine	Other	Phase PHASE3	Pneumococcal Disease	ClinicalTrials.gov
Experimental 20-valent pneumococcal conjugate vaccine (20vPnC)	Other	Phase PHASE3	Pneumococcal Disease	ClinicalTrials.gov
Marstacimab PFS	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Marstacimab PFP	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-07054894	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06700841 or Placebo	Other	Phase PHASE2	Ulcerative Colitis	ClinicalTrials.gov
Tobacco Cessation Counseling	Other	Phase PHASE3	Lung Carcinoma	ClinicalTrials.gov
Filanesib, pomalidomide and dexamethasone	Other	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Focus Group	Other	Preclinical	Breast Cancer	ClinicalTrials.gov
Blood Test	Other	Approved	Hypertension, Pulmonary	ClinicalTrials.gov
EndoPAT measurement	Other	Approved	Hypertension, Pulmonary	ClinicalTrials.gov
PF-07038124 ointment	Other	Phase PHASE2	Atopic Dermatitis	ClinicalTrials.gov
Everolimus	Other	Phase PHASE1	Human Epidermal Growth Factor 2 Negative Carcinoma of Breast	ClinicalTrials.gov
Standard cessation course	Other	Approved	Smoking	ClinicalTrials.gov
Compact cessation course	Other	Approved	Smoking	ClinicalTrials.gov
Brief advice	Other	Approved	Smoking	ClinicalTrials.gov
PF-07291177	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
sitaxsentan (Thelin)	Other	Phase PHASE2	Cardiac Surgery Subjects	ClinicalTrials.gov
PF-05212384 (gedatolisib)	Other	Phase PHASE1	Neoplasm	ClinicalTrials.gov
Administration of deuterated compounds for kinetic study	Other	Approved	Familial Hypobetalipoproteinemia	ClinicalTrials.gov
111-Indium-CMD-193	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Chimeric monoclonal antibody cG250	Other	Phase PHASE1	Renal Cell Carcinoma (RCC)	ClinicalTrials.gov
Optimized background antiretroviral drug regimen without maraviroc	Drug	Preclinical	Human Immunodeficiency Virus	ClinicalTrials.gov
Maraviroc along with an optimized background antiretroviral drug regimen	Drug	Preclinical	Human Immunodeficiency Virus	ClinicalTrials.gov
VXM01	Other	Phase PHASE1	Recurrent Glioblastoma	ClinicalTrials.gov
ILV-094	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Digital Physical Measures and Survey Assessments	Other	Approved	Oncology	ClinicalTrials.gov
Repevax	Other	Phase PHASE2	Meningococcal Vaccine	ClinicalTrials.gov
Vaccine	Other	Phase PHASE2	Meningococcal Vaccine	ClinicalTrials.gov
Elelyso	Other	Approved	Gaucher Disease, Type 1	ClinicalTrials.gov
quantitative chemical shift imaging (QCSI)	Other	Approved	Gaucher Disease, Type 1	ClinicalTrials.gov
Laser and rapamycin versus laser alone	Other	Phase PHASE1	Port Wine Stain	ClinicalTrials.gov
Rapamycin Treatment of Port Wine Stain	Drug	Phase PHASE1	Port Wine Stain	ClinicalTrials.gov
Placebo oral capsule	Other	Phase PHASE1	Depression, Unipolar	ClinicalTrials.gov
PF-04360365 0.5 mg/kg	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
PF-04360365 0.1 mg/kg	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
Motivational Enhancement	Other	Approved	Cardiovascular Risk Reduction of Having a Coronary Event	ClinicalTrials.gov
Motivational Interviewing	Other	Approved	Cardiovascular Risk Reduction of Having a Coronary Event	ClinicalTrials.gov
Minimal Intervention	Other	Approved	Cardiovascular Risk Reduction of Having a Coronary Event	ClinicalTrials.gov
SU11248	Other	Phase PHASE2	Metastatic Breast Cancer	ClinicalTrials.gov
BNT162b2	Other	Phase PHASE3	Pneumococcal Disease	ClinicalTrials.gov
Exposure of interest (studies 2 & 3).	Other	Preclinical	Alopecia Areata	ClinicalTrials.gov
ISA101b	Other	Phase PHASE2	Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites	ClinicalTrials.gov
interdisciplinary multimodal pain treatment	Drug	Preclinical	Chronic Pain	ClinicalTrials.gov
observational study	Other	Preclinical	Meningitis	ClinicalTrials.gov
Sitexsentin sodium	Other	Phase PHASE2	Diastolic Heart Failure	ClinicalTrials.gov
Saline for injection	Other	Phase PHASE4	Streptococcus Pneumonia	ClinicalTrials.gov
PPV23	Other	Phase PHASE4	Streptococcus Pneumonia	ClinicalTrials.gov
QOL questionaire	Other	Preclinical	Crohn Disease	ClinicalTrials.gov
Placebo for nirmatrelvir	Other	Phase PHASE2	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)	ClinicalTrials.gov
Nirmatrelvir	Other	Phase PHASE2	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)	ClinicalTrials.gov
BMS-927711 (CGRP Antagonist)	Other	Phase PHASE1	Migraine	ClinicalTrials.gov
Placebos	Other	Phase PHASE3	COVID-19	ClinicalTrials.gov
PF-07225570	Other	Phase PHASE1	Bladder Cancer	ClinicalTrials.gov
Bosutinib (Phase 2 part)	Other	Phase PHASE1	Amyotrophic Lateral Sclerosis	ClinicalTrials.gov
Bosutinib (Phase 1 part)	Other	Phase PHASE1	Amyotrophic Lateral Sclerosis	ClinicalTrials.gov
Endocrine therapy	Drug	Phase PHASE3	Breast Cancer Female	ClinicalTrials.gov
IGCDG	Other	Approved	Breast Cancer	ClinicalTrials.gov
Placebo vaginal cream	Other	Phase PHASE4	Microscopic Hematuria	ClinicalTrials.gov
Premarin vaginal estrogen cream	Other	Phase PHASE4	Microscopic Hematuria	ClinicalTrials.gov
CP-690,550 10 mg	Other	Phase PHASE4	Ulcerative Colitis	ClinicalTrials.gov
CP-690,500 5 mg	Other	Phase PHASE4	Ulcerative Colitis	ClinicalTrials.gov
VKAs	Other	Preclinical	Stroke	ClinicalTrials.gov
VLA15 without Alum	Other	Phase PHASE1	Lyme Borreliosis, Nervous System	ClinicalTrials.gov
VLA15 with Alum	Other	Phase PHASE1	Lyme Borreliosis, Nervous System	ClinicalTrials.gov
TTI-621 + radiation	Other	Phase PHASE1	Solid Tumors	ClinicalTrials.gov
TTI-621 + T-Vec	Other	Phase PHASE1	Solid Tumors	ClinicalTrials.gov
TTI-621 + pegylated interferon-α2a	Other	Phase PHASE1	Solid Tumors	ClinicalTrials.gov
TTI-621 + PD-1/PD-L1 Inhibitor	Other	Phase PHASE1	Solid Tumors	ClinicalTrials.gov
TTI-621 Monotherapy	Drug	Phase PHASE1	Solid Tumors	ClinicalTrials.gov
ceritinib	Other	Preclinical	ALK-positive NSCLC	ClinicalTrials.gov
brigatinib	Other	Preclinical	ALK-positive NSCLC	ClinicalTrials.gov
alectinib	Other	Preclinical	ALK-positive NSCLC	ClinicalTrials.gov
Midazolam/Propofol	Other	Preclinical	Gastrointestinal Endoscopy	ClinicalTrials.gov
Antiplatelets	Other	Preclinical	Atrial Fibrillation	ClinicalTrials.gov
There is no intervention in this study	Other	Preclinical	Pneumococcal Diseases	ClinicalTrials.gov
Survey Administration	Other	Approved	Anatomic Stage IV Breast Cancer AJCC v8	ClinicalTrials.gov
Informational Intervention	Other	Approved	Anatomic Stage IV Breast Cancer AJCC v8	ClinicalTrials.gov
RSVpreF (Group 3)	Other	Phase PHASE3	RSV	ClinicalTrials.gov
RSVpreF (Group 2)	Other	Phase PHASE3	RSV	ClinicalTrials.gov
RSVpreF (Group 1)	Other	Phase PHASE3	RSV	ClinicalTrials.gov
as per Physician's prescription	Other	Preclinical	Pulmonary Arterial Hypertension (PAH)	ClinicalTrials.gov
MenACWY-CRM	Other	Phase PHASE3	Meningococcal Vaccine	ClinicalTrials.gov
Trumenba	Other	Phase PHASE3	Meningococcal Vaccine	ClinicalTrials.gov
MenABCWY	Other	Phase PHASE3	Meningococcal Vaccine	ClinicalTrials.gov
20-valent pneumococcal conjugate vaccine	Other	Phase PHASE3	Pneumococcal Disease	ClinicalTrials.gov
HSCT	Other	Phase PHASE3	Leukemia, Myeloid, Acute	ClinicalTrials.gov
daunorubicin + cytarabine	Other	Phase PHASE3	Leukemia, Myeloid, Acute	ClinicalTrials.gov
Bavituximab	Other	Phase PHASE2	Hepatocellular Carcinoma	ClinicalTrials.gov
Placebo for Ritonavir	Other	Phase PHASE2	COVID-19	ClinicalTrials.gov
Placebo for PF-07321332	Other	Phase PHASE2	COVID-19	ClinicalTrials.gov
Patient Reported Outcomes	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Pain assessment	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
Clinical examination	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
RV521 oral tablet	Other	Phase PHASE2	RSV Infection	ClinicalTrials.gov
Zavegepant (BHV-3500)	Other	Phase PHASE2	Acute Migraine	ClinicalTrials.gov
doxorubicin and cyclophosphamide	Other	Approved	Breast Cancer	ClinicalTrials.gov
sunitinib plus paclitaxel	Other	Approved	Breast Cancer	ClinicalTrials.gov
sunitinib alone	Other	Approved	Breast Cancer	ClinicalTrials.gov
Perifosine	Other	Phase PHASE1	Brain Tumor, Recurrent	ClinicalTrials.gov
Cytoreductive surgery	Procedure	Phase PHASE1	Brain Tumor, Recurrent	ClinicalTrials.gov
venetoclax	Other	Preclinical	Leukemia, Myeloid, Acute	ClinicalTrials.gov
Proton Therapy	Drug	Phase PHASE1	Meningioma	ClinicalTrials.gov
Support	Other	Approved	Cancer, Breast	ClinicalTrials.gov
Abrocitinib	Other	Phase PHASE2	Prurigo Nodularis	ClinicalTrials.gov
Metformin Extended Release Oral Tablet	Other	Phase PHASE4	Breast Cancer Stage	ClinicalTrials.gov
Nifedipine	Other	Phase PHASE2	Chronic Kidney Disease	ClinicalTrials.gov
Open	Other	Phase PHASE2	Chronic Kidney Disease	ClinicalTrials.gov
PLD	Other	Phase PHASE3	Ovarian Cancer	ClinicalTrials.gov
PF-07321332/ritonavir	Other	Phase PHASE1	Healthy Participant	ClinicalTrials.gov
GBT440	Other	Phase PHASE1	Hepatic Impairment	ClinicalTrials.gov
Non-Exposure	Other	Preclinical	Malformations	ClinicalTrials.gov
cigarette smoke from maternal smoking	Other	Preclinical	Malformations	ClinicalTrials.gov
GBT021601	Other	Phase PHASE1	Sickle Cell Disease	ClinicalTrials.gov
Aztreonam-Avibactam	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Parenteral anticoagulant	Other	Preclinical	Venous Thromboembolism	ClinicalTrials.gov
Informational website	Other	Approved	Depression	ClinicalTrials.gov
Online eHealth tool	Other	Approved	Depression	ClinicalTrials.gov
Vinblastine	Other	Phase PHASE1	Recurrent Lymphoma	ClinicalTrials.gov
BKM120	Other	Phase PHASE1	Metastatic Colorectal Cancer	ClinicalTrials.gov
GEN-001	Other	Phase PHASE1	Solid Tumor	ClinicalTrials.gov
PF-06882961 + PF-06865571	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
PF-06882961/PF-06865571 followed by PF-06882961	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
PF-06882961 followed by PF-06882961/PF-06865571	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Pegaspargase	Other	Phase PHASE1	B-cell Acute Lymphoblastic Leukemia	ClinicalTrials.gov
Prednisone Pill	Other	Phase PHASE1	B-cell Acute Lymphoblastic Leukemia	ClinicalTrials.gov
Avelumab 1200 mg in combination with gemcitabine/cisplatin	Other	Phase PHASE1	Non-small Cell Lung Cancer	ClinicalTrials.gov
Avelumab 1200 mg in combination with pemetrexed/carboplatin	Other	Phase PHASE1	Non-small Cell Lung Cancer	ClinicalTrials.gov
Avelumab 800 mg in combination with gemcitabine / cisplatin.	Other	Phase PHASE1	Non-small Cell Lung Cancer	ClinicalTrials.gov
Avelumab 800 mg in combination with pemetrexed / carboplatin	Other	Phase PHASE1	Non-small Cell Lung Cancer	ClinicalTrials.gov
Recombinant Granulocyte Colony-Stimulating Factor	Other	Phase PHASE1	Acute Myeloid Leukemia	ClinicalTrials.gov
Cladribine	Other	Phase PHASE1	Acute Myeloid Leukemia	ClinicalTrials.gov
Bony scintigraphy	Other	Phase PHASE3	Transthyretin Cardiac Amyloidosis	ClinicalTrials.gov
RV299	Other	Phase PHASE1	Respiratory Syncytial Virus Infections	ClinicalTrials.gov
Infectious Titre 4	Other	Approved	Influenza A H1N1	ClinicalTrials.gov
Infectious Titre 3	Other	Approved	Influenza A H1N1	ClinicalTrials.gov
Infectious Titre 2	Other	Approved	Influenza A H1N1	ClinicalTrials.gov
Infectious Titre 1	Other	Approved	Influenza A H1N1	ClinicalTrials.gov
PF-06823859 high	Other	Phase PHASE2	Dermatomyositis	ClinicalTrials.gov
Placebo Arm	Other	Phase PHASE2	Dermatomyositis	ClinicalTrials.gov
PF-06823859 low	Other	Phase PHASE2	Dermatomyositis	ClinicalTrials.gov
Voxelotor 1500 mg oral per day (GBT440) for 48 weeks in patients with sickle-cell disease	Other	Phase PHASE2	Sickle Cell Disease	ClinicalTrials.gov
Intranasal Aptar Pharma Unit Dose System	Other	Phase PHASE2	Migraine	ClinicalTrials.gov
Zavegepant matching placebo	Other	Phase PHASE2	Migraine	ClinicalTrials.gov
Somavert (Pegvisomant)	Other	Preclinical	Acromegaly	ClinicalTrials.gov
Ramipril 2.5 MG Oral Capsule	Other	Phase PHASE2	COVID-19	ClinicalTrials.gov
PCV13 PAC study	Other	Approved	Immunogenicity, Vaccine	ClinicalTrials.gov
Ritonavir + Midazolam	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-07321332/ritonavir + Midazolam	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Tolbutamide	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF 07321332/ritonavir	Other	Phase PHASE1	Healthy Participant	ClinicalTrials.gov
Carbamazepine	Other	Phase PHASE1	Healthy Participant	ClinicalTrials.gov
Talazoparib Oral Capsule	Other	Phase PHASE1	BRCA1 Mutation	ClinicalTrials.gov
Talazoparib Phase 2	Other	Phase PHASE1	Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors	ClinicalTrials.gov
Avelumab Phase 2	Other	Phase PHASE1	Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors	ClinicalTrials.gov
Talazoparib Phase 1b	Other	Phase PHASE1	Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors	ClinicalTrials.gov
Avelumab Phase 1b	Other	Phase PHASE1	Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors	ClinicalTrials.gov
Follow-up	Other	Preclinical	NAFLD	ClinicalTrials.gov
Investigational Product	Other	Phase PHASE2	Crohn Disease	ClinicalTrials.gov
PF-06480605	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Stereotactic Body Radiation Therapy	Drug	Phase PHASE1	Malignant Mesothelioma (MPM)	ClinicalTrials.gov
Placebo first followed by open label pregabalin	Other	Phase PHASE4	Abdominal Pain	ClinicalTrials.gov
Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks	Other	Phase PHASE4	Abdominal Pain	ClinicalTrials.gov
Dorzolamide	Other	Phase PHASE2	Glaucoma	ClinicalTrials.gov
RSVpreF Vaccine	Other	Phase PHASE3	Respiratory Syncytial Virus	ClinicalTrials.gov
Ponatinib	Other	Preclinical	Chronic Myeloid Leukaemia	ClinicalTrials.gov
CDK4/6 Inhibitor	Other	Phase PHASE2	Metastatic Breast Cancer	ClinicalTrials.gov
Palbociclib 75mg-125mg	Other	Phase PHASE2	Metastatic Breast Cancer	ClinicalTrials.gov
Fulvestrant 500g	Other	Phase PHASE2	Metastatic Breast Cancer	ClinicalTrials.gov
Ipatasertib 300mg	Other	Phase PHASE2	Metastatic Breast Cancer	ClinicalTrials.gov
Physician's choice chemotherapy	Drug	Phase PHASE3	Low-grade Serous Ovarian Cancer	ClinicalTrials.gov
ARRY-502, CRTh2 antagonist; oral	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
PF-06753512	Other	Phase PHASE1	Prostatic Neoplasms	ClinicalTrials.gov
Tremelimumab	Other	Phase PHASE1	Prostatic Neoplasms	ClinicalTrials.gov
TDS-IM Electroporation Device	Device	Phase PHASE1	Prostatic Neoplasms	ClinicalTrials.gov
PF-06755990	Other	Phase PHASE1	Prostatic Neoplasms	ClinicalTrials.gov
PF-06755992	Other	Phase PHASE1	Prostatic Neoplasms	ClinicalTrials.gov
CoronaVac COVID-19 vaccine	Other	Preclinical	COVID-19	ClinicalTrials.gov
Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine	Other	Preclinical	COVID-19	ClinicalTrials.gov
Ad26.COV2.S COVID-19 Vaccine	Other	Preclinical	Covid19	ClinicalTrials.gov
ChAdOx1 nCoV-19 Covid-19 Vaccine	Other	Preclinical	Covid19	ClinicalTrials.gov
No Medical Intervention	Other	Preclinical	SLE	ClinicalTrials.gov
PF-07224826	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
APD418	Other	Phase PHASE2	Acute Heart Failure With Reduced Ejection Fraction	ClinicalTrials.gov
Ritlecitinib 200 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Gefitinib	Other	Phase PHASE3	Non-small Cell Lung Cancer With EGFR-Activating Mutations	ClinicalTrials.gov
Smoking cessation counseling	Other	Phase PHASE2	Smoking Cessation	ClinicalTrials.gov
Keytruda	Other	Preclinical	Renal Cell Carcinoma	ClinicalTrials.gov
Bavencio	Other	Preclinical	Renal Cell Carcinoma	ClinicalTrials.gov
Inlyta	Other	Preclinical	Renal Cell Carcinoma	ClinicalTrials.gov
TBE vaccine 0.25 mL	Other	Phase PHASE3	Tick-Borne Encephalitis	ClinicalTrials.gov
TBE vaccine 0.5 mL	Other	Phase PHASE3	Tick-Borne Encephalitis	ClinicalTrials.gov
Inotuzumab ozogamicin-dose level 1	Other	Phase PHASE4	Leukemia	ClinicalTrials.gov
inotuzumab ozogamicin-dose level 2	Other	Phase PHASE4	Leukemia	ClinicalTrials.gov
Placebo for PF-04171327	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Prednisone 5 mg	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Prednisone Placebo	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
PF-04171327 10 mg	Other	Phase PHASE2	Rheumatoid Arthritis	ClinicalTrials.gov
Crizotinib (PF-02341066)	Other	Phase PHASE2	Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma	ClinicalTrials.gov
Perioperative Corticosteroids	Other	Phase PHASE4	Kidney Transplantation	ClinicalTrials.gov
Neoral® (Cyclosporine)	Other	Phase PHASE4	Kidney Transplantation	ClinicalTrials.gov
Temanogrel	Other	Phase PHASE2	Microvascular Obstruction	ClinicalTrials.gov
Interactive decision support tool	Other	Approved	Chronic Pain	ClinicalTrials.gov
Palbociclib PD-0332991	Other	Phase PHASE3	Breast Cancer	ClinicalTrials.gov
Internet Survey	Other	Approved	Psoriasis	ClinicalTrials.gov
Comparator App	Other	Approved	Chemotherapy Effect	ClinicalTrials.gov
Palbociclib plus hormonal treatment - second line treatment	Drug	Preclinical	Breast Cancer	ClinicalTrials.gov
Palbociclib plus hormonal treatment - first line treatment	Drug	Preclinical	Breast Cancer	ClinicalTrials.gov
Escitalopram	Other	Phase PHASE3	Depression	ClinicalTrials.gov
ARRY-371797 (PF-07265803)	Other	Phase PHASE3	Dilated Cardiomyopathy	ClinicalTrials.gov
Clostridium difficile	Other	Phase PHASE3	Clostridium Difficile Associated Disease	ClinicalTrials.gov
Caffeine reduction	Other	Approved	Overactive Bladder	ClinicalTrials.gov
Placebo for PF-06946860	Other	Phase PHASE1	Non-small Cell Lung Cancer	ClinicalTrials.gov
PF-04449913 (Glasdegib)	Other	Phase PHASE1	Myelodysplastic Syndrome	ClinicalTrials.gov
Ketohexokinase inhibition	Other	Phase PHASE2	NAFLD	ClinicalTrials.gov
Skin Microbiome Swabs	Other	Phase EARLY_PHASE1	Atopic Dermatitis	ClinicalTrials.gov
Clopidogrel	Other	Phase PHASE1	Diabetes Mellitus Type 2	ClinicalTrials.gov
Medication Reminders	Drug	Phase PHASE2	Smoking Cessation	ClinicalTrials.gov
Oral Nicotine Replacement Therapy (NRT)	Drug	Phase PHASE2	Smoking Cessation	ClinicalTrials.gov
Sharps bin to collect used needles/injections	Other	Preclinical	Pediatric Growth Hormone Deficiency	ClinicalTrials.gov
influenza B/Connecticut/1/21 virus part b dose 2	Other	Phase PHASE2	Influenza B	ClinicalTrials.gov
influenza B/Connecticut/1/21 virus part b dose 1	Other	Phase PHASE2	Influenza B	ClinicalTrials.gov
influenza B/Connecticut/1/21 virus part a dose arm 2	Other	Phase PHASE2	Influenza B	ClinicalTrials.gov
influenza B/Connecticut/1/21 virus part a dose arm 1	Other	Phase PHASE2	Influenza B	ClinicalTrials.gov
BNT162b2 (Tozinameran)	Other	Preclinical	Immunocompromised	ClinicalTrials.gov
GBS6	Other	Phase PHASE2	Group B Streptococcal Infection	ClinicalTrials.gov
PF-06835919 25 mg	Other	Phase PHASE1	Hepatic Impairment	ClinicalTrials.gov
Letrozole 2.5mg	Other	Phase PHASE2	Ovarian Cancer	ClinicalTrials.gov
PF-07258669	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
SARS-CoV-2/Influenza/RSV RT-PCR	Other	Preclinical	Healthy	ClinicalTrials.gov
Epoetin biosimilar	Other	Preclinical	Chemotherapy-induced Symptomatic Anemia	ClinicalTrials.gov
COVID-19 Vaccine	Other	Preclinical	COVID-19	ClinicalTrials.gov
T-DM1	Other	Phase PHASE1	HER2-positive Breast Cancer	ClinicalTrials.gov
Azathioprine	Other	Phase PHASE4	Crohn's Disease	ClinicalTrials.gov
Exclusive enteral nutrition	Other	Phase PHASE4	Crohn's Disease	ClinicalTrials.gov
INC280	Other	Phase PHASE2	Melanoma	ClinicalTrials.gov
BGJ398	Other	Phase PHASE2	Melanoma	ClinicalTrials.gov
Rapid Diagnostics	Other	Phase PHASE4	Blood Stream Infections	ClinicalTrials.gov
bIRV BB	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
bIRV AA	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
QIV	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
qIRV	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
bIRV AB	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
mIRV	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
tafamidis meglumine	Other	Phase PHASE4	Transthyretin Amyloid Polyneuropathy (ATTR-PN)	ClinicalTrials.gov
PF-06947386	Other	Phase PHASE3	Complicated Intra-abdominal Infection	ClinicalTrials.gov
PF-07284890 Treatment C	Drug	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-07284890 Treatment B	Drug	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-07284890 Treatment A	Drug	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Nimenrix	Other	Phase PHASE3	Meningococcal Vaccine	ClinicalTrials.gov
Bosutinib 400 MG + Atezolizumab 840 MG in 14 ML Injection	Other	Phase PHASE1	Chronic Phase-Chronic Myeloid Leukemia	ClinicalTrials.gov
Bosutinib 400 MG Monotherapy	Drug	Phase PHASE1	Chronic Phase-Chronic Myeloid Leukemia	ClinicalTrials.gov
Tumor biopsy (optional)	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Circulating tumor cell blood draw	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Research blood draw	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Optional research biopsy	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
150mg	Other	Phase PHASE1	Inflammatory Bowel Disease	ClinicalTrials.gov
450mg	Other	Phase PHASE1	Inflammatory Bowel Disease	ClinicalTrials.gov
PF-06882961 20MG	Other	Phase PHASE1	Hepatic Impairment	ClinicalTrials.gov
ASTX727	Other	Phase PHASE1	Metastatic Breast Cancer	ClinicalTrials.gov
Therapeutic Liquid Paracetamol (TLP)	Other	Phase PHASE2	Meningococcal Vaccine	ClinicalTrials.gov
Scheduled Liquid Paracetamol (SLP)	Other	Phase PHASE2	Meningococcal Vaccine	ClinicalTrials.gov
Prophylactic Liquid Paracetamol (PLP)	Other	Phase PHASE2	Meningococcal Vaccine	ClinicalTrials.gov
Bexsero	Other	Phase PHASE2	Meningococcal Vaccine	ClinicalTrials.gov
Bivalent rLP2086 (120-µg Dose)	Other	Phase PHASE2	Meningococcal Vaccine	ClinicalTrials.gov
Bivalent rLP2086 (60-µg Dose)	Other	Phase PHASE2	Meningococcal Vaccine	ClinicalTrials.gov
Zinforo (ceftaroline fosamil)	Other	Preclinical	Community Acquired Pneumonia	ClinicalTrials.gov
Part B: Multiple-dose Ceftazidime-Avibactam, Cohorts 1-3	Other	Phase PHASE2	Gram-negative Bacterial Infection	ClinicalTrials.gov
Part A: Single Dose Ceftazidime-Avibactam, Cohorts 1-3	Other	Phase PHASE2	Gram-negative Bacterial Infection	ClinicalTrials.gov
Aromatase inhibitor	Other	Preclinical	Metastatic Breast Cancer	ClinicalTrials.gov
Palbociclib + aromatase inhibitor	Other	Preclinical	Metastatic Breast Cancer	ClinicalTrials.gov
Following the planned interim analysis for this study: Avelumab	Other	Phase PHASE3	Urothelial Cancer	ClinicalTrials.gov
Nirmatrelvir/Ritonavir	Other	Preclinical	COVID-19 Drug Treatment	ClinicalTrials.gov
Ritonavir + Dabigatran	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-07321332/ritonavir + Dabigatran	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Lortlatinib	Other	Preclinical	ALK-positive Non-small-cell Lung Cancer	ClinicalTrials.gov
Single dose of PF-07104091 as Tablet Formulation C (Treatment E)	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
Single dose of PF-07104091 as Tablet Formulation D (Treatment D)	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
Single dose of PF-07104091 as Tablet Formulation C (Treatment C)	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
Single dose of PF-07104091 as Tablet Formulation B (Treatment B)	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
Single dose of PF-07104091 as Tablet Formulation A (Treatment A)	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
IV pantoprazole	Other	Phase PHASE4	Gastroesophageal Reflux Disease	ClinicalTrials.gov
PF-07263689	Other	Phase PHASE1	Renal Cell Cancer	ClinicalTrials.gov
PCV15	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Candidate Control	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Candidate-6	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Candidate-5	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Candidate-4	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Candidate-3	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Candidate-2	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Candidate-1	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
PF-04360365 7.5 mg/kg	Other	Phase PHASE2	Alzheimer's Disease	ClinicalTrials.gov
Bisphosphonate	Other	Preclinical	Osteoporosis, Postmenopausal	ClinicalTrials.gov
Avelumab first-line maintenance	Other	Preclinical	Urinary Bladder Neoplasms	ClinicalTrials.gov
trans arterial chemoembolization	Other	Phase PHASE1	Colorectal Neoplasms Malignant	ClinicalTrials.gov
Hydroxychloroquine Pill	Other	Phase PHASE1	Colorectal Neoplasms Malignant	ClinicalTrials.gov
Axitinib 5 MG	Other	Phase PHASE1	Colorectal Neoplasms Malignant	ClinicalTrials.gov
Voxelotor Only Product in Oral Dose Form	Other	Phase PHASE3	Sickle Cell Disease	ClinicalTrials.gov
Nirmatrelvir/ ritonavir	Other	Phase PHASE1	Biological Availability	ClinicalTrials.gov
PF-06882961 20 mg	Other	Phase PHASE1	Diabetes Mellitus, Type 2	ClinicalTrials.gov
PF-07901800 (TTI-621) plus Nivolumab	Other	Phase PHASE1	Hematologic Malignancies	ClinicalTrials.gov
PF-07901800 (TTI-621) plus Rituximab	Other	Phase PHASE1	Hematologic Malignancies	ClinicalTrials.gov
PF-0791800 (TTI-621)	Other	Phase PHASE1	Hematologic Malignancies	ClinicalTrials.gov
200 mg RV521/78 µCi [ 14C]-RV521.	Other	Phase PHASE1	Respiratory Syncytial Virus Infections	ClinicalTrials.gov
Visual acuity test	Other	Preclinical	Acromegaly	ClinicalTrials.gov
Nerve conduction test	Other	Preclinical	Acromegaly	ClinicalTrials.gov
Stabilometry	Other	Preclinical	Acromegaly	ClinicalTrials.gov
Timed up-and-go test	Other	Preclinical	Acromegaly	ClinicalTrials.gov
Hand grip and leg extension strength	Other	Preclinical	Acromegaly	ClinicalTrials.gov
Bone microindentation	Other	Preclinical	Acromegaly	ClinicalTrials.gov
DXA scan	Other	Preclinical	Acromegaly	ClinicalTrials.gov
Assessment of body composition, bone mineral density and bone marrow adiposity.	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
Tafamidis free acid tablet (Reference)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tafamidis free acid tablet (Test)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tetanus, diphtheria, and acellular pertussis vaccine	Other	Phase PHASE2	Group B Streptococcus Infections	ClinicalTrials.gov
Omeprazole	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Tafamidis meglumine capsule (Reference)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07242813	Other	Phase PHASE1	Atopic Dermatitis	ClinicalTrials.gov
Tacrolimus, Myfortic and Sirolimus	Other	Phase PHASE4	Living Donor Kidney Transplants Patients	ClinicalTrials.gov
subcutaneous placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Intravenous placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07264660 subcutaneous multiple ascending dose	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07264660 intravenous single ascending dose	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Palbociclib + an aromatase inhibitor	Other	Preclinical	Metastatic Breast Cancer	ClinicalTrials.gov
Sham phototherapy	Drug	Phase PHASE2	Vitiligo	ClinicalTrials.gov
NBUVB phototherapy	Drug	Phase PHASE2	Vitiligo	ClinicalTrials.gov
PF-07038124 0.01% topical ointment	Other	Phase PHASE2	Vitiligo	ClinicalTrials.gov
Crisaborole 2 % Topical Ointment	Other	Phase PHASE2	Vitiligo	ClinicalTrials.gov
PF-07940367	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Zavicefta Treatment	Drug	Preclinical	Infection	ClinicalTrials.gov
Tafamidis 61 mg free acid capsule (Reference)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tafamidis 70 mg free acid tablet (Test 1)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tafamidis 61 mg free acid tablet (Test 1)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06952229	Other	Phase PHASE1	Breast Neoplasms	ClinicalTrials.gov
Axicabtagene Ciloleucel	Other	Phase PHASE1	Relapsed/Refractory Large B-cell Lymphoma	ClinicalTrials.gov
ILV-095 300 mg in a 4 to 1 ratio	Other	Phase PHASE1	Plaque Psoriasis	ClinicalTrials.gov
PF-06755347 subcutaneous ITP	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo subcutaneous healthy participant	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06755347 subcutaneous healthy participant	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo intravenous healthy participant	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06755347 intravenous healthy participant	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Collection of blood and bronchoalveolar samples to study Pharmacokinetics of ceftazidime/avibactam, meropenem/varbobactam, ceftolozane/tazobactam, or cefiderocol	Other	Preclinical	Acute Respiratory Distress Syndrome	ClinicalTrials.gov
Prazosin HCl 5 mg	Other	Phase PHASE1	Hypertension	ClinicalTrials.gov
Prazosin HCl 1 mg	Other	Phase PHASE1	Hypertension	ClinicalTrials.gov
Prazosin HCl 2mg	Other	Phase PHASE1	Hypertension	ClinicalTrials.gov
CMC-544 (Inotuzumab Ozogamycin)	Other	Phase PHASE2	Acute Lymphoblastic Leukemia	ClinicalTrials.gov
Drug: PF-07923568	Drug	Phase PHASE1	Renal Impairment	ClinicalTrials.gov
Scintigraphy	Other	Approved	Transthyretin Amyloid Cardiomyopathy	ClinicalTrials.gov
Aquaphor	Other	Phase PHASE4	Atopic Dermatitis	ClinicalTrials.gov
Triamcinolone ointment	Other	Phase PHASE4	Atopic Dermatitis	ClinicalTrials.gov
Hydrocortisone Ointment	Other	Phase PHASE4	Atopic Dermatitis	ClinicalTrials.gov
Health education for cadre (communicated project)	Other	Approved	Metastatic Breast Cancer	ClinicalTrials.gov
Standard dose multivalent pneumococcal conjugate vaccine control	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Low dose of multivalent pneumococcal conjugate vaccine control	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Low dose multivalent pneumococcal conjugate vaccine formulation B	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
Low dose multivalent pneumococcal conjugate vaccine formulation A	Other	Phase PHASE1	Pneumococcal Disease	ClinicalTrials.gov
PF-07209960	Other	Phase PHASE1	Non-small-cell Lung Cancer	ClinicalTrials.gov
CMP-001	Other	Phase PHASE1	Advanced Cancer	ClinicalTrials.gov
IV [14C]PF-06865571	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Oral PF-06865571	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Oral [14C]PF-06865571	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Rybelsus	Other	Phase PHASE2	Diabetes Mellitus	ClinicalTrials.gov
PF-07054894 or placebo	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Formulation B (PF-07081532 80 mg)	Other	Phase PHASE1	Overweight	ClinicalTrials.gov
Formulation A (PF-07081532 20 mg plus 60 mg)	Other	Phase PHASE1	Overweight	ClinicalTrials.gov
Voxelotor Oral Tablet	Other	Phase PHASE4	Sickle Cell Disease	ClinicalTrials.gov
SBRT	Other	Phase PHASE1	Early Stage Non-Small Cell Lung Cancer	ClinicalTrials.gov
PF-06881894 by prefilled syringe	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-06881894 by on-body injector	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
IFN-β inhibitor treatment	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
Levonorgestrel & Ethinyl Estradiol	Other	Phase PHASE1	Healthy Adults	ClinicalTrials.gov
Palbociclib + Letrozole	Other	Preclinical	Metastatic Breast Cancer	ClinicalTrials.gov
PF-06936308	Other	Phase PHASE1	Non-Small Cell Lung Cancer	ClinicalTrials.gov
Quadrivalent Influenza Vaccine	Other	Preclinical	Influenza, Human	ClinicalTrials.gov
Comirnaty	Other	Preclinical	Influenza, Human	ClinicalTrials.gov
PF-07321332 (nirmatrelvir)/ritonavir	Other	Phase PHASE1	COVID-19	ClinicalTrials.gov
PF-07321332 Dose 4 or Placebo (Fed)	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-07321332 Dose 5	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-07321332 Dose 4	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-07321332 Dose 3	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-07321332 Dose 2	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-07321332 Dose 1	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Best Available Treatment	Drug	Phase PHASE4	Urinary Tract Infection	ClinicalTrials.gov
Zavicefta, Ceftazidime-Avibactam	Other	Phase PHASE4	Urinary Tract Infection	ClinicalTrials.gov
Brentuximab vedotin	Other	Phase PHASE2	Diffuse Cutaneous Systemic Sclerosis	ClinicalTrials.gov
Pegylated Liposomal Doxorubicin (PLD)	Other	Phase PHASE1	Ovarian Cancer	ClinicalTrials.gov
maplirpacept (PF-07901801)	Other	Phase PHASE1	Ovarian Cancer	ClinicalTrials.gov
COL	Other	Phase PHASE3	Complicated Intra-abdominal Infection	ClinicalTrials.gov
MER	Other	Phase PHASE3	Complicated Intra-abdominal Infection	ClinicalTrials.gov
MTZ	Other	Phase PHASE3	Complicated Intra-abdominal Infection	ClinicalTrials.gov
Etrasimod Mini Tab in applesauce	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Etrasimod Mini Tab in yogurt	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Etrasimod Mini Tab in chocolate pudding	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Etrasimod Mini Tab in water	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Estraimod Immediate Release (IR)	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
mitoxantrone + etoposide + gemtuzumab ozogamicin	Other	Phase PHASE2	Acute Myeloid Leukemia	ClinicalTrials.gov
Infliximab [infliximab biosimilar 3]	Other	Preclinical	Crohn's Disease	ClinicalTrials.gov
entrectinib	Other	Preclinical	Non-Small Cell Lung Cancer	ClinicalTrials.gov
osimertinib	Other	Preclinical	Non-Small Cell Lung Cancer	ClinicalTrials.gov
afatinib	Other	Preclinical	Non-Small Cell Lung Cancer	ClinicalTrials.gov
In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio	Drug	Phase PHASE3	Arthritis Juvenile Idiopathic	ClinicalTrials.gov
In open-label phase: treatment with tofacitinib	Drug	Phase PHASE3	Arthritis Juvenile Idiopathic	ClinicalTrials.gov
Saliva collection	Other	Preclinical	Community Acquired Pneumonia (CAP)	ClinicalTrials.gov
PF-07976016 Formulation B	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
PF-07976016 Formulation A	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Brief smoking cessation counseling	Other	Phase PHASE3	Tobacco Smoking	ClinicalTrials.gov
Carbon Monoxide (CO) Level Test	Other	Phase EARLY_PHASE1	Smoking Cessation	ClinicalTrials.gov
Tobacco Treatment Program	Drug	Phase EARLY_PHASE1	Smoking Cessation	ClinicalTrials.gov
Anti-Smoking Drug	Drug	Phase EARLY_PHASE1	Smoking Cessation	ClinicalTrials.gov
Nicotine Patch	Other	Phase EARLY_PHASE1	Smoking Cessation	ClinicalTrials.gov
Pharmacotherapy Discussion	Drug	Phase EARLY_PHASE1	Smoking Cessation	ClinicalTrials.gov
Quitline	Other	Phase EARLY_PHASE1	Smoking Cessation	ClinicalTrials.gov
Cessation Counseling	Other	Phase EARLY_PHASE1	Smoking Cessation	ClinicalTrials.gov
Shared Decision Making + Video	Other	Phase EARLY_PHASE1	Smoking Cessation	ClinicalTrials.gov
Low Dose Computed Tomography Scan	Other	Phase EARLY_PHASE1	Smoking Cessation	ClinicalTrials.gov
Radical Cystectomy + pelvic lymph node dissection + urinary diversion	Other	Phase PHASE2	Urothelial Carcinoma Bladder	ClinicalTrials.gov
Etaneracept Smartclic	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
TUKYSA®	Other	Preclinical	HER2-positive Breast Cancer	ClinicalTrials.gov
Panoramic Bracelet and GENEActiv	Other	Preclinical	Child, Preschool	ClinicalTrials.gov
COHORT A: Actigraph	Other	Preclinical	Child, Preschool	ClinicalTrials.gov
Placebo comparator dosing	Other	Phase PHASE4	Migraine	ClinicalTrials.gov
Rimegepant 75mg every other day dosing	Other	Phase PHASE4	Migraine	ClinicalTrials.gov
Rimegepant 75mg daily dosing	Other	Phase PHASE4	Migraine	ClinicalTrials.gov
SBRT standard of care radiotherapy treatment	Drug	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Relugolix 120 MG [Orgovyx]	Other	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
PF-06939926	Other	Phase PHASE3	Duchenne Muscular Dystrophy	ClinicalTrials.gov
Osivelotor	Other	Phase PHASE2	Sickle Cell Disease	ClinicalTrials.gov
Combination 2	Other	Phase PHASE1	Carcinoma, Renal Cell	ClinicalTrials.gov
Combination 1	Other	Phase PHASE1	Carcinoma, Renal Cell	ClinicalTrials.gov
PF-08046037	Other	Phase PHASE1	Carcinoma, Non Small Cell Lung	ClinicalTrials.gov
PF-07832837	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
SEA-CD70	Other	Phase PHASE1	Myelodysplastic Syndrome	ClinicalTrials.gov
PF-08032562	Other	Phase PHASE1	Advanced Breast Cancer	ClinicalTrials.gov
Combination product: Trastuzumab + Pertuzumab	Other	Phase PHASE3	HER2 Positive Breast Cancer	ClinicalTrials.gov
Pertuzumab	Other	Phase PHASE3	HER2 Positive Breast Cancer	ClinicalTrials.gov
PF-08046044/SGN-35C	Other	Phase PHASE1	Hodgkin Disease	ClinicalTrials.gov
Self Administered Therapy	Drug	Phase PHASE4	Tobacco Use Disorder	ClinicalTrials.gov
Directly Observed Therapy	Drug	Phase PHASE4	Tobacco Use Disorder	ClinicalTrials.gov
Short-Term Varenicline	Other	Phase PHASE4	Tobacco Use Disorder	ClinicalTrials.gov
Long-Term Varenicline	Other	Phase PHASE4	Tobacco Use Disorder	ClinicalTrials.gov
Isatuximab	Other	Phase PHASE1	Lymphoma	ClinicalTrials.gov
Anti-CD20 Targeting agent	Other	Phase PHASE1	Lymphoma	ClinicalTrials.gov
PF-06804103 + Palbociclib +Letrozole	Other	Phase PHASE1	Breast Neoplasms	ClinicalTrials.gov
PF-06804103	Other	Phase PHASE1	Breast Neoplasms	ClinicalTrials.gov
Routine Medical Care	Other	Preclinical	Familial Adenomatous Polyposis (FAP)	ClinicalTrials.gov
PF-06700841 45 mg	Other	Phase PHASE2	Systemic Lupus Erythematosus	ClinicalTrials.gov
PF-06700841 30 mg	Other	Phase PHASE2	Systemic Lupus Erythematosus	ClinicalTrials.gov
PF-06700841 15 mg	Other	Phase PHASE2	Systemic Lupus Erythematosus	ClinicalTrials.gov
PF-07817883	Other	Phase PHASE1	COVID-19	ClinicalTrials.gov
sisunatovir	Other	Phase PHASE1	Respiratory Syncytial Viruses	ClinicalTrials.gov
Immuno-oncology (IO)	Other	Preclinical	Renal Cell Carcinoma (RCC)	ClinicalTrials.gov
Tyrosine kinase inhibitor (TKI)	Other	Preclinical	Renal Cell Carcinoma (RCC)	ClinicalTrials.gov
PF-07059013	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Nicotine Replacement Therapy (NRT)	Drug	Phase PHASE4	Nicotine Addiction	ClinicalTrials.gov
Cytisine	Other	Phase PHASE4	Nicotine Addiction	ClinicalTrials.gov
Visit frequency	Other	Approved	Duchenne Muscular Dystrophy	ClinicalTrials.gov
0.0mg placebo Varenicline b.i.d.	Other	Phase PHASE4	Tobacco Dependence	ClinicalTrials.gov
0.5mg Varenicline b.i.d.	Other	Phase PHASE4	Tobacco Dependence	ClinicalTrials.gov
1.0mg Varenicline b.i.d.	Other	Phase PHASE4	Tobacco Dependence	ClinicalTrials.gov
Vaginal estrogen	Other	Approved	Pelvic Organ Prolapse	ClinicalTrials.gov
PF-07202954 Single Dose	Other	Phase PHASE1	Non-Alcoholic Fatty Liver Disease	ClinicalTrials.gov
PF-07202954 Repeat Dose	Other	Phase PHASE1	Non-Alcoholic Fatty Liver Disease	ClinicalTrials.gov
Pharmacist Provision of healthy aging leaflets	Other	Approved	Lower Urinary Tract Symptoms	ClinicalTrials.gov
Pharmacist review of LUTS	Other	Approved	Lower Urinary Tract Symptoms	ClinicalTrials.gov
PF-07976016	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Oral PF-07081532 and IV [14C]PF-07081532	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Oral [14C]PF-07081532	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
RN564	Other	Phase PHASE1	Osteopenia	ClinicalTrials.gov
Talazoparib soft gel capsule	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
TALZENNA capsule	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
modafinil	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
bupropion immediate release (IR)	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Zavegepant 4 x 25mg enteric coated soft gel capsule	Other	Phase PHASE1	Biological Availability	ClinicalTrials.gov
Zavegepant 2 x 100mg immediate release tablets	Other	Phase PHASE1	Biological Availability	ClinicalTrials.gov
Zavegepant 100mg immediate release tablet	Other	Phase PHASE1	Biological Availability	ClinicalTrials.gov
Zavegepant 100mg non-enteric coated soft gel capsule	Other	Phase PHASE1	Biological Availability	ClinicalTrials.gov
Bone-cardiac scintigraphy	Other	Preclinical	Heart Failure	ClinicalTrials.gov
Palbociclib / Chemotherapy (capecitabine, epirubicin, paclitaxel, vinorelbine) / Endocrine therapy (exemestane, fulvestrant, letrozole, tamoxifen)	Drug	Phase PHASE4	Metastatic Breast Cancer	ClinicalTrials.gov
PF-07038124 ointment 0.06%	Other	Phase PHASE2	Atopic Dermatitis	ClinicalTrials.gov
PF-07038124 ointment 0.03%	Other	Phase PHASE2	Atopic Dermatitis	ClinicalTrials.gov
PF-07038124 ointment 0.01%	Other	Phase PHASE2	Atopic Dermatitis	ClinicalTrials.gov
Phenytoin (Vega Baja)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Phenytoin (Ascoli)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Zavegepant 10mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06954522 MR (Formulation 3)	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06954522 MR (Formulation 2)	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06954522 IR (Formulation 1)	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Ritlecitinib 20 mg	Other	Phase PHASE1	Alopecia Areata	ClinicalTrials.gov
PF-06264006	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07612577	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Decision Support System	Other	Approved	Metastatic Breast Cancer	ClinicalTrials.gov
Abrocitinib 100 mg	Other	Phase PHASE3	Atopic Dermatitis	ClinicalTrials.gov
Intra-articular corticosteroid injections	Other	Phase PHASE3	Oligoarthritis, Juvenile	ClinicalTrials.gov
Danuglipron	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc	Drug	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
Tofacitinib (Xeljanz)	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
Placebo PF-06700841	Other	Phase PHASE2	Crohn's Disease	ClinicalTrials.gov
PF-06651600 Placebo	Other	Phase PHASE2	Crohn's Disease	ClinicalTrials.gov
Tumor Tissue	Other	Phase PHASE2	High Grade Glioma	ClinicalTrials.gov
Research Bloods	Other	Phase PHASE2	High Grade Glioma	ClinicalTrials.gov
Talazoparib Tosylate	Other	Phase PHASE1	Recurrent Acute Myeloid Leukemia	ClinicalTrials.gov
Deep Repetitive Transcranial Magnetic Stimulation (Sham)	Other	Approved	Tobacco Use Disorder	ClinicalTrials.gov
Deep Repetitive Transcranial Magnetic Stimulation (Active)	Other	Approved	Tobacco Use Disorder	ClinicalTrials.gov
PF-06882961 (Cohort 3)	Other	Phase PHASE2	Obesity	ClinicalTrials.gov
Placebo (Cohort 3)	Other	Phase PHASE2	Obesity	ClinicalTrials.gov
PF-06882961 (Cohorts 1 and 2)	Other	Phase PHASE2	Obesity	ClinicalTrials.gov
Placebo (Cohorts 1 and 2)	Other	Phase PHASE2	Obesity	ClinicalTrials.gov
Hib	Other	Phase PHASE3	Pneumococcal Infections	ClinicalTrials.gov
PF-07329640	Other	Phase PHASE1	Advanced or Metastatic Solid Tumors	ClinicalTrials.gov
ARRY-380 Once Daily	Other	Phase PHASE1	Brain Metastases From HER2 and Breast Cancer	ClinicalTrials.gov
ARRY-380 Twice Daily Dosage	Other	Phase PHASE1	Brain Metastases From HER2 and Breast Cancer	ClinicalTrials.gov
DC AML Vaccine	Other	Phase PHASE2	Acute Myelogenous Leukemia	ClinicalTrials.gov
Bitrex	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Sinsunatovir	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07259955	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07295324	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Abrocitinib Suspension F6	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Abrocitinib Suspension F5	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Abrocitinib Suspension F4	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Abrocitinib Suspension F3	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Abrocitinib Suspension F2	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Abrocitinib Suspension F1	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Abrocitinib tablet	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Dabigatran etexilate (DE)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07220060 + PF-07104091 combination dose escalation	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
PF-07104091 + PF-07220060 + letrozole dose expansion	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
PF-07104091 + PF-07220060 + fulvestrant dose expansion	Other	Phase PHASE1	Breast Cancer	ClinicalTrials.gov
PF-07293893	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Maplirpacept	Other	Phase PHASE1	Non-Hodgkin Lymphoma	ClinicalTrials.gov
Furosemide	Other	Phase PHASE1	Sickle Cell Disease	ClinicalTrials.gov
Flurbiprofen	Other	Phase PHASE1	Sickle Cell Disease	ClinicalTrials.gov
Repaglinide	Other	Phase PHASE1	Sickle Cell Disease	ClinicalTrials.gov
RSVpreF + qIRV 0.5 mL formulation	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
RSVpreF + qIRV 1.0 mL formulation	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
RSVpreF+qIRV	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Wearable device	Device	Approved	Breast Cancer	ClinicalTrials.gov
None. Observational Study.	Other	Preclinical	Transthyretin Gene Mutations	ClinicalTrials.gov
[89Zr]Zr-crefmirlimab berdoxam	Other	Phase PHASE2	NSCLC	ClinicalTrials.gov
non-ablative radiotherapy	Drug	Phase PHASE2	NSCLC	ClinicalTrials.gov
Duavive 0.45Mg-20Mg Tablet	Other	Phase PHASE1	Menopause	ClinicalTrials.gov
Research blood draws	Other	Approved	Disease Progression	ClinicalTrials.gov
De novo tumor tissue biopsy	Other	Approved	Disease Progression	ClinicalTrials.gov
Placebo/ritonavir	Other	Phase PHASE2	Post-COVID-19 Syndrome	ClinicalTrials.gov
Exposure of venous thromboembolism	Other	Preclinical	Venous Thromboembolism	ClinicalTrials.gov
Vortioxetine	Other	Preclinical	Major Depression	ClinicalTrials.gov
Tianeptine	Other	Preclinical	Major Depression	ClinicalTrials.gov
Duloxetine	Other	Preclinical	Major Depression	ClinicalTrials.gov
Mirtazapine	Other	Preclinical	Major Depression	ClinicalTrials.gov
Ontorpacept (TTI-621)	Other	Phase PHASE2	Leiomyosarcoma	ClinicalTrials.gov
Inclacumab	Other	Phase PHASE3	Sickle Cell Disease	ClinicalTrials.gov
Fulvestrant Injectable Product	Other	Preclinical	Metastatic Breast Cancer	ClinicalTrials.gov
Normal Saline Placebo	Other	Phase PHASE2	Healthy Participants	ClinicalTrials.gov
Bivalent BNT162b2 (original/Omi BA.4/BA.5)	Other	Phase PHASE2	Healthy Participants	ClinicalTrials.gov
Combination [RSVpreF+BNTb162b2]	Other	Phase PHASE2	Healthy Participants	ClinicalTrials.gov
Path Pain	Other	Approved	Pain, Chronic	ClinicalTrials.gov
Growth Hormone Replacement Therapy	Drug	Preclinical	Growth Hormone Deficiency	ClinicalTrials.gov
Tiotropium 5 µg q.d.	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
Tiotropium 2.5 µg b.i.d	Other	Phase PHASE2	Asthma	ClinicalTrials.gov
Antiplatelet Drug	Drug	Phase PHASE4	Ischemic Stroke	ClinicalTrials.gov
Oral Anticoagulant	Other	Phase PHASE4	Ischemic Stroke	ClinicalTrials.gov
Machine learning algorithm	Other	Preclinical	ATTR-CM	ClinicalTrials.gov
PF-07853578	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-06939999 in combination with docetaxel	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
PF-06939999 monotherapy	Drug	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
PF-06939999 dose escalation	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
Semaglutide	Other	Phase PHASE1	Obesity	ClinicalTrials.gov
Exposure of skin cancer of interest	Other	Preclinical	Vitiligo	ClinicalTrials.gov
Topotecan	Other	Phase PHASE2	Ewing Sarcoma	ClinicalTrials.gov
Anti-VEGF	Other	Phase PHASE1	Gastrointestinal Tumors	ClinicalTrials.gov
Anti-PD1	Other	Phase PHASE1	Gastrointestinal Tumors	ClinicalTrials.gov
PF-07062119	Other	Phase PHASE1	Gastrointestinal Tumors	ClinicalTrials.gov
IV [14C] PF-06821497	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Oral PF-06821497	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Oral [14C] PF-06821497	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Belinostat	Other	Phase PHASE1	Metastatic Breast Cancer	ClinicalTrials.gov
Drug: PF-07817883	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
Whole-body & CZT bone tracer imaging (SPECT)	Other	Approved	Amyloidosis Transthyretin	ClinicalTrials.gov
carbamazepine ER	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Vyndaqel	Other	Preclinical	Transthyretin Familial Amyloid Polyneuropathy	ClinicalTrials.gov
Enco+bini	Other	Preclinical	Metastatic Melanoma	ClinicalTrials.gov
Anti-Beta Interferon (PF-06823859)	Other	Phase PHASE2	Dermatomyositis	ClinicalTrials.gov
PF04518600	Other	Phase PHASE1	Follicular Lymphoma	ClinicalTrials.gov
dacomitnib	Other	Preclinical	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
sunitinib and capecitabine	Other	Phase PHASE2	Metastatic Colorectal Cancer	ClinicalTrials.gov
Concomitant coaching	Other	Phase PHASE3	Renal Cell Carcinoma, Metastatic	ClinicalTrials.gov
Rimegepant 75mg Orally Disintegrating Tablets (ODT)	Other	Phase PHASE3	Acute Migraine	ClinicalTrials.gov
LDAC	Other	Phase PHASE1	Acute Myeloid Leukemia	ClinicalTrials.gov
Advanced therapy only without dietary intervention	Drug	Phase PHASE3	Ulcerative Colitis	ClinicalTrials.gov
A plant based high fiber diet that mimics fasting ("FMD") plus advanced therapy	Drug	Phase PHASE3	Ulcerative Colitis	ClinicalTrials.gov
RSVpreF 60 µg	Other	Phase PHASE1	RESPIRATORY SYNCYTIAL VIRUS (RSV)	ClinicalTrials.gov
RSVpreF 120 µg	Other	Phase PHASE1	RESPIRATORY SYNCYTIAL VIRUS (RSV)	ClinicalTrials.gov
Trametinib	Other	Preclinical	Melanoma	ClinicalTrials.gov
Dabrafenib	Other	Preclinical	Melanoma	ClinicalTrials.gov
Cobimetinib	Other	Preclinical	Melanoma	ClinicalTrials.gov
Vemurafenib	Other	Preclinical	Melanoma	ClinicalTrials.gov
Rimegepant 75 MG	Other	Phase PHASE3	Migraine	ClinicalTrials.gov
Rimegepant 25 MG	Other	Phase PHASE3	Migraine	ClinicalTrials.gov
Standard endocrine therapy	Drug	Phase PHASE3	Breast Cancer Recurrent	ClinicalTrials.gov
HCQ	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Use of "MAGHD App/MAGHD Framework"	Other	Approved	Growth Hormone Deficiency	ClinicalTrials.gov
PF-06863135 + pomalidomide	Other	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
PF-06863135 + lenalidomide	Other	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
PF-06863135 + dexamethasone	Other	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
PF-06863135 monotherapy IV or SC	Drug	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
Zirabev	Other	Preclinical	Non-small Cell Lung Cancer	ClinicalTrials.gov
Spironolactone/Hydrochlorothiazide (25 mg/25 mg) film coated tablets from Neolpharma.	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Spironolactone/Hydrochlorothiazide (25 mg/25 mg) film coated tablets from Viatris	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Remote Administration of NSAA	Other	Preclinical	Duchenne Muscular Dystrophy	ClinicalTrials.gov
PF-07923568	Other	Phase PHASE1	Liver Diseases	ClinicalTrials.gov
Etrasimod Immediate Release (IR)	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
PF-07261271	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Combination, Palbociclib + Binimetinib	Other	Phase PHASE1	Triple Negative Breast Cancer	ClinicalTrials.gov
rimegepant 75 mg ODT	Other	Phase PHASE3	Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps	ClinicalTrials.gov
BHV-3500 (zavegepant)	Other	Phase PHASE2	Migraine	ClinicalTrials.gov
Breast Cancer Survivor Education Program	Other	Approved	Breast Cancer	ClinicalTrials.gov
Binimetinib Pill	Other	Phase PHASE2	Non-Small Cell Lung Cancer	ClinicalTrials.gov
TRASTUZUMAB BS	Other	Preclinical	Gastric Cancer	ClinicalTrials.gov
Peripheral blood draw	Other	Phase PHASE2	Head and Neck Squamous Cell Carcinoma	ClinicalTrials.gov
Intensity-Modulated Radiation Therapy	Drug	Phase PHASE2	Head and Neck Squamous Cell Carcinoma	ClinicalTrials.gov
MenACWY Vaccine	Other	Preclinical	Gonorrhea	ClinicalTrials.gov
Trumenba Vaccine	Other	Preclinical	Gonorrhea	ClinicalTrials.gov
Menopausal hormone therapy Intervention Type: Drug	Drug	Preclinical	Menopause	ClinicalTrials.gov
Rabeprazole 20 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Sisunatovir suspension	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Rabeprazole 40 mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Placebo Ointment	Other	Phase PHASE2	Seborrheic Dermatitis	ClinicalTrials.gov
PF-07038124	Other	Phase PHASE2	Seborrheic Dermatitis	ClinicalTrials.gov
Sacituzumab Govitecan	Other	Phase PHASE2	Stage III Breast Cancer	ClinicalTrials.gov
Liposomal Doxorubicin	Other	Phase PHASE2	Stage III Breast Cancer	ClinicalTrials.gov
Anti-OX40 Antibody PF-04518600	Other	Phase PHASE2	Stage III Breast Cancer	ClinicalTrials.gov
External Beam Radiation Therapy	Drug	Phase PHASE1	Cancer	ClinicalTrials.gov
Counseling/Phone Calls	Other	Phase PHASE3	Smoking Cessation	ClinicalTrials.gov
B7-H4 IHC	Other	Phase PHASE1	Ovarian Neoplasms	ClinicalTrials.gov
PF-07260437	Other	Phase PHASE1	Ovarian Neoplasms	ClinicalTrials.gov
mPnC control	Other	Phase PHASE2	Healthy Participants	ClinicalTrials.gov
mPnC candidate	Other	Phase PHASE2	Healthy Participants	ClinicalTrials.gov
Quadrivalent influenza modRNA vaccine	Other	Phase PHASE3	Influenza, Human	ClinicalTrials.gov
Selenomethionine (SLM)	Other	Phase PHASE1	Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)	ClinicalTrials.gov
CTB-AVP in Tablet	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Avibactam prodrug	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
Ceftibuten	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07275315	Other	Phase PHASE1	Healthy Volunteers	ClinicalTrials.gov
Tafamidis 61 mg free acid tablet (Test)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06940434	Other	Phase PHASE1	Squamous Cell Carcinoma of the Head and Neck	ClinicalTrials.gov
PF-06954522	Other	Phase PHASE1	Type 2 Diabetes Mellitus (T2DM)	ClinicalTrials.gov
nirmatrelvir, ritonavir	Other	Preclinical	Covid-19	ClinicalTrials.gov
Sirolimus combined with CP, MT and ZA	Other	Phase PHASE1	Solid Tumor	ClinicalTrials.gov
Tozinameran (BNT162b2) / Famtozinameran (BNT162b2 OMI BA.4-5)	Other	Preclinical	COVID-19	ClinicalTrials.gov
Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1)	Other	Preclinical	COVID-19	ClinicalTrials.gov
Tozinameran (BNT162b2)	Other	Preclinical	COVID-19	ClinicalTrials.gov
PF-06821497 Treatment F	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06821497 Treatment E	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06821497 Treatment D	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06821497 Treatment C	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06821497 Treatment B	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-06821497 Treatment A	Drug	Phase PHASE1	Healthy	ClinicalTrials.gov
Xyntha	Other	Phase PHASE3	Hemophilia A	ClinicalTrials.gov
Isauvuconazole group	Other	Preclinical	Aspergillosis	ClinicalTrials.gov
Patients who received Palbociclib as first line therapy in MBC setting	Drug	Preclinical	Metastatic Breast Cancer	ClinicalTrials.gov
CMP 001	Other	Phase PHASE3	Advanced Malignancies	ClinicalTrials.gov
Lorlatanib	Other	Phase PHASE3	Advanced Malignancies	ClinicalTrials.gov
Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab	Drug	Phase PHASE2	Lung Cancer (NSCLC)	ClinicalTrials.gov
Palbociclib in combination with AI	Other	Preclinical	Breast Cancer	ClinicalTrials.gov
ThermaCare heatwrap	Other	Approved	Back Pain	ClinicalTrials.gov
thermal therapy	Drug	Approved	Back Pain	ClinicalTrials.gov
Bicalutamide	Other	Phase PHASE1	Metastatic Breast Cancer (MBC)	ClinicalTrials.gov
Somavert	Other	Preclinical	Acromegaly	ClinicalTrials.gov
Palbociclib + endocrine therapy	Drug	Preclinical	Breast Neoplasms	ClinicalTrials.gov
Placebp	Other	Phase PHASE3	Respiratory Syncytial Virus	ClinicalTrials.gov
COMIRNATY intramuscular injection	Other	Preclinical	SARS-CoV-2	ClinicalTrials.gov
Nonacog Alfa (Genetical Recombination)	Other	Preclinical	Hemophilia B	ClinicalTrials.gov
PF-07941944	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
nirmatrelvir-ritonavir	Other	Preclinical	COVID-19	ClinicalTrials.gov
XBB.1.5-adapted vaccinated	Other	Preclinical	COVID-19	ClinicalTrials.gov
BNT162b2 BA.4/5 bivalent	Other	Preclinical	COVID-19	ClinicalTrials.gov
Primary Exposure Status of Pfizer-BioNTech COVID-19 Vaccine	Other	Preclinical	COVID-19	ClinicalTrials.gov
tocilizumab or sarilumab	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
abatacept	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
tumor necrosis factor inhibitors (TNFi)	Other	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
(18F)Flutemetamol	Other	Phase PHASE1	Cardiomyopathies, Primary	ClinicalTrials.gov
Relugolix	Other	Phase PHASE2	Prostate Cancer	ClinicalTrials.gov
Controls	Other	Preclinical	COVID-19	ClinicalTrials.gov
PF-07940369	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Relugolix (40 mg) /estradiol (1 mg)/norethisterone acetate (0.5 mg) oral tablet	Other	Phase PHASE2	Pelvic Pain	ClinicalTrials.gov
DC/MM Fusion Vaccine	Other	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
GM-CSF	Other	Phase PHASE1	Multiple Myeloma	ClinicalTrials.gov
nirmatrelvir / ritonavir	Other	Preclinical	SARS-CoV-2 Infection	ClinicalTrials.gov
ceftazidime avibactam group	Other	Preclinical	Hospital Acquired Pneumonia	ClinicalTrials.gov
15-valent pneumococcal conjugate vaccine (PCV15)	Other	Phase PHASE2	Pneumococcal Disease	ClinicalTrials.gov
[14C] PF-07976016	Other	Phase PHASE1	Healthy Male Volunteers	ClinicalTrials.gov
Vaccination	Other	Preclinical	SARS-CoV-2	ClinicalTrials.gov
Ulixertinib	Other	Phase PHASE1	Tumor, Solid	ClinicalTrials.gov
Vaccine Acceptance Question	Other	Approved	COVID-19	ClinicalTrials.gov
Vaccine Messaging	Other	Approved	COVID-19	ClinicalTrials.gov
Filgrastim/pegfilgrastim	Other	Phase PHASE1	Neuroblastoma	ClinicalTrials.gov
PF-07820435	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Population Management System	Other	Approved	Arthritis	ClinicalTrials.gov
Mobile Application	Other	Approved	Arthritis	ClinicalTrials.gov
Talazoparib + Avelumab	Other	Phase PHASE2	Urothelial Carcinoma	ClinicalTrials.gov
Multivitamin placebo	Other	Phase PHASE4	Cardiovascular Disease	ClinicalTrials.gov
Cocoa extract placebo	Other	Phase PHASE4	Cardiovascular Disease	ClinicalTrials.gov
Multivitamin	Other	Phase PHASE4	Cardiovascular Disease	ClinicalTrials.gov
Cocoa extract	Other	Phase PHASE4	Cardiovascular Disease	ClinicalTrials.gov
PF-07264660	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
RSVpreF SDV	Other	Phase PHASE3	Respiratory Syncytial Virus (RSV)	ClinicalTrials.gov
RSVpreF MDV	Other	Phase PHASE3	Respiratory Syncytial Virus (RSV)	ClinicalTrials.gov
Screening tool	Other	Preclinical	Screening Tool	ClinicalTrials.gov
RIV	Other	Phase PHASE2	Influenza, Human	ClinicalTrials.gov
BNT162b2 (Omi XBB.1.5)	Other	Phase PHASE2	Influenza, Human	ClinicalTrials.gov
BNT162b2 (Omi XBB.1.5)/RIV	Other	Phase PHASE2	Influenza, Human	ClinicalTrials.gov
Blood sample analysis of patients treated as standard care	Other	Approved	Rheumatoid Arthritis	ClinicalTrials.gov
SB-525 (PF-07055480)	Other	Phase PHASE2	Hemophilia A	ClinicalTrials.gov
PF-06414300	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
NGENLA (Somatrogon)	Other	Preclinical	Growth Hormone Deficiency Without Epiphyseal Closure	ClinicalTrials.gov
Cardiac Imaging	Other	Phase PHASE4	Myocarditis	ClinicalTrials.gov
Avibactam sodium/Ceftazidime hydrate	Other	Preclinical	Infectious Diseases	ClinicalTrials.gov
Vaccine Administration	Other	Preclinical	HIV	ClinicalTrials.gov
fordadistrogene movaparvovec	Other	Phase PHASE3	Duchenne Muscular Dystrophy	ClinicalTrials.gov
Placebo for PF-07314470	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07314470	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07284890	Other	Phase PHASE1	Malignant Melanoma	ClinicalTrials.gov
Weight loss	Other	Approved	Non-alcoholic Fatty Liver Disease	ClinicalTrials.gov
Fulvestrant 50 MG/ML Prefilled Syringe [Faslodex or generic]	Other	Phase PHASE2	Lobular Breast Carcinoma	ClinicalTrials.gov
Crizotinib Oral Capsule [Xalkori]	Other	Phase PHASE2	Lobular Breast Carcinoma	ClinicalTrials.gov
HZ/su VACCINE	Other	Phase PHASE3	Respiratory Syncytial Virus (RSV)	ClinicalTrials.gov
RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE	Other	Phase PHASE3	Respiratory Syncytial Virus (RSV)	ClinicalTrials.gov
Not vaccinated with 2024-2025 formulated COVID-19 vaccine	Other	Preclinical	COVID-19	ClinicalTrials.gov
Pfizer-BioNTech BNT162b2 COVID-19 Vaccinated	Other	Preclinical	COVID-19	ClinicalTrials.gov
Phase II ARRY-614 + nivolumab+ipilimumab (RCC)	Other	Phase PHASE1	Renal Cell Carcinoma	ClinicalTrials.gov
Phase II ARRY-614 + nivolumab+ipilimumab (melanoma)	Other	Phase PHASE1	Renal Cell Carcinoma	ClinicalTrials.gov
Phase II ARRY-614 + nivolumab	Other	Phase PHASE1	Renal Cell Carcinoma	ClinicalTrials.gov
Phase Ib ARRY-614 + nivolumab+ipilimumab	Other	Phase PHASE1	Renal Cell Carcinoma	ClinicalTrials.gov
Phase Ib ARRY-614 + nivolumab	Other	Phase PHASE1	Renal Cell Carcinoma	ClinicalTrials.gov
Standard of Care FVIII Replacement therapy	Drug	Phase PHASE3	Hemophilia B	ClinicalTrials.gov
Standard of Care FIX Replacement therapy	Drug	Phase PHASE3	Hemophilia B	ClinicalTrials.gov
Endocrine Therapy 2	Drug	Phase PHASE1	HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer	ClinicalTrials.gov
Endocrine Therapy 1	Drug	Phase PHASE1	HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer	ClinicalTrials.gov
PF-06873600	Other	Phase PHASE1	HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer	ClinicalTrials.gov
PF-08049820 IR	Other	Phase PHASE1	Atopic Dermatitis	ClinicalTrials.gov
PF-08049820 MR2	Other	Phase PHASE1	Atopic Dermatitis	ClinicalTrials.gov
PF-08049820 MR1	Other	Phase PHASE1	Atopic Dermatitis	ClinicalTrials.gov
Gluten	Other	Phase PHASE2	Celiac Disease	ClinicalTrials.gov
Anti-human thymocyte immunoglobulin, equine	Other	Preclinical	Aplastic Anemia	ClinicalTrials.gov
Talzenna	Other	Preclinical	Breast Neoplasms	ClinicalTrials.gov
Raxtozinameran 6 months to 4 years of age	Other	Preclinical	COVID-19	ClinicalTrials.gov
Raxtozinameran 12 years of age and older	Other	Preclinical	COVID-19	ClinicalTrials.gov
Famtozinameran 5 to 11 Years of age	Other	Preclinical	COVID-19	ClinicalTrials.gov
Famtozinameran 12 Years of age and older	Other	Preclinical	COVID-19	ClinicalTrials.gov
Riltozinameran 12 Years of age and older	Other	Preclinical	COVID-19	ClinicalTrials.gov
Tozinameran 6 months to 4 years of age	Other	Preclinical	COVID-19	ClinicalTrials.gov
Tozinameran 5 to 11 Years of age	Other	Preclinical	COVID-19	ClinicalTrials.gov
Tozinameran 12 Years of age and older	Other	Preclinical	COVID-19	ClinicalTrials.gov
Tafamidis 61 milligrams	Other	Preclinical	Transthyretin Amyloid Cardiomyopathy	ClinicalTrials.gov
Bortezomib for Injection	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Daratumumab and Hyaluronidase-fihj	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Carbamazepine ER Tablet	Other	Phase PHASE1	Healthy Adults	ClinicalTrials.gov
PF-07899895	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Disease description	Other	Preclinical	COVID-19	ClinicalTrials.gov
SoC	Other	Preclinical	COVID-19	ClinicalTrials.gov
Fulvestrant or Tamoxifen or Aromatase Inhibitor	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
atirmociclib (PF-07220060)	Other	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Exposure of mental health condtion of interest	Other	Preclinical	Vitiligo	ClinicalTrials.gov
No treatment	Drug	Preclinical	COVID-19	ClinicalTrials.gov
Patient Post Intervention Survey	Other	Preclinical	Renal Cell Carcinoma Stage IV	ClinicalTrials.gov
European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire	Drug	Preclinical	Renal Cell Carcinoma Stage IV	ClinicalTrials.gov
Weekly Quiz	Other	Preclinical	Renal Cell Carcinoma Stage IV	ClinicalTrials.gov
eHEALS digital literacy test	Other	Preclinical	Renal Cell Carcinoma Stage IV	ClinicalTrials.gov
mHealth Smart Phone Application	Other	Preclinical	Renal Cell Carcinoma Stage IV	ClinicalTrials.gov
Portia (EE and LN) or equivalent oral tablet	Other	Phase PHASE1	Atopic Dermatitis	ClinicalTrials.gov
Dabigatran Etexilate	Other	Phase PHASE1	Atopic Dermatitis	ClinicalTrials.gov
palbociclib plus letrozole	Other	Preclinical	Breast Cancer	ClinicalTrials.gov
Surgery (standard of care)	Procedure	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
PD0332991	Other	Phase PHASE2	Breast Neoplasms	ClinicalTrials.gov
Epinephrine	Other	Phase PHASE4	Cardiac Arrest, Out-Of-Hospital	ClinicalTrials.gov
Tofacitinib 10mg	Other	Phase PHASE3	Glioblastoma	ClinicalTrials.gov
Chronic- PF-06480605 450 mg SC Q4W	Other	Phase PHASE2	Moderate to Severe Ulcerative Colitis	ClinicalTrials.gov
Chronic- PF-06480605 150 mg SC Q4W	Other	Phase PHASE2	Moderate to Severe Ulcerative Colitis	ClinicalTrials.gov
Chronic- PF-06480605 50 mg SC Q4W	Other	Phase PHASE2	Moderate to Severe Ulcerative Colitis	ClinicalTrials.gov
Induction- Placebo SC Q4W	Other	Phase PHASE2	Moderate to Severe Ulcerative Colitis	ClinicalTrials.gov
Induction- PF-06480605 450 mg SC Q4W	Other	Phase PHASE2	Moderate to Severe Ulcerative Colitis	ClinicalTrials.gov
Induction- PF-06480605 150 mg SC Q4W	Other	Phase PHASE2	Moderate to Severe Ulcerative Colitis	ClinicalTrials.gov
Induction- PF-06480605 50 mg SC Q4W	Other	Phase PHASE2	Moderate to Severe Ulcerative Colitis	ClinicalTrials.gov
Prior standard of care receipt of Pfizer's ABRYSVO vaccine	Other	Preclinical	Respiratory Syncytial Viruses	ClinicalTrials.gov
KAN-101	Other	Phase PHASE2	Celiac Disease	ClinicalTrials.gov
PF-07104091	Other	Phase PHASE1	Healthy Adults	ClinicalTrials.gov
Stool sample collection	Other	Preclinical	Ulcerative Colitis	ClinicalTrials.gov
PENBRAYA	Other	Phase PHASE4	Neisseria Meningitidis	ClinicalTrials.gov
Arthritis Self Management Program	Other	Phase PHASE1	Systemic Lupus Erythematosus	ClinicalTrials.gov
patterns of use of combination therapy and monotherapy	Drug	Preclinical	Rheumatoid Arthritis	ClinicalTrials.gov
No OAC	Other	Preclinical	Atrial Fibrillation	ClinicalTrials.gov
Biological examinations performed on blood and BAL	Other	Preclinical	Ventilator Associated Pneumonia	ClinicalTrials.gov
PF-07905428	Other	Phase PHASE1	Acne Vulgaris	ClinicalTrials.gov
Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine	Other	Phase PHASE1	Brain Metastases	ClinicalTrials.gov
Oxbryta® (voxelotor) 500mg Tablets	Other	Preclinical	Sickle Cell Disease	ClinicalTrials.gov
Various	Other	Preclinical	Migraine	ClinicalTrials.gov
Felmetatug Vedotin	Other	Phase PHASE1	Ovarian Neoplasms	ClinicalTrials.gov
SEA-TGT	Other	Phase PHASE1	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
Sasanlimab Prefilled syringe	Other	Phase PHASE1	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
PF-08052666	Other	Phase PHASE1	Carcinoma, Non-Small-Cell Lung	ClinicalTrials.gov
Placebo - Control 2	Other	Phase PHASE3	Migraine	ClinicalTrials.gov
Placebo - Control 1	Other	Phase PHASE3	Migraine	ClinicalTrials.gov
Zavegepant 10 mg	Other	Phase PHASE3	Migraine	ClinicalTrials.gov
Rimegepant for acute migraine treatment	Drug	Preclinical	Migraine	ClinicalTrials.gov
Bretovameran	Other	Preclinical	COVID-19 Vaccination	ClinicalTrials.gov
somatropin - adult cohort	Other	Phase PHASE3	Prader-Willi Syndrome	ClinicalTrials.gov
somatropin - GH treated cohort	Other	Phase PHASE3	Prader-Willi Syndrome	ClinicalTrials.gov
somatropin - GH naïve pediatric cohort	Other	Phase PHASE3	Prader-Willi Syndrome	ClinicalTrials.gov
clonoSEQ	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Elrantamab	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Motor Control Exercises	Other	Approved	Chronic Low-back Pain	ClinicalTrials.gov
Sham rTMS	Other	Approved	Chronic Low-back Pain	ClinicalTrials.gov
Active rTMS	Other	Approved	Chronic Low-back Pain	ClinicalTrials.gov
E coli Vaccine 5 Dose B	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
E coli Vaccine 5 Dose A	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
E coli Vaccine 4 Dose C	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
E coli Vaccine 4 Dose B	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
E coli Vaccine 4 Dose A	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
E coli vaccine 3	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
E coli vaccine 2	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
E coli vaccine 1 Dose B	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
E coli vaccine 1 Dose A	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Triptans	Other	Preclinical	Migraine	ClinicalTrials.gov
Aerobic and resistance exercise	Other	Approved	Androgen Deprivation Therapy	ClinicalTrials.gov
Bacillus Calmette-Guerin	Other	Phase PHASE3	Non-muscle Invasive Bladder Cancer	ClinicalTrials.gov
PF-08046045	Other	Phase PHASE1	Lymphoma, T-Cell, Cutaneous	ClinicalTrials.gov
real word drugs	Drug	Preclinical	Familial Mediterranean Fever (FMF )	ClinicalTrials.gov
Saline Placebo.	Other	Phase PHASE1	Clostridoides Difficile Associated Disease	ClinicalTrials.gov
C. difficile vaccine formulation 3.	Other	Phase PHASE1	Clostridoides Difficile Associated Disease	ClinicalTrials.gov
C. difficile vaccine formulation 2.	Other	Phase PHASE1	Clostridoides Difficile Associated Disease	ClinicalTrials.gov
C. difficile vaccine formulation 1.	Other	Phase PHASE1	Clostridoides Difficile Associated Disease	ClinicalTrials.gov
C. difficile vaccine (previously studied formulation).	Other	Phase PHASE1	Clostridoides Difficile Associated Disease	ClinicalTrials.gov
Ngenla	Other	Preclinical	Pediatric Growth Hormone Deficiency	ClinicalTrials.gov
Diagnostic test on urine samples	Other	Preclinical	Pneumonia	ClinicalTrials.gov
(Part C) Placebo	Other	Phase PHASE1	Obesity and Overweight	ClinicalTrials.gov
(Part C) MET097	Other	Phase PHASE1	Obesity and Overweight	ClinicalTrials.gov
Zavegepant 10 mg IN	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
triptorelin	Other	Preclinical	Metastatic Castration Sensitive Prostate Cancer (mCSPC)	ClinicalTrials.gov
leuprorelin	Other	Preclinical	Metastatic Castration Sensitive Prostate Cancer (mCSPC)	ClinicalTrials.gov
degarelix	Other	Preclinical	Metastatic Castration Sensitive Prostate Cancer (mCSPC)	ClinicalTrials.gov
Lutetium-177	Other	Preclinical	Metastatic Castration Sensitive Prostate Cancer (mCSPC)	ClinicalTrials.gov
Radium-223	Other	Preclinical	Metastatic Castration Sensitive Prostate Cancer (mCSPC)	ClinicalTrials.gov
cabazitaxel	Other	Preclinical	Metastatic Castration Sensitive Prostate Cancer (mCSPC)	ClinicalTrials.gov
apalutamide	Other	Preclinical	Metastatic Castration Sensitive Prostate Cancer (mCSPC)	ClinicalTrials.gov
abiraterone	Other	Preclinical	Metastatic Castration Sensitive Prostate Cancer (mCSPC)	ClinicalTrials.gov
Provider-level and patient-level	Other	Approved	Metastatic Prostate Cancer	ClinicalTrials.gov
Provider-level and patient education at end of study	Other	Approved	Metastatic Prostate Cancer	ClinicalTrials.gov
ABRYSVO Vaccination	Other	Preclinical	Respiratory Syncytial Viruses	ClinicalTrials.gov
Hospital-Based Vaccination Pathway	Other	Preclinical	Chronic Disease	ClinicalTrials.gov
TG4001	Other	Phase PHASE1	HPV-Related Carcinoma	ClinicalTrials.gov
Saliva Test	Other	Phase PHASE4	Tobacco Use Cessation	ClinicalTrials.gov
Lab Session	Other	Phase PHASE4	Tobacco Use Cessation	ClinicalTrials.gov
Counseling Sessions	Other	Phase PHASE4	Tobacco Use Cessation	ClinicalTrials.gov
Vizimpro	Other	Preclinical	Lung Neoplasms	ClinicalTrials.gov
Thioguanine	Other	Phase PHASE2	Acute Lymphoblastic Leukemia	ClinicalTrials.gov
Calaspargase	Other	Phase PHASE2	Acute Lymphoblastic Leukemia	ClinicalTrials.gov
6-Mercaptopurine	Other	Phase PHASE2	Acute Lymphoblastic Leukemia	ClinicalTrials.gov
IT MHA	Other	Phase PHASE2	Acute Lymphoblastic Leukemia	ClinicalTrials.gov
Blinatumomab	Other	Phase PHASE2	Acute Lymphoblastic Leukemia	ClinicalTrials.gov
Inotuzumab	Other	Phase PHASE2	Acute Lymphoblastic Leukemia	ClinicalTrials.gov
Hydrocortisone	Other	Phase PHASE2	Acute Lymphoblastic Leukemia	ClinicalTrials.gov
Adjuvant Epirubicin+ Cyclophosphamide	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Adjuvant palbociclib (if palbociclib given neoadjuvant)	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Adjuvant tamoxifen + goserelin (premenopausal women)	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Adjuvant letrozole (postmenopausal women)	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Adjuvant trastuzumab	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Postoperative radiotherapy breast/chest wall + regional lymph nodes	Drug	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Breast conserving surgery or mastectomy + SNB/axillary dissection	Procedure	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Neoadjuvant cyclophosphamide (after 10 weeks of olaparib alone)	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Neoadjuvant olaparib	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Neoadjuvant docetaxel + cyclophosphamide + trastuzumab + pertuzumab	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Neoadjuvant docetaxel + trastuzumab + pertuzumab	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Neoadjuvant docetaxel	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Neoadjuvant docetaxel + cyclophosphamide	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Neoadjuvant endocrine therapy + palbociclib (if lack of response to endocrine therapy alone)	Drug	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Neoadjuvant letrozole (postmenopausal women)	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
Neoadjuvant tamoxifen + goserelin (premenopausal women)	Other	Phase PHASE2	Breast Cancer	ClinicalTrials.gov
PF-07220060 CDK4 inhibitor	Other	Phase PHASE2	Advanced or Metastatic Breast Cancer	ClinicalTrials.gov
Decision Aid	Other	Approved	Psoriatic Arthritis	ClinicalTrials.gov
Stem cell transplant	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
G-CSF	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Plerixafor	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Melphalan	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
PF-07265028	Other	Phase PHASE1	Advanced Solid Tumors	ClinicalTrials.gov
IV [14C] PF-07248144	Other	Phase PHASE1	Healthy Adult Participants	ClinicalTrials.gov
Oral unlabeled PF-07248144	Other	Phase PHASE1	Healthy Adult Participants	ClinicalTrials.gov
Oral [14C] PF-07248144	Other	Phase PHASE1	Healthy Adult Participants	ClinicalTrials.gov
Trastuzumab (Herceptin)	Other	Phase PHASE2	Metastatic Breast Cancer ( HER2 Negative)	ClinicalTrials.gov
Tucatinib (ONT-380)	Other	Phase PHASE2	Metastatic Breast Cancer ( HER2 Negative)	ClinicalTrials.gov
SOC (anti-PD-1 + platinum -based chemo)	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
PF-07826390	Other	Phase PHASE1	Neoplasms	ClinicalTrials.gov
Licensed influenza vaccine	Other	Phase PHASE1	Grippe	ClinicalTrials.gov
pdmFlu vaccine	Other	Phase PHASE1	Grippe	ClinicalTrials.gov
Brain & Spinal Radiation	Other	Phase PHASE2	HER2-positive Breast Cancer	ClinicalTrials.gov
Tucatinib 150 MG	Other	Phase PHASE2	HER2-positive Breast Cancer	ClinicalTrials.gov
Elranatamab + lenalidomide + dexamethasone	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Elranatamab + Nirogacestat	Other	Phase PHASE2	Multiple Myeloma	ClinicalTrials.gov
Computed Tomography Angiography	Other	Phase PHASE3	Recurrent Prostate Carcinoma	ClinicalTrials.gov
Biospecimen Collection	Other	Phase PHASE3	Recurrent Prostate Carcinoma	ClinicalTrials.gov
tisotumab vedotin	Other	Phase PHASE3	Cervical Cancer	ClinicalTrials.gov
Test formulation (Treatment D)	Drug	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Test formulation (Treatment C)	Drug	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Reference formulation (Treatment B)	Drug	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
Test formulation (Treatment A)	Drug	Phase PHASE1	Healthy Volunteer	ClinicalTrials.gov
PF-07934040	Other	Phase PHASE1	Carcinoma, Pancreatic Ductal	ClinicalTrials.gov
Coronary CT Angiography (CCTA)	Other	Approved	Prostate Cancer	ClinicalTrials.gov
Meningococcal (groups A, C, W-135 and Y [ACWY]) oligosaccharide diphtheria CRM197 conjugate vaccine	Other	Phase PHASE3	Alopecia Areata	ClinicalTrials.gov
Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine	Other	Phase PHASE3	Alopecia Areata	ClinicalTrials.gov
Encorafenib Pill	Other	Phase EARLY_PHASE1	Melanoma Stage III	ClinicalTrials.gov
Trifluridine and Tipiracil Hydrochloride	Other	Phase PHASE1	Advanced Malignant Solid Neoplasm	ClinicalTrials.gov
Whole Brain Radiotherapy	Drug	Phase PHASE1	Leptomeningeal Metastases	ClinicalTrials.gov
Conversational Agent/Chatbot	Other	Approved	Lung Cancer	ClinicalTrials.gov
Talazoparib in Combination with Low Dose Radiotherapy (RT)	Drug	Phase PHASE1	Lung Cancer	ClinicalTrials.gov
Patient Navigation Program	Other	Approved	HER2+ Metastatic Breast Cancer (MBC)	ClinicalTrials.gov
Physical Performance Testing	Other	Phase PHASE2	Prostate Adenocarcinoma	ClinicalTrials.gov
Magnetic Resonance Imaging	Other	Phase PHASE2	Prostate Adenocarcinoma	ClinicalTrials.gov
Contrast Agent	Other	Phase PHASE2	Prostate Adenocarcinoma	ClinicalTrials.gov
Oral PF-07220060	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
IV [14C] PF-07220060	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Oral [14C]PF-07220060	Other	Phase PHASE1	Healthy Participants	ClinicalTrials.gov
Group 4 in Part B and Part C	Other	Phase PHASE1	Celiac Disease	ClinicalTrials.gov
Group 3 in Part B and Part C	Other	Phase PHASE1	Celiac Disease	ClinicalTrials.gov
Group 2 in Part B and Part C	Other	Phase PHASE1	Celiac Disease	ClinicalTrials.gov
Placebo: Group 1 in Part B and Part C	Other	Phase PHASE1	Celiac Disease	ClinicalTrials.gov
Cohort 2 in Part A	Other	Phase PHASE1	Celiac Disease	ClinicalTrials.gov
Cohort 1 in Part A	Other	Phase PHASE1	Celiac Disease	ClinicalTrials.gov
TIVDAK	Other	Phase PHASE4	Cervical Cancer	ClinicalTrials.gov
Pneumococcal 20-valent conjugate vaccine	Other	Preclinical	Pneumococcal Immunization	ClinicalTrials.gov
Lorlatinib post Radiation	Other	Phase EARLY_PHASE1	High Grade Glioma	ClinicalTrials.gov
Lorlatinib with chemotherapy 2	Drug	Phase EARLY_PHASE1	High Grade Glioma	ClinicalTrials.gov
Lorlatinib with chemotherapy1	Drug	Phase EARLY_PHASE1	High Grade Glioma	ClinicalTrials.gov
Pfizer-BioNTech COVID-19 mRNA vaccine	Other	Preclinical	SARS-CoV-2	ClinicalTrials.gov
Xeljanz	Other	Preclinical	Psoriatic Arthritis, Juvenile	ClinicalTrials.gov
Tailored Intervention	Other	Approved	Hematopoietic and Lymphatic System Neoplasm	ClinicalTrials.gov
Patient Navigation	Other	Approved	Hematopoietic and Lymphatic System Neoplasm	ClinicalTrials.gov
Interview	Other	Approved	Hematopoietic and Lymphatic System Neoplasm	ClinicalTrials.gov
Electronic Health Record Review	Other	Approved	Hematopoietic and Lymphatic System Neoplasm	ClinicalTrials.gov
Educational Intervention	Other	Approved	Hematopoietic and Lymphatic System Neoplasm	ClinicalTrials.gov
Discussion	Other	Approved	Hematopoietic and Lymphatic System Neoplasm	ClinicalTrials.gov
Sunitinib Malate + Valproic Acid	Other	Phase PHASE2	Ciliary Body and Choroid Melanoma, Medium/Large Size	ClinicalTrials.gov
Axitinib plus Toripalimab	Other	Phase PHASE3	Renal Cell Carcinoma	ClinicalTrials.gov
Trastuzumab Emtansine (T-DM1)	Other	Phase PHASE2	Brain Metastases	ClinicalTrials.gov
PF-08046031	Other	Phase PHASE1	Malignant Melanoma	ClinicalTrials.gov
Optional Cohort D: Matched placebo	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Optional Cohort D: Ponsegromab high dose	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Optional Cohort C: Matched placebo	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Optional Cohort C: Ponsegromab low dose	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Open-label, PK Cohort (Cohort B): ponsegromab high dose	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Open-label, PK Cohort (Cohort B): ponsegromab medium dose	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Open-label, PK Cohort (Cohort B): ponsegromab low dose	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Main cohort (Cohort A): Matched placebo	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Main cohort (Cohort A): ponsegromab high dose	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Main cohort (Cohort A): Ponsegromab medium dose	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Main cohort (Cohort A): Ponsegromab low dose	Other	Phase PHASE2	Heart Failure	ClinicalTrials.gov
Tafamidis (Test)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Tafamidis (Reference)	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-08065010	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07985631	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
CIBINQO	Other	Preclinical	Atopic Dermatitis	ClinicalTrials.gov
nasopharyngeal sample (optional)	Other	Approved	Nasopharyngeal Carriage	ClinicalTrials.gov
Stools collection or anorectal swab samples (optional)	Other	Approved	Nasopharyngeal Carriage	ClinicalTrials.gov
nasopharyngeal sample (mandatory)	Other	Approved	Nasopharyngeal Carriage	ClinicalTrials.gov
TIV1 or TIV2	Other	Phase PHASE2	Healthy Adults	ClinicalTrials.gov
Vaccine Candidate #6	Other	Phase PHASE2	Healthy Adults	ClinicalTrials.gov
Vaccine Candidate #5	Other	Phase PHASE2	Healthy Adults	ClinicalTrials.gov
Vaccine Candidate #4	Other	Phase PHASE2	Healthy Adults	ClinicalTrials.gov
Vaccine Candidate #3	Other	Phase PHASE2	Healthy Adults	ClinicalTrials.gov
Vaccine Candidate #2	Other	Phase PHASE2	Healthy Adults	ClinicalTrials.gov
Vaccine Candidate #1	Other	Phase PHASE2	Healthy Adults	ClinicalTrials.gov
PF-07999415	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-07915048 Influenza saRNA	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
PF-07914705 Influenza saRNA	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
PF-07871987 Influenza saRNA	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
PF-07867246 Influenza saRNA	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
PF-07836396 Influenza saRNA	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
PF-07836395 Influenza saRNA	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
PF-07836394 Influenza saRNA	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
PF-07836391 Influenza saRNA	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
PF-07852352 Influenza saRNA 1	Other	Phase PHASE1	Influenza, Human	ClinicalTrials.gov
PF-07921585	Other	Phase PHASE1	Non Small Cell Lung Cancer	ClinicalTrials.gov
trastuzumab deruxtecan	Other	Phase PHASE2	HER2 Positive Breast Cancer	ClinicalTrials.gov
Obtaining biological samples	Other	Preclinical	Immune-Mediated Hepatitis	ClinicalTrials.gov
Receipt of PCV20	Other	Preclinical	Pneumonia	ClinicalTrials.gov
Obinutuzumab	Other	Phase PHASE1	Diffuse Large B-Cell Lymphoma	ClinicalTrials.gov
Glofitamab	Other	Phase PHASE1	Diffuse Large B-Cell Lymphoma	ClinicalTrials.gov
Lorviqua	Other	Preclinical	Metastatic ALK+ Non Small Cell Lung Cancer	ClinicalTrials.gov
Tofacitinib XR	Other	Preclinical	Active Moderate to Severe Rheumatoid Arthritis	ClinicalTrials.gov
6-tioguanine+Standard Maintenance Therapy	Drug	Phase PHASE3	Leukemia, Acute Lymphoblastic	ClinicalTrials.gov
Inotuzumab Ozogamicin+Standard Maintenance Therapy	Drug	Phase PHASE3	Leukemia, Acute Lymphoblastic	ClinicalTrials.gov
Omitted Vincristine+Dexamethasone pulses	Other	Phase PHASE3	Leukemia, Acute Lymphoblastic	ClinicalTrials.gov
Omitted Doxorubicin	Other	Phase PHASE3	Leukemia, Acute Lymphoblastic	ClinicalTrials.gov
Vyndamax (tafamidis 61mg)	Other	Preclinical	ATTR-CM (Transthyretin Amyloid Cardiomyopathy)	ClinicalTrials.gov
intra-articular injection of steroid	Other	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
intra-articular injection of etanercept	Other	Phase PHASE3	Rheumatoid Arthritis	ClinicalTrials.gov
PF-08046032	Other	Phase PHASE1	Peripheral T Cell Lymphoma	ClinicalTrials.gov
Ibrance	Other	Preclinical	Advanced or Metastatic Breast Cancer	ClinicalTrials.gov
PF-07850327, ARV-471, vepdegestrant	Other	Phase PHASE2	Locally Advanced or Metastatic ER+ HER2- Breast Cancer	ClinicalTrials.gov
PF-0704091 + Fulvestrant (post CDK4/6)	Other	Phase PHASE2	Small Cell Lung Cancer	ClinicalTrials.gov
PF-07104091 + Fulvestrant (post CDK4/6)	Other	Phase PHASE2	Small Cell Lung Cancer	ClinicalTrials.gov
PF-07104091 monotherapy dose expansion (SCLC)	Drug	Phase PHASE2	Small Cell Lung Cancer	ClinicalTrials.gov
PF-07104091 monotherapy dose expansion (ovarian)	Drug	Phase PHASE2	Small Cell Lung Cancer	ClinicalTrials.gov
PF-07104091 + palbociclib + letrozole	Other	Phase PHASE2	Small Cell Lung Cancer	ClinicalTrials.gov
PF-07104091 + palbociclib + fulvestrant	Other	Phase PHASE2	Small Cell Lung Cancer	ClinicalTrials.gov
PF-07104091 monotherapy dose escalation	Drug	Phase PHASE2	Small Cell Lung Cancer	ClinicalTrials.gov
Ibrutinib	Other	Phase PHASE2	Mantle Cell Lymphoma	ClinicalTrials.gov
IV [14C]PF-07328948	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Oral Unlabeled PF-07328948	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Oral [14C]PF-07328948	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-02921367	Other	Phase PHASE1	Non-muscle Invasive Bladder Cancer	ClinicalTrials.gov
BCG	Other	Phase PHASE1	Non-muscle Invasive Bladder Cancer	ClinicalTrials.gov
PF-08052667	Other	Phase PHASE1	Non-muscle Invasive Bladder Cancer	ClinicalTrials.gov
Docetaxel monotherapy	Drug	Phase PHASE3	Non-small Cell Carcinoma	ClinicalTrials.gov
PF-08046054	Other	Phase PHASE3	Non-small Cell Carcinoma	ClinicalTrials.gov
PF-08046876	Other	Phase PHASE1	Advanced/Metastatic Solid Tumors	ClinicalTrials.gov
Treatment of Encorafenib & Binimetinib & Cetuximab	Drug	Phase PHASE4	Solid Tumors	ClinicalTrials.gov
Treatment of Encorafenib & Binimetinib & Ribociclib	Drug	Phase PHASE4	Solid Tumors	ClinicalTrials.gov
Encorafenib & Binimetinib Treatment	Drug	Phase PHASE4	Solid Tumors	ClinicalTrials.gov
Encorafenib only Treatment	Drug	Phase PHASE4	Solid Tumors	ClinicalTrials.gov
Binimetinib only treatment	Drug	Phase PHASE4	Solid Tumors	ClinicalTrials.gov
PG4 vaccine in Buffer 2	Other	Phase PHASE1	Streptococcus Pneumoniae	ClinicalTrials.gov
PG4 vaccine in Buffer 1 with high dose PA-002	Other	Phase PHASE1	Streptococcus Pneumoniae	ClinicalTrials.gov
PG4 in Buffer 1 with high dose PA-001	Other	Phase PHASE1	Streptococcus Pneumoniae	ClinicalTrials.gov
PG4 in Buffer 1 with low dose PA-002	Other	Phase PHASE1	Streptococcus Pneumoniae	ClinicalTrials.gov
PG4 vaccine in Buffer 1 with low dose PA-001	Other	Phase PHASE1	Streptococcus Pneumoniae	ClinicalTrials.gov
PF-08046049	Other	Phase PHASE1	Cutaneous Melanoma	ClinicalTrials.gov
Genotropin 4mg	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
New Genotropin Injector Pen	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
Marketed Genotropin Pen 12	Other	Phase PHASE1	Healthy	ClinicalTrials.gov
PF-08046033	Other	Phase PHASE1	Non-Small-Cell Lung	ClinicalTrials.gov

💼 Business Developments:

Partnership
Acquisition
Licensing
Regulatory Approval
Executive Changes: Not available

Structured Data:

Company Name: PFIZER INC
Ticker Symbol: PFE

Abiopharma

PFIZER INC (PFE)

📋 PFIZER INC (PFE) - Regulatory Update

Event Details:

🔬 Clinical Development Pipeline (PFIZER INC):

💼 Business Developments:

Structured Data:

Search

News categories

News list

PFIZER INC (PFE)

📋 PFIZER INC (PFE) - Regulatory Update

Event Details:

🔬 Clinical Development Pipeline (PFIZER INC):

💼 Business Developments:

Structured Data:

Search

News categories